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Chapter  1
General background
The genomic integrity of a cell is constantly challenged by environmental and endogenous 
factors. High energy radiation, endogenous free radicals and replication stress are common 
causes of DNA damage that result in a wide variety of lesions that need to be repaired 1. 
Double strand breaks (DSBs) are among the most toxic of possible lesions and faithful repair 
is crucial for cellular survival and protection from disease, in particular from cancer 1,2. Two 
major pathways (and sub-pathways therein) are responsible for the repair of DSBs, homo-
logous recombination (HR), commonly thought of as error-free, and error-prone non-homo-
logous end joining. Repair by homologous recombination mechanisms are preferred in late 
S- and G2-phase where a sister chromatid is present and  gene conversion (GC), one of the 
HR-mechanisms, is the most accurate form of DNA damage repair3.
The balance between the pathways needs to be tightly controlled to maintain genomic sta-
bility and the pathway choice needs to be made with respect to the given situation 3–5.  One 
important factor in initiating DNA repair and determining repair pathway choice are chro-
matin modifications, in particular posttranslational modifications (PTM) of histones 6.
Whereas the  genomic code is inherently static and protected from change, the chromatin 
itself, the complex of histone proteins and DNA,  is inherently dynamic, constantly remode-
led, with the histones acting as molecular signposts to guide and control chromatin biology. 
Histones can get modified by a variety of PTMs such as phosphorylation, acetylation, ubi-
quitination or methylation, among many more, and their functional consequences are just 
as diverse 7. The importance of histone modification in the response to DNA DSBs is well 
established 1,8,9 though the exact molecular details and mechanisms of signaling are not very 
well understood for most of these PTMs. The newly emerging paradigm of crosstalk bet-
ween histone modification, where signals are integrated over several different PTMs, adds 
another layer of complexity to the field 9–11. Site specific ubiquitination of histone H2A has 
in recent years emerged as one of the central PTMs regulating the DNA damage response. 
The molecular determinants for site-specific ubiquitination and deubiquitination of H2A are 
the subject of this thesis.
Ubiquitination
Ubiquitination, the modification of a target protein lysine with ubiquitin, a small 76 amino 
acid protein, is a major regulatory PTM in eukaryotes. Three classes of enzymes are involved 
in protein ubiquitination reactions: ubiquitin activating enzymes (E1), ubiquitin conjugating 
enzymes (E2) and ubiquitin ligases (E3). The E1 activates the ubiquitin C-terminus in an ATP 
dependent step and transfers the activated ubiquitin to its active site cysteine. Ubiquitin is 
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then transferred to the E2 active site cysteine and eventually the E3 catalyzes the isopeptide 
bond formation with the target protein lysine (Figure 1)12. This can lead to monoubiquiti-
nation of a target protein or the formation of ubiquitin chains by conjugating one ubiquitin 
to one of the 7 lysine residues, or the N-terminus, of another ubiquitin. These chains can 
be linkage specific (e.g. only linked via lysine 48 of ubiquitin) or they can consist of mixed 
linkages, they can be free or attached to a target protein13. 
The diversity of possible ubiquitin based signaling entities allows for a great variety of dif-
ferent biological responses directed by this one signaling molecule. Different chain are in-
volved in different cellular processes13. The most prominent example are K48-linked chains 
that are attached to target proteins and mark them for proteasomal degradation. K63-lin-
ked chains are involved in non-proteolytic signaling networks, for example in the DNA da-
mage response. Monoubiquitination of specific lysine residues on different proteins is part 
of many different signaling cascades. The role of H2A monoubiquitination and K63-linked 
chains in the DNA damage response will be discussed in detail in chapter 2.
Specificity in ubiquitin signaling
Given the complexity of the ubiquitin signaling network, ubiquitination reactions need to 
have a certain degree of specificity to make sure only the desired signaling output is achie-
ved and to prevent short-circuiting the cell. Specificity in the conjugation reaction is provi-
ded by the E3 ligases. 
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Figure 1: Overview of the RING E3 ligase ubiquitination system. The E1 transfers activated ubiquitin to the E2 active 
site. The E2 is bound by the E3 to stabilize a conformation prone to aminolysis. At the same time the E3 will specif-
ically bind the target protein to orient the E2 towards the target lysine to allow ubiquitin conjugation to take place. 
Products of this reaction can be ubiquitin chains of different linkage types, monoubiquitinated target proteins or 
target proteins modified with ubiquitin chains. Ubiquitinated substrates can be cleaved by deubiquitinating en-
zymes to regenerate the free ubiquitin pool. 
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E3 ligases
E3 ligases exert a dual function, they select the right target and promote catalysis. There are 
three classes of E3 ligases, HECT, RING between RING (RBR)  and RING E3 ligases. HECT and 
RBR E3 ligases transfer ubiquitin to the target lysine via their active site cysteine, forming 
a thioester intermediate with the C-terminus of ubiquitin. RING E3 ligases lack an active 
site. They exert their function by facilitating the ubiquitin transfer directly from the E2 to 
the target lysine. This is achieved by stabilizing the otherwise flexible14 ubiquitin-charged 
E2 in a certain conformation that renders the active site thioester prone to aminolysis15–17. 
The RING domain of the E3 interacts with a hydrophobic patch on ubiquitin, locking its con-
formation perched against a central alpha helix on the E2. The C-terminal tail of ubiquitin 
is embedded in a channel leading to the E2 active site. This orients and immobilizes the 
thioester linkage in a position in which the target lysine can attack, which leads to increased 
catalytic rates15–18. The E3 mediated conformational selection leads to correct positioning of 
flanking residues with respect to the thioester and the target lysine, including residues that 
are crucial for activity such as aspartic acid 117 and asparagine 77 (in UBE2D3)15,16,19,20.  Apart 
from promoting catalysis the RING E3 interacts with the target protein in order to place the 
E2 active site in close vicinity to the target lysine21,22.
Ubiquitin conjugation catalyzed by RING E3 ligases formally follows a bisubstrate kinetic me-
chanism21 where the charged E2 is one substrate and the target protein the other. Structures 
of E3-E2 complexes have been very informative in establishing the mechanism of thioester 
activation and conformational selection15–17, which seems to be a shared mechanism among 
all RING E3 ligases23. The recognition of target proteins on the other hand is less well under-
stood and mechanisms seem to be more diverse. Target recognition can follow very general 
patterns. San1, for example, is an E3 ligase that recognizes exposed hydrophobic stretches in 
misfolded target proteins via its own disordered domains and marks them for degradation24.
Cullin-RING ligases are more specialized. They recognize their targets through degron mo-
tifs, short sequence motifs that serve as a recognition signal for the E3 which will then ubi-
quitinate target proteins in a defined ‘ubiquitination zone’, marking them for proteasomal 
degradation25–29. Posttranslational modification of the degron is often necessary for recog-
nition by the E3 ligase30–32. The propensity of some E3 ligase to form homo- and hetero-
dimers can extend the range of substrates by employing two degrons for recognition29,33. 
Enzymes of the N-end rule pathway use a ubiquitin recognin- (UBR-) domain to specifically 
bind N-terminal arginine residues34,35.
Other E3s select specific lysine residues on defined target proteins for ubiquitination. 
Through protein-protein interaction with the target protein they orient the E2 active site 
11
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towards the target lysine, thus restricting ubiquitination to one, or a group of, specific lysi-
nes22,36. In chapter 4 of this thesis we show that the target protein itself can play an active 
role in promoting site-specific ubiquitination. The nucleosome, the target of the RING E3 li-
gase RNF168, contributes to the reaction by activating RNF168 catalyzed ubiquitin discharge 
from the E2 to the target lysine through an acidic patch on the nucleosome surface37.
Ubiquitination of nucleosomes, more specifically ubiquitination of histone H2A, is a remar-
kable example of lysine specificity of E3 ligases. Three distinct ubiquitination sites on H2A 
are ubiquitinated specifically by three different E3 ligases. Lysine 118/119 is ubiquitinated 
by RING1B (RNF2) in a PRC1 complex38, lysine 13/15  by RNF16839,40 and lysine 125/127/129 
by BRCA1/BARD141. Ubiquitination of these sites has distinct biological outcomes and a de-
tailed discussion on specific H2A ubiquitination follows in chapter 2. 
A structure of a RING1B/BMI1-E2 fusion construct in complex with a nucleosome core par-
ticle (NCP)22 explains the specificity of RING1B for lysine 119. The E2-E3 complex makes 
contacts with the nucleosomal acidic patch and DNA to orient the E2 active site towards 
K119. These specific E2-E3-target interactions are a common theme in lysine selection in 
the ubiquitin and ubiquitin-like systems. PCNA can be sumoylated on lysine 164. The E3 Siz1 
is responsible for specificity by forcing a complex conformation that only allows K164 to be 
ubiquitinated36. CULLIN1 gets neddylated at lysine 720 by the E3 ligase RBX1. Again specific 
E2-E3-target interaction guides lysine selection. Additionally, the UBL itself contributes by 
interacting with residues on RBX1. These residues act as a ‘pivot’ and ‘lever’ to translate 
UBL-E3 interaction to a conformation of the E2-E3 complex on the target that favors specific 
neddylation of lysine 72042.
Specificity of deubiquitinating enzymes
Ubiquitination can be reversed, or cleaved off, by deubiquitinating enzymes (DUBs). There 
are about 100 DUBs encoded in the human genome43 and all are members of one of six 
families of isopeptidases. Ubiquitin specific protease (USP), Ubiquitin C-terminal hydrolase 
(UCH), Ovarian Tumor protease (OTU), Machado Joseph Disease protease (MJD) and the ne-
wly discovered motif interacting with Ub-containing novel DUB (MINDY)44 family are all fa-
milies of cysteine proteases whereas the Jab1/Mov34/Mpn protease (JAMM) family mem-
bers are metalloproteases. All of these DUB families have evolved to cleave ubiquitinated 
substrates. The USP family is the biggest of these DUB families43. 
USPs are cysteine proteases that cleave isopeptide linkages through a nucleophilic attack on 
the isopeptide bond catalyzed by three, sometimes two, active site residues. The active site 
histidine, coordinated by an aspartate or asparagine residue, lowers the pKa of the catalytic 
12
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cysteine, allowing the nucleophilic attack45.
The degree of lysine-specificity of DUBs varies between families and within the same fa-
mily46. Some DUBs are specific for a certain linkage type of polyubiquitin chains. The mem-
bers of the OTU family show a remarkable variety in their specificity for different linkage ty-
pes, with different family members cleaving certain linkage types exclusively47. Most JAMM 
proteases seem to cleave K63-linked chains48–50. MINDY-1 has been shown to be specific for 
longer K48-linked chains44, which it recognizes via a ubiquitin binding domain51. 
In contrast, USPs show very little linkage specificity48,52,  with the exception of the K63 and 
M1 specific CYLD53–55 . Rather than cleaving chains of a specific linkage type, USPs can cleave 
monoubiquitination and polyubiquitin chains off target proteins and disassemble polyubi-
quitin chains without apparent linkage specificity. Regulation of these DUBs is likely achie-
ved through inter- and intramolecular mechanisms that regulate localization and restrict 
activity56. It should be stressed that studies on linkage specificity so far have only been done 
using di-ubiquitin substrates and these di-ubiquitins do not necessarily resemble the geo-
metry of longer chains. It remains possible that USPs recognize features only conserved in 
longer chains and only retain their linkage selectivity on chains of a certain length.
USPs can be specific for defined monoubiquitination sites on their target proteins. USP1 
cleaves monoubiquitinated PCNA57  and FANCD258. USP22 (Ubp8 in yeast), the DUB module 
of the SAGA complex, deubiquitinates lysine 120 (lysine 123 in yeast) on histone H2B59. The 
structure of the yeast SAGA DUB module, consisting of Ubp8 /Sgf11/Sus1 and Sgf73, in 
complex with the nucleosome has been solved recently60. It shows how defined interactions 
with the acidic patch on the nucleosome aid lysine selection by positioning the DUB towards 
K123. 
Given the exclusive specificity of the E3 ligases acting on H2A it seemed reasonable to as-
sume that there are equally specific DUBs removing ubiquitin from the three different H2A 
ubiquitination sites. USP361, USP1662, USP4463, USP5164, USP1165 and BAP1/ASXL166,67 have 
all been proposed to deubiquitinate H2A. However, none of these enzymes has been shown 
to be exclusively specific for one site. In chapter 3 we test a subset of DUBs for site specificity 
on ubiquitinated H2A. We identify USP48, a previously little studied DUB, to be specific for 
the BRCA1/BARD1 catalyzed ubiquitination of H2A. 
Specific ubiquitination and deubiquitination in cancer 
Due to its diverse role in many different regulatory pathways the ubiquitin system is connec-
ted to a variety of malignancies. With respect to cancer it can regulate both tumor suppres-
sors and oncogenes68. Misregulation of tumor suppressors and oncogenes can lead to sus-
13
1
General  Introduction
tained proliferative signaling, evasion of growth suppressors, the ability to resist cell death 
and genomic instability, processes considered to be among the hallmarks of cancer69. The 
role of the ubiquitin system in cancer development and treatment has been reviewed ex-
tensively elsewhere (e.g.68,70,71). Here we focus on selected examples of oncogenic or tumor 
suppressive mechanisms where specific E3-substrate or DUB-substrate pairs are key to tu-
morigenesis and as such present possible targets for therapeutic intervention. The examples 
discussed are limited to DNA repair and cell cycle regulation.
The anaphase promoting complex/cyclosome (APC/C) and S-phase kinase-associated pro-
tein 1 (SKP1)–CUL1–F-box protein (SCF) complex are multi-protein complexes of the cul-
lin-RING ligase family that utilize substrate adapters to gain specificity. The APC/C regulates 
ordered progression in the cell cycle through ubiquitin mediated degradation of Securin 
(PTTG1), Shugoshin 1 (SGO1) and G2/mitotic-specific cyclin-B1 (Cyclin B). Degradation of Se-
curin and Shugoshin 1 triggers anaphase and  degradation of cyclin B regulates the exit from 
mitosis72,73. A dysfunctional APC/C complex will lead to accumulation of its target proteins, a 
defective cell cycle progression and ultimately genomic instability74,75. On the other hand, a 
prematurely activated APC/C will lead to early degradation of its substrates and premature 
entry into mitosis, which can lead to aneuploidy76. The APC/C furthermore affects genome 
stability via regulation of the DNA damage response through ubiquitinating its substrates 
CtIP (RBBP8)77, Claspin78, USP179 and RAD1780. 
SCF complexes are also implicated in various oncogenic mechanisms.  The SCF complex 
utilizing SKP2 as a substrate adapter (SCFSKP2) ubiquitinates the tumor suppressor p27 and 
marks it for degradation81–83. Several other tumor suppressors have also been identified to 
be SKP2 targets84. By degrading a wide array of tumor suppressors, SCFSKP2 can act as an 
oncogene and SCFSKP2 overexpression promotes tumor growth in different model systems84. 
In combination with a different substrate adapter, FBW7 (FBXW7), the SCF complex marks 
targets for degradation that positively regulate cell cycle progression85 and as such acts as a 
tumor suppressor itself, showing that one E3-ligase (-complex) can have opposing functions 
through altering its specificity. This once again highlights the importance for regulation to 
assure the right proteins are degraded at the right moment. On the other hand it opens 
up opportunities for targeted intervention. Unique interaction of the SCF and APC adaptor 
proteins with their substrates could be exploited to inhibit or enhance degradation of only 
selected targets. 
p53 (TP53) is a tumor suppressor which carries inactivating mutations in about 50 % of 
human cancers86. It is ubiquitinated by the E3 ligase MDM2 with the consequence that p53 
and the ligase itself are targeted for degradation by the proteasome87–91.  Based on this 
mechanism, overexpression or amplification of MDM2 can be a means for cancer cells to 
14
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evade growth regulation92. Given the specificity of the MDM2-p53 interaction, MDM2 is an 
interesting drug target, following the rationale that inhibiting MDM2 driven ubiquitination 
would increase p53 stability and trigger apoptosis in tumor cells. The small molecule inhi-
bitors nutlin-3a and RITA target MDM2-p53 interaction93,94 and nutlin-3a has reached phase 
I/II clinical trials, highlighting the possible opportunities in targeting E3-target interactions. 
Several E3 ligases involved in the DNA damage response are related to cancer development. 
FANCL is a ubiquitin ligase and part of the Fanconi Anemia (FA) core complex95. It site-spe-
cifically monoubiquitinates FANCD2 (on lysine 561) and FANCI (on lysine 523) in response 
to DNA damage96,97. Several mutations in FANCL have been identified as a possible causes 
of FA (see Fanconi Anemia Mutation Database: http://www2.rockefeller.edu/fanconi/), a 
rare disorder that causes defects in the repair of interstrand DNA crosslinks and predisposes 
patients to develop solid tumors and leukemia due to genomic instability95.
Germline mutations in BRCA1, an E3 ligase involved in the DNA damage response, render in-
dividuals susceptible to breast and ovarian cancer. BRCA1 dimerizes with BARD1 through its 
RING domain and ubiquitinates H2A to direct DNA repair pathway choice towards HR98 but 
the importance of the E3 ligase function in tumor development is still a matter of debate11. 
Tumors that are impaired in BRCA1 function are, due to HR defects, exceptionally vulnerable 
to PARP inhibitor treatment and this synthetic lethality is exploited in cancer therapy99.  
A recent study showed that a triple negative breast cancer cell line resistant to proteotoxic 
stress achieved this resistance through upregulation of the E3 ligase RNF168100. A conse-
quence of proteotoxic stress is the depletion of free ubiquitin due to the overload of the 
ubiquitin proteasome system. Ubiquitin will be sequestered on proteins in line for degrada-
tion and will not be available for its other signaling functions, such as regulation of the DNA 
damage response. High levels of RNF168 can compensate, to a certain extent, by compe-
ting for the little available free ubiquitin. As a consequence DNA repair through NHEJ will 
proceed normally in cells with high RNF168 levels despite proteotoxic stress, conferring a 
survival benefit, albeit at the expense of genomic instability100. In the clinic this could be 
exploited in two ways. Patients treated for tumors resistant to proteasome inhibitors might 
benefit from additional targeting of RNF168 which could override the resistance mecha-
nism. On the other hand tumors with high RNF168 levels effectively mimic a BRCA1 deficient 
phenotype, making them potentially vulnerable to PARP inhibition. This is true for at least 
some tumor cell lines100. 
Polycomb group (PcG) proteins are important regulators of gene expression and are often 
involved in tumorigenesis. The PcG proteins RING1B and BMI1 form a heterodimer through 
their RING domains. As such they form one of the possible active E3 ligases in the polycomb 
15
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repressive complex 1 (PRC1). BMI1 was identified as an oncogene functioning together with 
Myc proto-oncogene 101 and is frequently overexpressed in cancer102. PRC1 is a transcrip-
tional repressor that silences gene expression through ubiquitination of H2A at lysine 119. 
Overexpression of components of the PRC1 complex leads to misregulation of several target 
genes and consequently induces a variety of phenotypes promoting tumorogenesis102. 
Different target specific DUBs are also involved in cancer development. BAP1 together with 
ASXL1 forms the PR-DUB complex that deubiquitinates H2A specifically on lysine 11966. 
Germline mutations in BAP1 are related to development of mesotheliomas, uveal melano-
mas and cutaneous melanomas103,104 but to what extent deubiquitination of H2A plays a role 
in these malignancies is not understood105.
As mentioned before, the p53 pathway features heavily in tumorigenesis and different DUBs 
play a role in regulating p53 stability. USP15 deubiquitinates MDM2 and protects it from 
degradation. USP15 overexpression was found in a melanoma and a colorectal cancer cell 
line and prevents apoptosis of these cells by indirectly regulating p53 levels. By stabilizing 
MDM2, the E3 ligase targeting p53 for degradation, USP15 activity keeps p53 levels low, 
thus inhibiting apoptotic signaling106. USP7 targets both MDM2 and p53, which explains the 
curious observation that both, deletion and overexpression of USP7, have a stabilizing effect 
on p53 and promote apoptosis107–109. Overexpression would directly stabilize p53 by deubi-
quitinating it and deletion of USP7 would destabilize MDM2, preventing p53 ubiquitination 
in the first place. The physiological role of this dual function of USP7 is not fully understood. 
By regulating the p53 pathway both DUBs present an interesting drug target.  
USP1, with its activator UAF1, targets monoubiquitination on PCNA to avoid untimely re-
cruitment of the error-prone translesion synthesis polymerase57. It also targets FANCD2 mo-
noubiquitination and regulates inter-strand crosslink repair58. USP1 knockout renders cells 
hypersensitive to cis-platin and Camptothecin110, making USP1 an interesting target in can-
cer therapy. A selective, high affinity inhibitor has been developed for USP1/UAF1111 and has 
been shown to sensitize cells to cisplatin112.   
While lysine specific ubiquitination has a clear role in cancer development, it opens up op-
portunities for targeted intervention at the same time. Drugs aimed at specific ubiquitina-
tion sites can be promising and a full understanding how particular lysines are selected for 
ubiquitination will benefit the development of these drugs. Target sites in ubiquitin ligation 
reaction are selected by the E3 ligases, in deconjugation reactions by the DUBs. As such, 
both classes of enzymes present an interesting drug target to interfere with the ubiquitin 
system in a controlled manner. To understand specificity, interrogation of unique ubiquitina-
tion sites is crucial to identify which E3 ligase will ubiquitinate that particular site and which 
16
1
Chapter  1
DUB will remove the mark. When E3-target and DUB-target pairs are identified the question 
becomes how site specificity is achieved on a molecular level. Solving structures of E3-tar-
get complexes and DUB-target complexes to atomic resolution is essential to understand 
the molecular details of specificity and to identify enzyme-target interaction sites that are 
possibly unique for a certain complex. Once the molecular details are deciphered, informed 
choices can be made on how to interfere with the particular reaction. Unique interaction 
sites of enzyme-substrate complexes are of particular interest because they open up the 
possibility of therapeutic intervention aimed exclusively at this complex, thus minimizing 
off-target effects.
Targeting DNA repair pathways in cancer therapy is promising, as synthetic lethality can be 
exploited, exemplified by the efficiency of PARP inhibitors in a BRCA1-null background. Ge-
nomic instability is a hallmark of cancer and cancer cells often downregulate or shut down 
certain repair pathways, making them more reliable on others to prevent cell death69. Site 
specific ubiquitination guides and regulates several different repair pathways and know-
ledge of the details determining this specificity could open up opportunities for precision 
targeting of a certain repair pathway in a context beneficial for therapy. 
Apart from the clinical relevance this thesis will help to understand basic molecular mecha-
nisms underlying ubiquitination and deubiquitination reactions, especially with respect to 
target specificity of E3 ligases and DUBs and the active involvement of the target in catalysis 
and lysine selection. 
Outline of this thesis
Chapter 2 provides a detailed introduction to specific ubiquitination of histone H2A in the 
DNA damage response with a particular emphasis on crosstalk between different histone 
modifications. It highlights the dynamic nature of histone modifications and propose an 
integrated model of DNA damage response regulation through site specific histone ubiqui-
tination.
In chapter 3 a set of DUBs is probed for specific deubiquitination of the three distinct H2A 
ubiquitination sites. USP48 is identified to be specific for the BRCA1 site and is shown to 
function in the DNA damage response by regulating the extent of BRCA1 induced H2A ubi-
quitination and thereby the extent of DNA end resection
Chapter 4 analyzes the substrates role in an E3 ligase reaction. It shows that RNF168-cata-
lyzed H2A ubiquitination is activated by the substrate itself through an acidic patch on the 
nucleosome surface.
Chapter 5 presents different strategies to stabilize transient E3-target complexes for struc-
tural analysis. A crosslinking strategy and fusion proteins are employed to stabilize the UB-
CH5C-RNF168-NCP complex.
 Chapter 6 closes with a general discussion of the results presented in this thesis and high-
17
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lights the direction for future research.            
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Abstract 
DNA double strand breaks need to be repaired in an organized fashion to preserve genomic 
integrity. In the organization of faithful repair, histone ubiquitination plays a crucial role. Re-
cent findings suggest an integrated model for DNA repair regulation through site-specific his-
tone ubiquitination and crosstalk to other posttranslational modifications. Here we discuss 
how site-specific histone ubiquitination is achieved on a molecular level and how different 
multi-protein complexes work together to integrate different histone ubiquitination states. 
We propose a model where site-specific H2A ubiquitination organizes the spatio-temporal 
recruitment of DNA repair factors which will ultimately contribute to DNA repair pathway 
choice between homologous recombination and non-homologous end joining.  
Introduction
To ensure genomic integrity and prevent diseases such as cancer, DNA double strand breaks 
(DSB) need to be faithfully repaired1. The two major pathways responsible for this repair 
are non-homologous end joining (NHEJ) and homologous recombination (HR). The choice 
between these two depends on the cell cycle phase with pathway choice carefully regulated 
by integrated signaling networks2. 
Histone modifications play an important part in these signaling networks. In response to 
DNA damage, different posttranslational modifications (e.g. methylation, ubiquitination, 
acetylation) form recruitment platforms for downstream effectors, guide the activity of 
chromatin remodelers and modulate enzymatic signaling cascades3. In this way the histone 
modifications act as conductors, orchestrating the appropriate damage response (Figure 1).
This histone signaling network is organized by multi-protein complexes, containing different 
functional modules able to “read”, “write” and “erase” chromatin marks. The modularity 
of these complexes allows for integration of different histone modifications. For instance 
a chromatin modifying complex might read methylated histones through one module and 
erase ubiquitination with another. These modular assemblies allow a great complexity of 
possible signaling events.
Ubiquitination of histone H2A and H2B is one important posttranslational modification in 
the DNA damage response4. H2A and H2B ubiquitination is unusually site-selective. Three 
enzymes or enzyme complexes, RNF168, RING1B(RNF2) in polycomb repressive complex 1 
(PRC1) and BRCA1/BARD1, modify H2A on three distinct sites (K13/K15, K119 and K127/129 
respectively). RNF20/RNF40 specifically modifies K120 on H2B5–9. All four ligases, with the 
possible exception of RNF168, exert their function as parts of bigger multiprotein complexes 
allowing for functional integration through the above mentioned modularity of readers, wri-
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ters and erasers. Several different PRC1 complexes have in fact been identified and subunit 
composition has been shown to have functional importance10.
Ubiquitination of different sites on H2A has distinct physiological consequences. In the DNA 
damage response ubiquitination of H2A by BRCA1/BARD1 is believed to promote HR11 and 
ubiquitination by RNF168 seems to promote NHEJ2,12. Ubiquitination of H2A by PRC1 com-
plexes has a global function in transcriptional silencing13 and it may fulfil the same role lo-
cally around the damage site. H2B ubiquitination in the context of DNA damage is crucial for 
damage checkpoint activation and timely initiation of repair4,12. 
Specific histone ubiquitination forms an integral part of the regulatory network guiding the 
DNA damage response and recent advances help to explain the molecular basis of specifici-
ty and its consequences with respect to repair pathway choice. Those advances also support 
the notion of a form of crosstalk, where specific ubiquitination states at different sites affect 
each other and are affected themselves by different PTMs. In such a model, integration over 
several signaling entities will ultimately decide repair pathway choice.  
H2A13/15ub – RNF168 driven decision making 
The E3 ligase RNF168 catalyzes the formation of two different signaling entities in response 
to double strand breaks, H2A K15 monoubiquitination and K63-linked ubiquitin chains (Figu-
re 2A). Both are strictly dependent on another E3 ligase, RNF8, which is recruited first to the 
damage site, in response to a phosphorylation cascade initiated by ATM. Initially it was pro-
posed that RNF8 acts first as a priming E3 ligase, initiating H2A ubiquitination, which would 
then recruit RNF168 to extend K63-linked chains to recruit other downstream effectors14–16. 
Later it became clear that in fact RNF168 is responsible for the priming event by monou-
biquitinating H2A and RNF8 can extend a monoubiquitination on H2A to form K63-linked 
ubiquitin chains6. Furthermore RNF168 was shown to be exclusively specific for K13/15 on 
H2A and not 1196,17, identifying the first non-canonical H2A ubiquitination site. Recently the 
question how RNF8 manages to recruit RNF168 was solved with the identification of the 
linker histone H1 as its main target18. In our current understanding RNF8 will first ubiqui-
tinate H1, leading to the recruitment of RNF168 which in turn monoubiquitinates H2A at 
lysine 13/15. RNF168 can bind its own product which will lead to increasing concentrations 
of RNF168 at the break site and amplification of H2A monoubiquitination19,20. The priming 
ubiquitination may then get extended by RNF8 to form K63-linked ubiquitin chains which 
are important to recruit downstream effectors, although this step is uncertain as it is only 
seen with RNF168 overexpression6. Under physiological conditions RNF168 concentrations 
are kept at low levels to prevent excessive amplification of its signaling function. TRIP12 and 
UBR5 have been shown to be responsible for this regulation21.
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One downstream factor that is recruited by K63-linked chains is the BRCA1-A complex22. 
The complex consists of RAP80 (UIMC1), Abraxas (FAM175A), MERIT40 (BABAM1), BRCC36 
(BRCC3), BRCC45 (BRE) and BRCA1/BARD1. RAP80 is responsible for recruitment of the 
complex to break sites by interaction with K63-linked ubiquitin chains through its ubiquitin 
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Figure 1: Structure of the nucleosome core particle, indicating discussed modifications and interaction sites hig-
hlighted. Four different E3 ligases play a role in DNA damage response, each modifying a specific site on the nu-
cleosome. In vivo RNF168 ubiquitinates both K13 and K15, but only K15 has so far been shown to have functional 
relevance. The PRC1 E3 ligases modify only K119 in vivo, unless this residue is deleted, when K118 can substitute. 
Proteomics analysis showed that BRCA1/BARD1 can modify K127 and K129, but in vitro K125 is also modified. 
Residue numbers of human histones are mapped to the location on a Xenopus laevis crystal structure that contains 
the tails(PDB code:1KX5123). 
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interacting motif (UIM) motifs. Once recruited the complex is understood to limit DNA end 
resection and protect from hyper-active HR23,24. BRCC36 is a DUB believed to cleave K63-lin-
ked chains and its catalytic activity has been shown to be crucial for limiting end resection25. 
The role of BRCA1 and its catalytic activity in this complex is poorly understood. However, 
the mechanism RNF168 works together with RNF8 to initiate the recruitment of BRCA1 hig-
hlights the possibility of a crosstalk between both pathways. 
RNF168-catalyzed H2A monoubiquitination is understood to affect repair pathway choice 
through recruitment of 53BP1 (TP53BP1) to sites of damage. 53BP1 binds directly and selec-
tively to H2AK15ub, but not H2AK13ub, making 53BP1 one of the first site-specific readers 
of histone monoubiquitination26 (Figure 1). H2AK13ub occurs in cells as well, but has not 
been assigned a specific role yet26,27. The recruitment of 53BP1 is suggested to tip the balan-
ce in favor of NHEJ by inhibiting DNA end resection, the critical first step in HR2,28. This binary 
model is challenged by recent findings that suggest a more dynamic regulation where 53BP1 
is not merely blocking but rather fine-tuning resection length through relative abundance 
at the break site and competition with end resecting enzymes29. 53BP1, once recruited to 
the break site, acts as a scaffold to assemble other proteins that restrict and guide DNA 
end resection30. Recruitment relies on integration of two histone modifications, H2AK15ub 
and lysine 20 dimethylation on histone H4 (H4K20me2). 53BP1 engages with H4K20me2 
through a tandem TUDOR domain31 and with H2AK15ub via a ubiquitin dependent recruit-
ment (UDR) domain C-terminal of the TUDOR domain 26. The presence of both domains is 
necessary for formation of ionizing radiation induced foci (IRIF)26. 
A recent cryo-EM structure of a 53BP1 dimer bound to a nucleosome modified with a dime-
thyl-lysine mimic at H4K20 and a ubiquitin at K15 of H2A shed light on the molecular details 
of this interaction27. It shows how 53BP1 establishes its binding specificity through interacti-
on with both PTMs, the H2B-H4 cleft on the nucleosome and the nucleosomal acidic patch, 
a known binding hotspot for chromatin interacting proteins32–41, making it a prime example 
for multivalent recognition of epigenetically modified chromatin. The structure explains the 
strict binding specificity of 53BP1 for H2AK15ub over H2AK13ub, which is governed by inter-
action of nucleosomal DNA with the N-terminal tail of H2A, and illustrates the importance of 
ubiquitin making specific interaction with the H2B alpha-C Helix for 53BP1 binding27. 
The specifics of these interactions emphasize the possibility of crosstalk with other signaling 
pathways. The nucleosomal acidic patch is a known interaction surface for a number of 
chromatin interacting proteins in addition to 53BP132–41. Use of the same binding platform 
by many chromatin interactors creates a strong competition for access to the acidic patch. 
Relative protein levels, local concentrations and relative affinities will likely play an impor-
tant regulatory function in chromatin biology to decide which protein engages in productive 
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interaction with the nucleosome. The importance of ubiquitin interaction with the alpha-C 
helix of H2B suggests the possibility of crosstalk to other histone PTMs. In close proximity to 
the alpha-C helix tyrosine 119 can get phosphorylated42, and lysine 120 on H2B can get ubi-
quitinated8,9. In principle either of these modifications could interfere with 53BP1 recruit-
ment but only phosphorylation of T119 has been shown to reduce 53BP1 binding, making a 
regulatory histone PTM crosstalk plausible 27. Ubiquitination at K120 does not seem to have 
an effect on 53BP1 recruitment27.
Intriguingly, H4K20me2 has recently been identified as a binding platform for the NuA4/
TIP60 acetyltransferase complex43. TIP60 (histone acetyltransferase KAT5) acetylates the 
histone H4 tail44 and has been proposed to disrupt 53BP1 interaction with the nucleoso-
me, thus inhibiting NHEJ and promoting HR45. Now it has been shown that the Nu4A/TIP60 
complex directly competes for H4K20me2 binding with 53BP143. Interestingly, TIP60 is able 
to acetylate K15 on H2A43. Acetylation of K15 is mutually exclusive with K15 ubiquitination 
responsible for 53BP1 recruitment, further establishing regulation of 53BP1 biology through 
the Nu4A/TIP60 complex and illustrating a complex regulatory network revolving around 
three different H2A PTMs (acetylation, ubiquitination and methylation), and the proteins 
that read and write these PTMs.
As every on-switch is usually opposed by an off-switch it is to be expected that RNF168 de-
pendent histone ubiquitination will be counteracted by equally specific deubiquitinating en-
zymes (DUBs). Among the DUBs reported to potentially deubiquitinate H2A USP51, USP44, 
USP11 and USP3 stand out as likely regulators of the H2AK15ub-centered pathway46–50.
USP3 deubiquitinates H2AK13/15ub as well as H2A119ub in response to DNA damage and 
affects recruitment of 53BP1 in cells19,46. USP3 knockout mice show elevated levels of his-
tone ubiquitination, reduced hematopoetic stem cell reserves over time, defective double 
strand break response and spontaneous tumor development, all phenotypes with possible 
links to RNF168 induced damage response48. However, direct evidence for USP3 counterac-
ting the RNF168 catalyzed DSB response is lacking. 
USP44 was identified in an USP overexpression screen to counteract RNF8/RNF168 depen-
dent 53BP1 recruitment50. Recruitment of USP44 to DNA damage sites was shown to be 
dependent on RNF168 and it was suggested that USP44 binds to and deubiquitinates RNF8/
RNF168 dependent ubiquitination at DSB breaks, though it is not clear if H2A is a direct 
target of USP4450.  
USP51 deubiquitinates H2A specifically at K13/15 in vitro. In cells depletion of USP51 leads 
to a higher sensitivity to ionizing radiation, increased 53BP1 foci formation and slower clea-
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rance of these foci47. USP11 was shown to specifically deubiquitinate H2AX phosphorylated 
at serine 139  (γH2AX)51. Even though site-specificity of the deubiquitination activity was 
not established it was shown that USP11 knockdown affects residence time of 53BP1 at IRIF, 
suggesting a link to the DSB response. The unique specificity for γH2AX is another example 
of PTM crosstalk and it will be interesting to clarify the molecular details underlying this 
specificity.
Two DUBs, USP26 and USP37, have recently been reported to affect BRCA1 signaling, likely 
by affecting RNF168/RNF8 dependent ubiquitination52. Both are recruited to DSBs and their 
knockdown induces HR defects. The authors propose a mechanism where USP26 and USP37 
counterbalance RNF168/RNF8 ubiquitination-dependent sequestering of BRCA1 in the un-
productive RAP80 complex52.  The substrate specificity of USP26 and USP37 still needs to be 
addressed to substantiate such a model. It nevertheless highlights the interconnection of 
the BRCA1 and RNF168 pathways.  
The recent advances in our understanding of the RNF168 dependent DNA damage response 
paint an intricate picture of regulatory switches centered around H2A monoubiquitination 
at lysine 15 and formation of K63-linked chains. It suggests a dual role of RNF168 in repair 
pathway choice: 1. Fine tuning of HR through K63-linked ubiquitin chains and 2. Promoti-
on of NHEJ by H2A monoubiquitination. Both modifications should be viewed as part of a 
bigger signaling network relying on crosstalk between different histone modifications and 
their readers, writers and erasers. Integration over several signals will eventually guide the 
appropriate repair pathway choice and there seems to be substantial crosstalk with the 
BRCA1 pathway. 
H2AK127/129ub – BRCA1 initiated end resection
The tumor suppressor network centered around BRCA1 and its cognate protein complexes 
has long been acknowledged for its importance in cancer development and cancer pre-
disposition and this has been reviewed extensively elsewhere (e.g.:53,54). Here we focus on 
recent findings that advance our understanding of BRCA1 enzymatic function as ubiquitin E3 
ligase and its role in HR (Figure 2B). 
BRCA1 forms a heterodimer with BARD1 through its N-terminal RING domain55 and the 
BRCA1/BARD1 dimer possesses E3 ligase activity56. The target of BRCA1/BARD1 E3 ligase 
activity has recently been identified as lysine 127 and 129 on H2A5 (Figure 1). Specificity for 
this site is already present within the minimal RING/RING dimer5. Ubiquitination at K127/129 
was shown to promote end resection and HR in a SMARCAD1 dependent manner11. This es-
tablished a third distinct ubiquitination site on H2A  that is independent of K13/15 (modified 
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by RNF168) and K119 (modified by RING1B/BMI1 or its PRC1 paralogs) and is suggested to 
be involved in DNA damage response. The exclusive specificity of BRCA1/BARD1 for a site 
just eight residues away from the polycomb site is remarkable and so far mechanistic and 
structural explanations are missing. It has been proposed that the BRCA1/BARD1 dimer en-
gages with the nucleosome in a similar manner to RING1B/BMI137, where the orientation 
towards the target lysine is guided by interaction with the nucleosomal acidic patch and 
flanking residues. The molecular differences that determine the unique specificity of the 
two ligases will need to be worked out.
In the DNA damage response BRCA1/BARD1 can participate in the formation of several mul-
ti-protein complexes that differ in subunit composition and localization with respect to the 
break site24. These BRCA1 complexes can integrate signals from different histone modifica-
tions to orchestrate HR and tip the balance of pathway choice towards HR by fine-tuning 
resection-length and RAD51 recruitment57. It is still unclear to which extent the E3 ligase 
activity of BRCA1/BARD1 itself is involved in this, but the molecular details defining this 
signal integration are starting to become known. 
BRCA1 protein levels peak in close vicinity to the break site and spread up to 10 kilobases 
around it. The already mentioned BRCA1-A complex is formed several kilobases away from 
the break site and complex formation is governed by RAP80 interaction with RNF168/RNF8 
catalyzed K63-linked ubiquitin chains58,59. RAP80 has been shown to also bind to ubiquitina-
ted H2B but the importance of this interaction in the DNA damage response is uncertain60. 
The RAP80 sequestered BRCA1-A complex was shown to restrict rather than promote DNA 
end resection23,58. In direct vicinity to the DSB BRCA1 is recruited through BARD1 interacti-
on with K9-dimethylated histone H3 (H3K9me2) mediated by heterochromatin protein 1 
(HP1) and seems to promote HR through CtIP (RBBP8) interaction in an MRN (RAD50/NBS1/
MRE11)-dependent manner24,61. Recruitment of the BRCA1/CtIP/MRN complex (sometimes 
referred to as BRCA1-C) is dependent on ATM and poly ADP-ribosylation (PARylation) but 
not on RNF168/RNF861. The interaction with K9me2 opens up the possibility of integrating 
methylation signaling and H2A ubiquitination through BRCA1 catalytic activity, though a role 
for BRCA1-dependent ubiquitination activity in this signaling cascade has not yet been es-
tablished.
BRCA1 forms another complex with PALB2, RAD51 and BRCA2 which is understood to fa-
cilitate RPA displacement by RAD51. This function depends on direct interaction of BRCA1 
with PALB262–64. BRCA1-PALB2 interaction is modulated by site-specific ubiquitination of the 
N-terminus of PALB2 by the KEAP1-CUL3-RBX1 E3 ligase complex65. Ubiquitination of PALB2 
is cell cycle dependent and will prevent HR in G1 phase by disrupting BRCA1 interaction 
with ubiquitinated PALB2. This provides an explanation for HR inhibition in G165. Also for this 
35
2
Histone ubiquitination in the DNA damage response
process the role of BRCA1/BARD1 E3 ligase  activity is unclear. 
The presence of three functionally distinct BRCA1 complexes involved in DSB response with 
different effects on end resection stresses the need for mechanistic explanations. Most mi-
croscopy studies do not distinguish between the different BRCA1 complexes and it will be 
interesting to address where, with respect to the break site, BRCA1 engages in which com-
plexes. Of particular interest is what role the E3 ligase activity of BRCA1 might play in the 
context of different complexes. 
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Figure 2: Model of site-specific ubiquitination in the DNA damage response. (A) RNF168 induced H2AK15ub regu-
lates end resection through regulation of relative abundance of 53BP1. Low levels of 53BP1 promote end resection 
and high levels of 53BP1 inhibit end resection. K63-linked chains recruit the BRCA1-A complex distant from the 
break site (B) BRCA1 induced H2AK127ub (and/or H2AK129ub) drives end resection close to the break site, the 
BRCA1-A complex distant from the break inhibits resection. (C) PRC1 and PRC2 establish a H2AK119ub dependent 
transcription barrier distant from the break site.
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Overall the role of H2A ubiquitination by BRCA1/BARD1 in the DNA damage response is 
poorly understood and literature is at times contradicting. Studies on a catalytically inac-
tive BRCA1 mutant (I26A) found no effect on tumor formation in mice66 and in ES cells the 
same mutant had no effect on DNA repair through homologous recombination67. Knock-
down of BRCA1 has been shown to reduce ubiquitination at alpha satellite repeats and in-
duce transcriptional de-repression. The phenotype can be rescued by ectopic expression of 
a H2A-ubiquitin fusion protein, indicating that catalytic activity is important in this context68.
In mice loss of BRCA1 is embryonically lethal and lethality can be rescued by loss of 53BP169,70. 
Mice expressing an E3 ligase deficient BRCA1 mutant (C61G)71 or a RING-less variant72,73 also 
show embryonic lethality, stressing the importance of the RING domain. Conditional tumor 
models of these variants show that they develop sporadic mammary tumors with a similar 
frequency compared to tumor models for BRCA1 loss and tumors show high genomic insta-
bility71,73,74. In cell lines C61G mutant and RING-less BRCA1 variants show partial HR defects 
but still form RAD51 foci71–73,75. 
A recent study suggests a subtle role of BRCA1 catalytic activity in fine tuning DNA end re-
section11. The authors  identified a point mutation in BARD1 (R99E) that abrogates BRCA1 
catalytic activity without destabilizing the BRCA1/BARD1 dimer. Using this mutant it was 
possible to show that BRCA1/BARD1 catalytic activity promotes long range DNA end resec-
tion by facilitating SMARCAD1 dependent displacement of 53BP1 from the center of IRIF 
to the flanking regions. This is in agreement with high resolution microscopy studies that 
placed BRCA1 in the center of IRIF and 53BP1 at the periphery76,77. Initial limited resection 
was shown to be independent of BRCA1 catalytic activity and relying on CtIP and MRE11 
activity11. These findings underline the importance of BRCA1 activity in regulating DNA end 
resection and thereby pathway choice, in line with previous suggestions70,78. 
Many mechanistic details of the BRCA1 dependent DNA damage response are still uncle-
ar but regulation of DNA end resection seems to be one important regulatory function of 
BRCA1. Its catalytic activity, monoubiquitination of H2A, could be one of the factors guiding 
resection length. 
K119ub – Polycomb repression, transcriptional regulation and repair
H2A ubiquitination at K119 was the first histone mark to be identified79. It is deposited by 
the catalytic subunit of some polycomb repressive complexes 1 (PRC1)7. The polycomb re-
pressive complexes 1 and 2 (PRC1/PRC2) are well known regulators of development and 
transcriptional silencing. Both are multi-protein complexes that can be composed of several 
different subunits10 and they exhibit distinct enzymatic activity. PRC1 ubiquitinates H2A at 
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lysine 119 7 and PRC2 catalyzes the methylation of lysine 27 on H3 (H3K27me3)80. Polycomb 
complexes and their biology have been reviewed extensively elsewhere (e.g.13) and it has 
been shown that subunit composition will affect their function10. Here we will focus on the 
recent advances in our understanding of the functional interdependence of PRC1 and PRC2 
as an example for histone PTM crosstalk, the mechanistic details underlying the PRC1 ubi-
quitin ligase activity and emerging roles of PRC1 in the DNA damage response (Figure 2C).
Recruitment of PRC1 and PRC2 has long been thought of as a hierarchical process. Based 
on the observation that some PRC1 complexes recognizes H3K27me3 through their CBX 
proteins, it was proposed that PRC2 first methylates target chromatin which allows PRC1 to 
engage and catalyze H2AK119ub, thus establishing genetic silencing81–83. However, this see-
mingly solid model was basically turned upside down by recent findings that PRC2 recruit-
ment can depend on PRC1 activity84,85. The authors provide evidence that ubiquitination of 
H2A at lysine 119 can be important for recruitment of PRC2 and show that PRC1 will bind 
to unmethylated CpG islands via its KDM2B subunit, switching the hierarchy of recruitment. 
Mechanistic insight into the nature of PRC2 recruitment has been gained by the finding 
that its JARID2 subunit is required for recruitment to H2AK119ub via direct interaction with 
ubiquitinated H2A through its ubiquitin interacting motif (UIM)86. This establishes PRC1 and 
PRC2 as multiprotein chromatin modifying complexes with bivalent function as readers and 
writers of chromatin marks. PRC1 reads H3K27me3 and writes H2AK119ub, PRC2 reads 
H2AK119ub and writes H3k27me3, supporting the notion that multi protein complexes can 
act as one entity providing reader and writer functions to integrate diverse epigenetic sig-
nals. The mechanistic and biological details of this integrative signaling network have yet 
to be worked out. Some progress has been made in our understanding of the basic bioche-
mistry underlying PRC1 catalytic activity and of its biological significance in transcriptional 
regulation and DNA damage response which we will discuss in the following. 
RING1B with a PCGF subunit, such as BMI1 or MEL18 forms the catalytic core of the PRC1 
complex7,87,88, which specifically ubiquitinates K119 on H2A (not K13/15 or K127/1295,6). The 
basis for this specificity has been explained by a crystal structure of the nucleosome core 
particle bound by RING1B/BMI1 fused to its cognate E2, UBCH5C (UBE2D3) 37. The binding 
is primarily governed by RING1B interaction with the nucleosomal acidic patch. Most pro-
minently, R98 of RING1B serves as an anchor and inserts into an acidic pocket provided by 
the H2A-H2B dimer, analogous to other published structures of chromatin binding modu-
les34–36,40. Further interaction of RING1B and BMI1 with all four histone proteins, and impor-
tantly of UBCH5C with the nucleosomal DNA, arrange the complex in the appropriate orien-
tation, placing the active site in a catalytically competent position towards the target lysine 
and restricting its movement to avoid unspecific reaction with other lysines37. Mutational 
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studies suggest a similar mode of interaction for BRCA1/BARD1 even though mechanistic 
details explaining the different specificity are missing 37.
A link between PRC1 catalyzed H2A ubiquitination and the DNA damage response has long 
been suggested89–92 but the underlying mechanisms are not clear. Furthermore, another 
report suggest no recruitment of PRC1 complexes to double strand break sites induced by 
the restriction enzyme ASiSI93 and there is no clear consensus in the field. 
The established function of polycomb group proteins in gene repression and the observation 
of H2A ubiquitination at sites of double strand breaks has prompted the idea that PRC1 and 
PRC2 could be involved in transcriptional silencing in response to DNA damage94. Transcrip-
tion was found to be silenced up to several kilobases away from the DSB site in an ATM and 
H2AK119ub dependent manner94,95. H2A ubiquitination at double strand breaks depends 
on the PBAF chromatin remodeling complex and is important for rapid repair of DNA da-
mage occurring in close proximity to the transcription machinery, likely through promoting 
NHEJ95. Intriguingly, it was found that both, BMI1 and EZH2 (the catalytic subunit of PRC2), 
are required for DSB-induced transcriptional silencing95, hinting at crosstalk of both enzyme 
complexes in response to DNA damage. Further functional insight came through a recent 
study96 which showed that in response to double strand breaks transcriptional elongation 
factor ENL is phosphorylated by ATM. This enables direct interaction with BMI1, leading to 
enhanced ubiquitination of H2A on K119 and resulting in transcriptional silencing, providing 
a functional rationale for ATM dependence of H2A K119 ubiquitination96. The physiologi-
cal role of H2AK119ub in the DNA damage response is not very well understood but one 
possibility is that it shields the break site from intrusion of the transcription machinery by 
establishing a H2AK119ub-dependent barrier of silenced transcription at a defined distance 
from the break site. The involvement of chromatin remodelers like PBAF adds another layer 
of complexity to the regulation of the damage response and it will be interesting to study if 
histone ubiquitination might affect histone eviction and chromatin remodeling. 
The best characterized deubiquitinating enzyme specific for H2AK119ub is the UCH-class 
DUB BAP1 with its activator ASXL1. BAP1/ASXL1 form the PR-DUB complex which has been 
shown deubiquitinate H2A97. In vitro studies showed that the enzyme complex exclusively 
deubiquitinates H2A119ub, not H2AK13/15ub98. BAP1/ASXL1 has two closely related para-
logues, UCHL5/RPN13 and UCHL5/INO80G, for which the molecular mechanisms of acti-
vation have been worked out by detailed structure-function studies99,100. BAP1 is activated 
by ASXL1 in a similar manner where the DEUBAD domain of ASXL1 increases affinity of 
BAP1 for the ubiquitinated substrate98. Additionally, the C-terminal tail of BAP1 is crucial 
for nucleosome binding. This suggests a two-way model to explain activation and specificity 
where BAP1 is tethered to the nucleosome via its C-terminal tail but only engages in produc-
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tive deubiquitination of H2AK119ub after activation by ASXL198. While in vitro specificity of 
BAP1/ASXL1 is well established, the physiological role it plays in DSB response is not as clear 
and deserves further attention. First studies into this subject have shown that BAP1 is recrui-
ted to DSB sites in an ATM dependent manner and counteracts H2AK119ub in the vicinity 
of DNA break sites. Depletion of BAP1 results in a small reduction in HR efficiency101,102. This 
suggests that deubiquitination of H2A by BAP1 promotes HR which is complementary to the 
finding that ubiquitination of K119 in response to DNA damage favors NHEJ95. 
Another DUB suggested to deubiquitinate H2AK119ub is USP16. Biological evidence sug-
gests that USP16 restarts transcription upon H2AK119ub induced silencing by reducing ubi-
quitination levels94, though biochemical confirmation of USP16 target specificity is missing. 
H2B K120 ubiquitination and damage response
Ubiquitination of histone H2B has been implicated in transcriptional elongation103, replicati-
on104 and DNA damage response105–109. We will discuss recent advances in our understanding 
of the molecular mechanisms that guide site-specificity and the involvement of H2BK120ub 
in the damage response. 
H2Bub-dependent signaling in the DNA damage response centers around specific ubiqui-
tination of lysine 120 (123 in yeast) on H2B by RNF20/RNF40 (Bre1 in yeast) working in 
concert with the E2 UBE2B (Rad6 in yeast)8,9. A recent mass spectrometry study highlights 
some details governing specificity, showing that binding of the Bre1/Rad6 complex to the 
nucleosome depends on the nucleosomal acidic patch41. The importance of the acidic patch 
for the ubiquitination reaction was confirmed by mutagenesis and several residues crucial 
for Bre1/Rad6 interaction have been identified. 
Almost simultaneously the crystal structure of the nucleosome complex of the yeast SAGA 
DUB module, the protein complex responsible for removal of H2BK123ub110, was solved38. 
The yeast SAGA DUB module is a multi-protein complex consisting of Ubp8/Sgf11/Sus1/
Sgf73, where the deubiquitination activity is provided by Ubp8 (USP22 in human)38. The 
structure revealed that the SAGA DUB module contacts the nucleosome almost exclusive-
ly through the H2A/H2B dimer via interaction of the Sgf11 zinc finger with the nucleoso-
mal acidic patch. Further contacts are made between Ubp8, H2A and ubiquitin. The fact 
that both writer and eraser complexes engage the nucleosome through the acidic patch 
opens up interesting regulatory possibilities through competition for access amongst each 
other38,41 and with other chromatin binders.
The physiological role of H2B ubiquitination in the response to DNA damage is not very 
well understood. It has been shown that H2B ubiquitination is important for DNA damage 
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checkpoint activation and timely initiation of repair107,109. RNF20/RNF40 dependent H2B mo-
noubiquitination is needed for recruitment of repair factors in an ATM dependent manner 
and is necessary for faithful repair through both pathways, HR and NHEJ107. Knockdown of 
RNF20/40 was shown to not affect formation of γH2AX foci but rather their persistence107. 
A recent study showed that H2B deubiquitination by the SAGA complex is crucial for proper 
DNA repair function, reminiscent of PR-DUB which is important for PRC1 function 97. Deubi-
quitination was shown to act downstream of ATM and to facilitate formation of γH2AX foci 
111. More work in this direction will be needed to work out mechanistic details and explain 
why ubiquitination and deubiquitination seem to have a similar role. 
In yeast, knockout of Bre1 leaves cells unable to activate the DNA damage checkpoint as 
measured by Rad53 phosphorylation112. This checkpoint defect can be rescued by expres-
sion of a H2A construct with a ubiquitin tethered to Serine 1 or 19, a position resembling 
H2BK123ub, suggesting a global function of H2B ubiquitination in the damage response112. 
Another study links H2B ubiquitination to transcription coupled nucleotide excision repair, 
showing rapid deubiquitination of H2B by yeast Ubp8 and Ubp10 upon UV damage and tran-
scriptional stalling113. Furthermore, yeast Ubp8/Ubp10 knockout strains show much slower 
transcription coupled repair kinetics113. 
H2BK120ub exhibits interesting functional crosstalk with DOT1L catalyzed methylation of 
histone H3 on lysine 79114,115 where histone ubiquitination is crucial for efficient methylation 
of H3. Biochemical analysis has shown that ubiquitinated H2B directly stimulates DOT1L ca-
talytic activity116–118 and a recent study has elucidated molecular details of this activation119. 
Based on crosslinking experiments and biochemical validation the authors show specific 
interaction of ubiquitin with the N-terminal tail of H2A but not with DOT1L. The authors pro-
pose a “corralling” mechanism where DOT1L binds to unmodified nucleosomes aspecifically 
and thus will mostly be in a catalytically incompetent position. In presence of H2BK120ub 
DOT1L binding is restricted to the catalytically competent mode, leading to more efficient 
methylation of H3K79119. This model is in agreement with in vivo studies in yeast where the 
exact position of ubiquitin on the nucleosome was not found to be crucial for Dot1 activa-
tion, establishing a certain plasticity in the H2BK120ub-Dot1 crosstalk112. Plasticity of Dot1 
activation was also observed in vitro116. DOT1L has been implicated in the 53BP1 dependent 
DNA damage response in human120 and chicken DT40 cells121 an knockdown of DOT1L in 
mouse embryonic fibroblasts leads to hypersensitivity to UV damage and affects transcrip-
tional restart122. 
Future research needs to establish a clear correlation of repair phenotypes with H2B ubiqui-
tination and elaborate on the mechanistic details that define specificity to clarify the role of 
H2B ubiquitination in the damage response. 
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Closing thoughts – an integrated model for DNA damage signaling through H2A ubiquiti-
nation
Recent advances in our understanding of the mechanisms guiding the DNA damage respon-
se put forward the notion of an integrated signaling network where specific ubiquitination 
of histones at four different sites will contribute to faithful repair by promoting appropriate 
repair pathway choice. This choice is heavily influenced by crosstalk between the four sites 
and to other PTMs.  
Here we reviewed how RNF168 catalyzes H2AK13/15ub, limits resection and tips the ba-
lance in favor of NHEJ via 53BP1 recruitment2,6,14,15,17,29,78 and how BRCA1/BARD1 pulls into 
the opposite direction, ubiquitinating H2AK127/1295 and thus promoting end resection and 
HR57. However, not all BRCA1 complexes act in the same way, as they come in different 
flavors with seemingly opposing function, one promoting resection near the break site24,61 
and one inhibiting it together with RAP80 distant from the break23,58,59. At the fringes of the 
double strand break PRC1 and PRC2 play a game of mutual recruitment81–86 to inhibit tran-
scription and guard faithful repair from the distance94–96. 
Since all these enzyme complexes will likely be recruited to the same break site, the outco-
me will be determined by how, when, where and to what extent they influence each other in 
response to a defined physiological challenge, during a defined moment in the cell cycle and 
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Figure 3: Site-specific H2A ubiquitination defines regulatory zones in the DNA damage response dependent on 
relative abundance of E3 ligases and localization with respect to the DNA break site
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in a particular cell type. The outcome is expected to be different in different situations but 
their enzymatic activity, ubiquitination of the nucleosome, and crosstalk to other histone 
modifications will likely play an important role.
Repair pathway choice seems to be one process that is guided by specific histone ubiqui-
tination and the first crucial step is the tight regulation of resection length. Over-resecti-
on is detrimental and inhibition of resection prevents error-free HR2. We have discussed 
how 53BP1 limits DNA end resection in a H2AK15ub dependent manner26,29 and how BRCA1 
counteracts this by promoting resection through H2A K127 ubiquitination and displacement 
of 53BP111. In the most simple straight forward model (Figure 3) one could assume that 
the extent of either one of these epigenetic marks defines the extent of DNA end resection 
by defining molecular reaction chambers at a defined position with respect to the break, 
through specific recruitment of some factors and selective exclusion of others. BRCA1 ca-
talyzed ubiquitination near the break would initially drive resection until it reaches a thres-
hold area where it is overwhelmed by RNF168-driven K15 ubiquitination. This threshold 
area would be enforced by the presence of K63-linked chains that sequester BRCA1 into 
the RAP80-BRCA1 complex with possible effects on its catalytic activity. The PRC1 complex 
would establish a H2AK119ub dependent boundary at a certain distance from the break site 
to guard against intrusion of the transcription machinery. In this model RNF168 and BRCA1 
would be in constant catalytic competition and tight regulation is expected to fine-tune re-
section length and pathway choice in response to distinct challenges. Regulation can be as 
simple as changes in protein abundance throughout the cell cycle or more elaborate such as 
PTMs that affect catalytic activity and protein stability and  the crosstalk with other histone 
modifications. As we have seen, active remodeling of chromatin around the break site by 
chromatin remodelers such as PBAF is crucial for efficient DNA repair and will add another 
layer of complexity95. 
The proposed model should be viewed as a working hypothesis rather than a scientifically 
sound model as experimental evidence for such a regulatory mechanism is still scarce. Sup-
port for a more dynamic view of the players involved in the damage response comes from 
a recent study that emphasizes the importance of RNF168 dynamic range in regulating DNA 
end resection and proposes that relative protein levels rather than simply the presence or 
absence of major regulators such as 53BP1 are the deciding factor in pathway choice29. In 
the future it will be crucial to look at the precise molecular architecture of a single double 
strand break site. Which protein complexes and PTMs are present at what levels and in what 
distance to the break site? Answering these questions will be imperative in understanding 
the biology of the DNA damage response. Super-resolution fluorescent microscopy and sin-
gle molecule biophysics will help to address these questions. 
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Abstract
BRCA1/BARD1-catalyzed ubiquitination of histone H2A is an important regulator of the DNA 
damage response, priming for repair by homologous recombination. However no specific 
deubiquitinating enzymes (DUBs) are known to antagonize this function. Here we identify 
USP48 as a H2A DUB, specific for the BRCA1 ubiquitination site. Detailed biochemical ana-
lysis shows that an auxiliary ubiquitin modulates USP48 activity, which has possible impli-
cations for its regulation in vivo. We show that USP48 antagonizes BRCA1 E3 ligase function 
in cells. Consequently, in BRCA1-proficient cells, loss of USP48 results in extended resection 
lengths and extended 53BP1 positioning. Moreover USP48 acts to restrain gene conversion 
and single strand annealing and USP48 repression confers a survival benefit to cells trea-
ted with camptothecin. We propose that USP48 promotes genome stability by antagonizing 
BRCA1 E3 ligase function. 
Introduction
To assure genomic integrity and protect against disease such as cancer, DNA double strand 
breaks (DSB) need to be faithfully repaired. The cell can employ two major pathways to 
repair DSB, homologous recombination (HR), commonly thought of as error free, and the 
more error-prone non-homologous end joining (NHEJ). The choice between these two pa-
thways is made at the point of DNA end resection1. Long-range resection is crucial for repair 
through HR and short resection will initiate NHEJ repair.  Specific ubiquitination of H2A by 
BRCA1/BARD1 can act to increase DNA resection lengths2.  
Minimal processing directs repair to non-homologous end-joining (NHEJ), and 5’ end resec-
tion in late S-phase and G2 directs repair to homologous recombination (HR) mechanisms 
including gene conversion (GC), the most accurate, and thus least mutagenic form of DSB 
repair (reviewed in3,4). However extensive resection can result in the use of a sub-pathway 
of HR-repair known as single-strand annealing (SSA). In this process extended resection re-
veals direct repeat sequences around the DNA breaks that can be annealed, followed by flap 
processing to delete the material between the repeats (reviewed in4–6). SSA and GC compete 
for the repair of DSBs in budding yeast7, but since SSA requires extended resection to expose 
direct repeats, limiting DNA end processing is critical to promoting accurate DSB repair. How 
the degree of end resection is controlled is not well understood.
Resection takes place over several defined phases. It begins by the endo- and then exonu-
clease activity of MRE11-CtIP, and is extended by the Exo1 and BLM-DNA2 helicase/endonu-
clease complexes. The extensive ssDNA is bound by RPA, which is either exchanged for the 
recombinase RAD51, required for homology searching, strand invasion and gene conver-
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sion, or the RPA bound sequences are annealed by RAD52 if homologous sequences are 
present in the resected ends4–6.
BRCA1, the breast and ovarian cancer predisposition gene product, and 53BP1, the p53 
binding protein, are opposing regulators to the degree of DNA end resection. In the absence 
of BRCA1, resection is blocked by 53BP1 and its effector proteins, promoting NHEJ and sup-
pressing HR repair (reviewed in8,9). BRCA1 overcomes the 53BP1-mediated block through 
interaction with the resection protein CtIP10 and through its E3 ubiquitin ligase activity2. 
The N-termini of BRCA1 and BARD1 associate and establish an active E3 ubiquitin ligase11,12. 
The role the ligase activity plays in BRCA1 function has been controversial. Studies on the 
catalytically inactive Brca1-I26A mutant in murine cells suggest no effect on DNA repair13,14, 
whereas studies on RING-less Brca1 variants and another ligase deficient point mutant link 
loss of ligase function to genomic instability and defects in homologous recombination15–17,36 
. Synthetic viability of BRCA1 mutants and knock out strains with 53BP1 loss further suggests 
an important role in DNA repair pathway determination17-19 
Recently the target of BRCA1 E3 ligase activity has been identified as a specific group of 
lysines on H2A20, establishing a third specific ubiquitination site on H2A. K13/15 and K119 
on H2A have previously been established as targets of RNF168 and polycomb complexes 1 
(PRC1) respectively21,22. Ubiquitination of H2A by BRCA1 promotes resection and HR-repair 
through the recruitment and activity of the Swr1-like remodeler, SMARCAD1, which repo-
sitions the 53BP1 block and permits resection2. Conversely, in the absence of 53BP1, or its 
recruitment pathway, resection lengths are extended10,23–26 and SSA becomes the dominant 
repair pathway26. 
Deubiquitinating enzymes (DUBs) are able to counteract ubiquitination by cleavage of the 
isopeptide bond between ubiquitin’s C-terminus and the target protein lysine. Several DUBs 
have been suggested to target H2A27–31 but very little is known about their site specificity or 
their role in the different repair pathways. We wanted to investigate whether DUBs that act 
on H2Aub substrates show site specificity and whether known H2A DUBs would counteract 
the BRCA1-induced DNA damage response.
To find DUBs antagonizing BRCA1 E3 ligase activity we tested a panel of DUBs for site spe-
cific H2A deubiquitination. In this analysis USP48, previously identified as an interactor of 
ubiquitinated nucleosomes32 but otherwise poorly characterized, appeared specific for the 
BRCA1 site and seems to need an auxiliary ubiquitin to be fully active. We show that in cells 
USP48 counteracts BRCA1 E3 ligase activity, restricting DNA end resection and RAD51 re-
cruitment. Knock down of USP48 increases SSA and confers a survival benefit to cells treated 
with camptothecin. We propose USP48 as a novel regulator of the DNA damage response, 
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counteracting BRCA1 E3 ligase activity.
Results
Assessing site specificity of H2A DUBs
Each of the E3 ligases that modify H2A, specifically monoubiquitinates distinct groups of 
lysines. K125/127/129 are ubiquitinated by BRCA1/BARD1 (H2ABRCA1ub), K118/119 by PRC1 
complexes (H2APRC1ub) and K13/15 by RNF168 (H2A168ub). This site specificity is retained in 
vitro20–22 and allows reconstitution of ubiquitinated nucleosomes. We wondered if there are 
DUBs specific for these three sites. We selected a subset of DUBs, previously suggested 
to deubiquitinate H2A (USP3, USP16, BAP1/ASXL127–31) and/or being involved in the DNA 
damage response (USP1/UAF1, USP11, USP7,USP15, USP12/UAF1)33. We included USP48 
because it has been identified as a potent binder of ubiquitinated nucleosomes32
We produced all the DUBs recombinantly and purified them for biochemical characterizati-
on (Figures S1a and b). Full kinetic analysis, done on minimal substrate ubiquitin-rhodamine 
(UbRho) in which ubiquitin is linked to a cleavable small peptide labeled with Rhodamine and 
the increase of fluorescence intensity due to liberation of free fluorescent Rhodamine from 
the quenched substrate is measured, show that all DUBs are active (Figure S1a and Supple-
mental Table 1).
We then designed an assay for site specific cleavage of ubiquitinated nucleosome core par-
ticles (NCPs) using a fluorescence based approach where a drop in the fluorescence polari-
zation (FP) signal indicates cleavage (Figure 1a). We tested our panel of DUBs in this assay 
(Figures S1c, d) and the results indicate that most DUBs have no clear substrate preference. 
We normalized the observed rates from this assay to the activity of the respective DUBs 
on minimal substrate (Figure S1e) to assess if a nucleosomal substrate is preferred over 
the minimal substrate (Figure 1b). Of all DUBs tested USP3 and USP48 seem to prefer the 
nucleosomal substrate. USP48 has a preference for H2ABRCA1ub over H2A168ub and H2APRC1ub. 
USP48 is specific for H2ABRCA1ub 
Analysis of USP48 cleavage time courses on western blot confirmed the observed prefe-
rence for H2ABRCA1ub over H2A168ub or H2APRC1ub (Figure 1c). Surprisingly, USP48 only cleaves 
H2ABRCA1ub efficiently if H2A is ubiquitinated on more than one lysine (H2ABRCA1ub3, H2ABRCA1ub2). 
To test if this reflects a general preference for multi-monoubiquitinated substrates or a site 
specificity for the BRCA1-site we created NCP substrates where we push the reaction equi-
librium to enrich for H2A168ub2, H2APRC1ub2 and H2ABRCA1ub2/3 (Figure S2a, “0” time points). Cle-
avage was analyzed on gel with fluorescently labeled ubiquitin as readout (Figure S2a). The 
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experiments show that USP48 can cleave all three substrates but shows a preference for 
H2ABRCA1ub. Comparison of the initial linear reaction rates revealed that H2ABRCA1ub is cleaved 
with an activated rate, roughly five times faster than on the other two sites (Figure 1d). We 
conclude that USP48 only cleaves H2ABRCA1ub efficiently if more than one ubiquitin is present 
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Figure 1 USP48 specifically deubiquitinates H2ABRCA1ub 
a Schematics of the fluorescence polarization screen. Recombinant nucleosome core particles are site specifically 
ubiquitinated using the E3 ligase named and TAMRAUb. Upon addition of a DUB, cleavage can be followed by a de-
crease in FP signal. 
b USP48 prefers nucleosomal substrates. Site specific cleavage of H2A168ub, H2APRC1ub and H2ABRCA1ub in relation to ac-
tivity on minimal substrate. Observed k values from the FP assay (k
obs(NCP)
) (Figure S1c) were normalized to observed 
k values on minimal substrate (k
obs(Rho)
) obtained from fitting an exponential function to the traces in Figure S1e). A 
value above one indicates that NCPs are the preferred substrate. Replicates of two experiments ± SEM
c Time course of USP48 cleavage of H2A168ub, H2APRC1ub and H2ABRCA1ub, anti-H2A western blot. USP48 only cleaves 
efficiently when more than one ubiquitin is present on the BRCA1-site. 
d USP48 cleaves multi-monoubiquitinated H2ABRCA1ub faster than multi-monoubiquitinated H2A168ub and H2APRC1ub. 
Quantification of the initial reaction velocity (V0) of USP48 measured by the liberation of free 
TAMRAUb. Gels used for 
quantification are shown in Figure S2A. Replicates of two experiments ± SEM
e USP48 does not cleave H2APRC1ub when H2ABRCA1ub is present. Left panel: Cleavage of NCPs, ubiquitinated on PRC1 
site with unlabeled ubiquitin and on the BRCA1 site with TAMRAub ,by USP48 was followed on gel. The TAMRA fluo-
rescence is used as readout. Right panel: Quantification of the initial reaction velocity (V0) measured by liberation 
of free ubiquitin. Replicates of two experiments ± SEM
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Figure 2 USP48 cleavage rates on H2ABRCA1ub are modulated by an auxiliary ubiquitin
a An auxiliary ubiquitin activates USP48 processivity. Gel-based assay to measure USP48 cleavage of H2ABRCA1ub. 
TAMRAUb was used as readout. Cleavage was recorded under several different substrate and enzyme concentrations. 
Four (stacked) gels are shown as an example (Figure S3 for the full panel). 
b Quantification of a. 4 out of 12 different conditions shown as an example (Figure S2 for full panel). Solid lines 
show fit obtained by global fitting of all 12 quantified time courses and binding data to the model defined in e 
using Kintek Explorer.
c Binding of USP48 to H2ABRCA1ub, H2APRC1ub and unmodified nucleosomes measured by surface plasmon resonance. 
Nucleosomes were immobilized on the surface. 10 successive injections of different USP48 concentrations (indi-
cated). 
d USP48 binds nucleosomes of different ubiquitination status with similar  affinities. Processed and fitted data from 
c. Kd and standard error of the fit are indicated.
e USP48 cleaves H2ABRCA1ub in nucleosomes 15-30 times faster than when auxiliary ubiquitin is present. Kinetic 
model describing USP48’s cleavage pattern on H2ABRCA1ub with the fitted values for k
cat(ub3)
, k
cat(ub2)
 and k
cat(ub1)
 and the 
standard error of the fit.
f Parameters for k
cat(ub3)
, k
cat(ub2)
 and k
cat(ub1) 
in e are well constrained by the data. Evaluation of the goodness of fit. 
The upper three panels show how well defined the lower and upper boundaries are for the individual parameters. 
The lower panel shows how Chi2 varies when two of the fitted variables are varied against each other. Red indicates 
a Chi2 minimum.  
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on the site. We will refer to the additional ubiquitin needed for activity as the auxiliary ubi-
quitin because it aides USP48 cleavage but itself does not get cleaved.
We wondered how the observed preference for H2ABRCA1ub translates to a situation where 
multiple ubiquitination sites are available for cleavage on a single H2A. To test this we ge-
nerated NCPs with an unlabeled ubiquitin conjugated to the polycomb site and a TAMRAUb 
conjugated to the BRCA1 site. As expected, we find that USP48 cleaves these substrates 
with the activated rate (Figure 1e). Interestingly, no monoubiquitinated H2A with TAMRAUb 
conjugated is observed, showing that the unlabeled ubiquitin on the PRC1 site is not cleaved 
as long as there is a labeled ubiquitin on the BRCA1 site. In other words, H2APRC1ub will not 
get cleaved as long as H2ABRCA1ub is available, once again highlighting the specificity of USP48 
for H2ABRCA1ub. 
We next analyzed cleavage of all the possible di-ubiquitin linkages by USP48 (Figure S2b) 
and find that very little cleavage by USP48 takes place (USP16 serves as an unspecific 
positive control), further suggesting a certain degree of specificity for the nucleosome. 
Taken together our data suggests USP48 to be a DUB specific for multi-monoubiquitinated 
H2ABRCA1ub
USP48 needs an auxiliary ubiquitin to be fully active 
To investigate the effect of the auxiliary ubiquitin on USP48 rates we performed substrate 
binding assays combined with a detailed kinetic analysis. We quantified USP48 catalyzed 
cleavage of H2ABRCA1ub under different conditions, achieved by titrating either USP48 concen-
tration while keeping substrate concentration fixed or vice versa (Figures 2a and b). We then 
tested affinities of USP48 for nucleosomes of different ubiquitination status and find that 
affinities are essentially the same for unmodified nucleosomes (NCP), monoubiquitinated 
nucleosomes (H2APRC1ub1) and multi-monoubiquitinated nucleosomes (H2ABRCA1ub) (Figure 2c 
and d). We fitted these binding and kinetic data, using the software KinTek Explorer 34,35, to 
the simplest model that could describe the observed USP48 H2A deubiquitination pattern 
(Figure 2e). We fixed the binding constants of the model to approximate the equilibrium 
constants determined by the Surface Plasmon Resonance (SPR) experiments (Figure 2d) and 
fitted the catalytic rates using the data from the quantified cleavage reactions (Figure S3a) 
as input. The obtained best fit values for k
cat(ub3)
, k
cat(ub2)
 and k
cat(ub1)
 describe the experimen-
tal data well (Figure 2b for example and Figure S3 for all experiments) and are well cons-
trained (Figure 2f). k
cat(ub1)
 and k
cat(ub2)
 fall into a well-defined local minimum. For k
cat(ub3)
 the 
lower boundaries are well defined which allows the conclusion that K
cat(ub3)
 should always be 
faster than k
cat(ub1)
 The kinetic modeling indicates increased processivity when an auxiliary 
ubiquitin is present. The rates for k
cat(ub3)
 (0.027 s-1) and k
cat(ub2)
 (0.014 s-1) are similar, whereas 
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k
cat(ub1)
 is roughly 15 times slower (0.00095 s-1). These results can be explained by a catalytic 
activation in the presence of the auxiliary ubiquitin, possibly induced by a conformational 
change or reorientation, or the inability of USP48 to cleave one of the three ubiquitinated 
lysines efficiently. 
We further asked if free ubiquitin could act as the auxiliary ubiquitin and increase USP48 
processivity. To address this we performed UbRho and H2ABRCA1ub cleavage assays in the pre-
sence and absence of ubiquitin (Figures S3b and c). On both substrates the addition of free 
ubiquitin does not lead to activation of USP48. This indicates that the activating ubiquitin 
needs to be on the nucleosome and possibly in a defined orientation towards USP48 to cau-
se activation. In our analysis we regarded affinities measured by SPR (Figure 2d) as actual 
a b
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Figure 3 USP48 deubiquitinase activity restrains resection.
a USP48 recruits to sites of damage. BrdU sensitised HeLa cells were subjected to laser stripe irradiation followed 
by fixation after 1 hour and staining for endogenous USP48. White arrows mark the laser-induced damage stripe. 
Scale bar = 10 µm. 
b Expression levels of USP48 in stable HeLa FlpIn cell lines following depletion of USP48 and DOX-induced comple-
mentation of siResistant Flag-WT or Flag-C98S-USP48. 
c USP48 knockdown increases resection length. Resection lengths were measured in HeLa cells depleted for USP48 
and complemented as in B. Cells were treated with 10 mM BrdU for 24 hours with addition of 10 µM Olaparib for 
the final 16 hours. Cells were lysed and DNA fibres spread before staining for BrdU-positive single-stranded DNA 
resection tracks. A minimum of 120 tracks were measured using ImageJ for each condition. Bars indicate median. 
*** p<0.005 Mann-Whitney test.
d USP48 knockdown increases Rad51 foci formation. Foci formation in S-phase (EdU positive) HeLa cells depleted 
for USP48 and complemented as in B. Cells were fixed at 2 hours post-5 Gy irradiation. Scale bars = 10 µm. 
E. Graph shows quantification of mean number of RAD51 foci per S-phase cell (n=200 cells from 3 independent 
experiments, error bars are S.E.M). *** p<0.005 Student’s T-test.
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Figure 4 USP48 antagonises BRCA1-mediated resection.
a USP48 knockdown only shows an effect if BRCA1 and SMARCAD1 are present. Resection lengths were measured 
in HeLa cells depleted as indicated. Cells were treated with 10 mM BrdU for 24 hours with addition of 10 µM Olapa-
rib for the final 16 hours. Cells were lysed and DNA fibres spread before staining for BrdU positive single-stran-
ded DNA resection tracks. 190 tracks were measured using ImageJ for each condition. Bars indicate median. *** 
p<0.005 Mann-Whitney test.
b Western blots to demonstrate protein expression levels following siRNA as indicated.
c Rad51 foci formation in S-phase (EdU positive) HeLa cells depleted as indicated. Cells were fixed at 2 hours post-
5Gy irradiation. Scale bars = 10 µm. 
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substrate affinities. However, in order to engage the substrate (ubiquitin on H2A) a reorien-
tation or conformational change of USP48 may occur on the nucleosome. This second step 
might be masked in our assays as binding is dominated by the affinities for the nucleoso-
me. In the kinetic analysis such a possible conformational change would be reflected in 
the calculated k
cat
 values which include the rate for catalysis and the rate for any possible 
conformational change. Therefore the detailed analysis does not yet fully assign the role of 
the auxiliary ubiquitin, but it does firmly establish that some form of activation takes place. 
In summary our biochemical analysis identified USP48 as a deubiquitinating enzyme specific 
for nucleosomes ubiquitinated by BRCA1/BARD1, identifying what is to our knowledge the 
first H2A DUB with in vitro specificity for the BRCA1-site. We also demonstrated the need 
of an auxiliary ubiquitin for USP48 to be fully active. We next sought to analyze USP48’s 
importance in cells.
USP48 deubiquitinating activity restrains resection.
Since BRCA1/BARD1 is known to ubiquitinate H2A following DNA DSBs2,20, we sought to ad-
dress whether USP48 is likely to have a role in the response to DSBs by first assessing USP48 
localization to laser-induced lines of DNA damage. Endogenous USP48 was detected along 
the line of the laser indicating recruitment to sites of DNA damage (Figure 3a). The BRCA1:-
BARD1 E3 Ub ligase activity promotes long-range resection2. To assess the possible role of a 
DUB capable of cleaving the BRCA1 H2A mark we next assessed DNA resection. Cells treat-
ed with USP48 and control siRNA were incubated with Bromodeoxyuridin (BrdU) exposed to 
olaparib and track-lengths of exposed BrdU epitope, indicative of ssDNA, were spread and 
measured. Median lengths of ssDNA were longer in cells treated with USP48 siRNA than in 
control cells (from 31.2 μm in control cells to 51.7 μm in USP48 depleted cells) (Figures 3b-
c). Moreover expression of siRNA-resistant wild type (WT) USP48 restored shorter lengths 
to depleted cells (25.7 μm) whereas expression of USP48 in which the catalytic cysteine was 
mutated to serine (C98S) failed to do so (40 μm)(Figures 3b-c).
The single-strand DNA binding protein RPA quickly loads on the resected, ssDNA and is then 
exchanged for RAD51 to enable subsequent strand invasion and gene conversion. We noted 
that cells depleted for USP48 showed an increase in the numbers of RAD51 foci compared 
d USP48 overexpression phenotypes can be rescued by co-expression of an uncleavable H2A-Ub fusion. Resection 
lengths were measured in HeLa cells depleted as indicated. Cells were prepared as in A and 210 tracks were measu-
red using ImageJ for each condition. Bars indicate median. *** p<0.005, ns=non-significant, Mann-Whitney test.
e USP48 restricts positioning of 53BP1 in damage foci. Images of BRCA1 and 53BP1 in cells treated with USP48 
siRNA exposed to 2 Gy IR and fixed 8 hours later. Quantification of mean relative intensity profiles for co-localising 
foci. n=25, bars = S.E.M.
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Figure 5 USP48 restrains homology-directed repair mechanisms
a Gene conversion (GC) was measured using U20S DR3-GFP reporter cells as illustrated. Note functional GFP cannot 
be produced by SSA from this substrate as the template iGFP lacks the 5’ and 3’ regions of GFP 38. Cells depleted for 
USP48 were transfected with RFP, Sce1 and either Flag-WT or Flag-C98S-USP48. GFP-positive cells were normalised 
to  RFP-transfection efficiency.  %-repair is given compared to NTC. Graph shows mean, n=5,, error bars are S.E.M. 
b Single-strand annealing (SSA) was measured using U20S SA-GFP reporter cells as illustrated. The two GFP frag-
ments of the substrate share 266 nucleotides of homology. In principle GC with crossing over could also produce 
functional GFP, however these have been shown to be rare events38 . Cells were treated and analysed as in a. Graph 
shows mean, n=3, error bars are S.E.M. 
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to control cells, as did those complemented with the siRNA-resistant catalytic mutant form 
of the enzyme (Figures 3d-e and S4a-b). In contrast, expression of siRNA-resistant wild-type 
(WT) enzyme brought the observed RAD51 foci down to levels similar to those seen in con-
trol cells (Figures 3d-e). Together these data indicate that the catalytic function of USP48 is 
required to restrain DNA resection lengths.
USP48 antagonises the BRCA1-H2Aub-SMARCAD1 resection pathway.
Resection promoted by the BRCA1-BARD1 E3 Ub ligase promotes SMARCAD1-mediated re-
modelling of chromatin-associated 53BP12. To address whether USP48 is relevant to this 
pathway we tested whether the increased resection lengths observed on USP48 loss re-
quires BRCA1 or SMARCAD1. As expected2, loss of BRCA1 or SMARCAD1 alone resulted in 
shortened ssDNA lengths (respectively 19.5 and 23.1 μm, compared to 32.6 μm in control 
cells Figures 4a-b). Significantly, loss of USP48 did not change the ssDNA lengths in BRCA1 
or SMARCAD1 depleted cells (respectively 21.3 and 24.4 μm in co-depleted cells compared 
to 47.1 μm in USP48 depleted cells (Figure 4a), suggesting that repressing USP48 expression 
has little impact on resection if there is no ubiquitination to be cleaved or no reader to in-
terpret that ubiquitination mark.
Consistent with the relationship between USP48 and BRCA1 and SMARCAD1 in resection 
RAD51 foci numbers remain decreased in cells co-depleted for BRCA1, or SMARCAD1 and 
USP48 (Figures 4c and S4c-e). Intriguingly loss of USP48 and 53BP1 have a similar impact on 
RAD51 foci numbers as loss of either protein alone (Figures 4c and S4c-e), suggesting the 
impact of USP48 loss on RAD51 nucleofilament formation is similar and in the same path-
way as 53BP1 removal. 
We2 and others36 have noted that expression of a fusion protein in which ubiquitin is genet-
ically fused to the C-terminus of H2A can restore measures of gene conversion in BRCA1/
BARD1 deficient cells. Such a fusion lacks an isopeptide bond and is resistant to proteases. 
To test the hypothesis that USP48 acts to cleave ubiquitin from the C-terminus of H2A in 
cells we addressed the impact of ectopic USP48 over-expression on resection lengths in cells 
expressing control H2A and an H2A-Ub fusion. (Note previous analysis has shown ectopic 
H2A and H2A-Ub are incorporated into chromatin 2). Increased USP48 expression resulted 
in short ssDNA lengths (17.9 mm, compared to 35.2 μm in controls), consistent with the en-
zyme’s ability to restrict resection (Figure 4d). This effect was unaffected by co-expression of 
c  Camptothecin colony survival curves of HeLa cells depleted for USP48 and complemented with Flag-WT- or Flag-
C98S-USP48. Graph shows mean % survival normalised to untreated controls, n=4,, error bars are S.E.M. 
d Western blot shows USP48 expression levels.
e Camptothecin colony survival curves of HeLa cells depleted for USP48  and/or RAD52.  Graph shows mean % 
survival normalised to untreated controls, n=6, error bars are S.E.M. *** p<0.005, * p<0.05, Student’s T-test.
f Western blot shows levels of YFP-RAD52 expression as a marker for RAD52 siRNA efficiency. 
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H2A (where they remained 17.8 μm). In contrast, when the H2A-Ub fusion was co-expressed 
increased USP48 expression did not result in short ssDNA lengths (lengths of 37.6 μm) (Fig-
ure 4d). Thus a protease-resistant H2A-Ub renders resection insensitive to the impact of 
USP48 overexpression, consistent with the enzyme’s function in cleaving C-terminal H2A 
modifications.
These data are consistent with the notion that USP48 DUB activity acts to restrain resection 
through processing the H2ABRCA1ub and thus in turn restrains SMARCAD1-mediated remodel-
ling. A consequence of BRCA1 ligase activity and SMARCAD1 function is the positioning of 
53BP1 to the periphery of the IR foci2. To test the impact of USP48 on 53BP1 we measured 
the distribution of 53BP1 in foci associated with BRCA1 in USP48 depleted and control cells. 
53BP1 accumulations exhibited a greater spread in USP48 depleted cells compared to con-
trols (half peak intensity width ~1.1 μm in USP48 depleted cells compared to ~0.8 μm in 
control cells), and exhibited a larger ‘hole’ at foci cores (53BP1 peak to peak distance of 
~0.5 μm within foci of USP48 depleted cells, compares to ~0.3 μm in control cells Fig 4e). 
Thus, consistent with its relationship with BRCA1, SMARCAD1 and H2A-Ub, USP48 appears 
to constrain 53BP1 repositioning at IRIF.
USP48 restrains HR repair mechanisms.
DNA end resection is the decision point committing cells to DSB repair by HR-mechanisms 
and inhibiting NHEJ. Incomplete resection results in IR sensitivity, and in reduced NHEJ repair, 
that can be rescued by inhibiting the initiation of resection37. USP48 depleted cells showed a 
slight reduction in NHEJ and slightly increased sensitivity to IR (Figures S4f-g). CtIP depletion 
restored IR-resistance in USP48 depleted cells (Figures S4h-i) suggesting that the sensitivity 
seen, is due to resection. This minor resection-dependent NHEJ impairment suggests USP48 
contributes only in a small way to the decision between HR-mediated repair and NHEJ.
Long range resection creates stretches of ssDNA, quickly coated by RPA. In gene conversion 
RPA is exchanged for the RAD51 recombinase. Our data shows that USP48 loss increases re-
section and RAD51 nucleofilament foci numbers (Figures 4a-c). We also observed increased 
GFP products from an integrated substrate specific for gene conversion in cells transfected 
with I-Sce138 and depleted for USP48 or complemented with the catalytic mutant enzyme 
(Figure 5a). Taken together these data indicate USP48 activity restrains HR-repair by gene 
conversion. Since extended resection can reveal sequences that are substrates for SSA we 
also tested repair of an integrated reporter construct dependent on extensive resection and 
SSA for generation of a functional GFP (Figure 5b)38. USP48 depletion resulted in increased 
repair of this substrate which could similarly be suppressed by complementation with WT, 
but not with the catalytic mutant enzyme, consistent with the role of USP48 DUB activity 
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restricting extended resection (Figure 3c). 
To further assess the possible functional role of USP48 we addressed the consequences of 
its loss on survival of cells exposed to camptothecin, as repair of the DSB lesions produced 
relies on resection and HR-repair39. USP48 depleted cells, or cells complemented with cat-
a
b c
Figure 6. Model of USP48 function in restricting extended DNA end resection.
a USP48 cleaves the C-terminal Ub modification of H2A, limiting the extent of SMARCAD1 nucleosome remodelling 
and 53BP1 positioning. 53BP1 in turn restrains DNA end processing and consequently direct repeats are rarely 
exposed either side of the DSB, favoring GC (one side of the break is illustrated). Without USP48 activity H2A mo-
dification is unopposed and SMARCAD1 nucleosome remodeling is extended further from the break, resulting in 
53BP1 positioning further from the break site. 53BP1 is unable to constrain extended resection, resulting in incre-
ased GC and, as repeats either side of the break are more often exposed, SSA is also increased.
b USP48 cannot cleave BRCA1-initiated H2A monoubiquitination efficiently, SMARCAD1 can bind and initiate 
downstream signaling
c A second ubiquitination on H2A can activate USP48, cleaving BRCA-initiated ubiquitination, SMARCAD1 cannot 
engage with the nucleosome anymore and signalling is stopped.
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alytically mutant enzyme, were more resistant to camptothecin than control cells or cells 
complemented with WT USP48 (Figures 5C-D). The annealing of flanking repeats in SSA 
requires RAD5240–42, to assess the contribution of RAD52-mediated mechanisms to the ob-
served resistance we silenced RAD52 expression. Depletion of RAD52 alone had little im-
pact on camptothecin sensitivity of control cells, but those in which USP48 was depleted 
RAD52 co-depletion dramatically increased sensitivity (Figures 5e-f). Thus a proportion of 
the camptothecin resistance seen on USP48 loss stems from a reliance of cells without the 
enzyme on HR-repair by SSA.
Discussion
The data we present here establishes USP48 as a DUB that antagonises the BRCA1-depen-
dent DNA resection. We show that USP48 specifically counteracts BRCA1-initiated H2A 
ubiquitination. By limiting the extent of this ubiquitination mark USP48 affects positioning 
of 53BP1 through SMARCAD1 and thus limits the length of resection. Its likely function is 
to fine tune resection length, to avoid over resection and prevent deleterious SSA. On a 
mechanistic level we show that USP48 needs an auxiliary ubiquitin on the substrate to be 
activated, possibly allowing cross-talk between different ubiquitination sites, generated by 
different ligases.  
The FP assay we developed to measure site specific deubiquitination is a quick way to 
qualitatively assess site specificity of a panel of DUBs. Quantitation is complicated by the 
many variables influencing the FP signal: Some DUBs will bind free ubiquitin and change 
FP properties; additionally the ubiquitinated NCPs present a very heterogeneous substrate 
with a mix of mono-, di- and tri-ubiquitinated H2A, further complicating the analysis. Ne-
vertheless, as a qualitative measure the assay proved to be useful and could be extended to 
other ubiquitinated substrates. 
Under the conditions tested most DUBs do not show site specificity or a clear substrate spe-
cificity as they cleave both NCP and minimal substrate. In most cases the minimal substrate 
is cleaved more efficiently which suggests that nucleosomes are not the preferred target. 
With many other ubiquitinated proteins in the cell that are potentially better targets there 
might not be a need for clear cut substrate specificity as relative enzyme and substrate 
concentrations in a given situation will decide which target eventually gets cleaved. Partici-
pation in protein complexes and possible post-translational modifications will add another 
layer of regulation as reported for many other DUBs43. 
Besides the enzymes tested there may be specific DUBs that were not included in this study, 
such as USP51, which has been reported to be specific for H2A168ub 44. Of the DUBs we did 
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test USP48 seems to be unique in showing clear intrinsic substrate specificity. Our biochemi-
cal analysis suggests that USP48 is specific for H2A ubiquitinated by BRCA1/BARD1. 
Interestingly USP48 only reaches its full catalytic potential when more than one lysine on 
the BRCA1 site is ubiquitinated. A similar requirement for multiple ubiquitinations was re-
ported for the proteasome associated DUB USP1445, which cleaves supernumerary chains. 
However, it is not clear whether USP14 cleaves any target with multiple sites ubiquitinated 
or only selected substrates, a question that can be extended to USP48. Our data suggest 
that USP48 is only fully active on H2ABRCA1ub, not on H2APRC1ub nor H2A168ub, showing that it in-
deed only acts on a selected substrate. This suggests a two-fold regulatory switch for USP48: 
the first being the intrinsic target specificity for the BRCA1 site on the nucleosome, and the 
second the dependence on the auxiliary ubiquitin for full catalytic activation. While USP14 
cleaves supernumerary chains marking targets for degradation, we show that USP48 can 
cleave signaling monoubiquitination highlighting that a similar regulatory mechanism is em-
ployed in two profoundly different pathways.   
In cells we show that resection directed by BRCA1/BARD1 can be countered by the deu-
biquitinating activity of USP48. We show that manipulation of USP48 has striking conse-
quences for DNA end resection. Without its activity cells exhibit increased DNA end pro-
cessing which is dependent on BRCA1 and the remodeler SMARCAD1 and results in extended 
53BP1 positioning around DNA break sites. Conversely, overexpression of USP48 drastically 
shortens resection lengths in a manner that can be reversed by expression of a protease resis-
tant H2A-Ub fusion. These data suggest to us a model in which USP48-mediated removal of 
the BRCA1/BARD1 H2A-Ub mark on chromatin restrains subsequent SMARCAD1 function, 
thereby halting the mobilization of 53BP1, and bounding resection (Figure 6 a). In this mod-
el the opposing activities of BRCA1/BARD1 versus USP48 determine local H2ABRCA1ub modi-
fications and consequently, in the presence of 53BP1, are capable of directing the degree of 
DNA end resection. We speculate that when USP48 is absent H2A-modification is sustained 
even at low levels of BRCA1/BARD1 accumulation so that SMARCAD1-mediated nucleo-
some sliding or H2A/B eviction46 extends more widely than in control cells. 
The observation that a H2A-Ub fusion rescues USP48 over-expression phenotypes is seemingly 
at odds with our biochemical data that suggests USP48 needs an auxiliary ubiquitin for efficient 
cleavage. The precise requirements for SMARCAD1’s reading of the H2A-Ub C-terminus are 
not yet known. It is possible that the C-terminally linked ubiquitin fusion, due to its orientati-
on and accessibility, can act as a more efficient signaling entity and thus alleviates the need, 
perhaps needed with endogenous substrate, for an additional ubiquitin to initiate signaling. 
Alternatively the results may indicate that one ubiquitin on the BRCA1 site is enough to 
initiate signaling but a second, auxiliary ubiquitin is needed to switch it off, through activa-
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tion of USP48. This is an intriguing model given the recent data suggesting that BRCA1 activity 
is evolutionarily “underpowered”47, and thereby implying that too much activity may be toxic. 
Such a model would suggest two distinct ubiquitination sites: a signaling site responsible for 
SMARCAD1 recruitment and an auxiliary site, activating USP48 to cleave the ubiquitin on 
the signaling site. The auxiliary ubiquitin could be conjugated to one of the two unoccupied 
lysines on the BRCA1-site or may be placed by another E3 ligase on a different site, possibly 
by the PRC1 E3 ligase, at K118/119, providing a potential step in the observed crosstalk between 
DNA damage and transcriptional regulation (Figure 6 b &c)48–50. 
Our data supports the idea of a continuum between increased resection that promotes GC 
and increased resection leading to SSA as we see both an increase in RAD51 foci and GC 
repair outcomes as well as increased SSA and RAD52 dependency when USP48 is inactive or 
reduced. While one model suggests ever longer ssDNA lengths may promote SSA over GC 
another possibility is that a proportion of increased resection does not reveal direct repeat 
sequences either side of the break, and thus encourages GC, while another exposes such 
sequences and SSA results. In contrast to our findings with USP48 loss, cells without 53BP1 
exhibit a shift of HR repair dramatically to SSA26. A possible explanation for this difference 
is that in USP48 depleted cells, although 53BP1 is dramatically repositioned, it nevertheless 
restricts resection somewhat26.
Repetitive elements are numerous in the human genome so that restricting SSA would be 
expected to be significant in preventing large-scale rearrangements that cause deletions of 
sequences located between the repeats. High levels or activity of USP48 would be expected 
to decrease resection lengths and thus reduce GC, and phenocopy aspects of BRCA1 loss. 
In contrast USP48 loss or its decreased activity would be expected to increase resection 
lengths and favour SSA. Indeed, the occurrence of T-cell lymphoma in ATM-deficient mice 
is suppressed following Rad52 deletion and reduced  SSA51, thus supporting  a mutagenic 
role for SSA. In addition, cancers in individuals with increased RAD52 expression have been 
shown to be more aggressive52. We predict that an imbalance in the BRCA1/BARD1–USP48 
circuit could have deleterious consequences for genome stability and be significant in the 
prevention or progression of cancer.
These data also suggest a further mode of resistance against PARP or topoisomerase in-
hibitor treatment in cancer therapy. However in contrast to 53BP1 loss, which can restore 
HR-repair to BRCA1 deficient tumours, USP48 loss is not an expected mechanism of tumour 
resistance in BRCA1 patients as hyper-resection following USP48 loss requires BRCA1 function. 
Nevertheless USP48 loss of function would be expected to increase the resistance of tumours 
in which the BRCA1-resection pathway is intact to agents that force a reliance on HR-mediated 
repair.
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Material and Methods
Plasmids. Flag-HA-USP48 isoform 2 was a gift from Wade Harper (Addgene plasmid # 
22585). RNF168 RING domain (1-113) was cloned into pETNKI-His-SUMO2-LIC-kan. Plas-
mids for RING1b(1-159)/BMI1(1-109) RING domain expression were described in53. UB-
CH5C (UBE2D3) plasmid was a gift from P Jackson (Stanford University School of Medicine). 
BRCA1 and BARD1 constructs inpCOT7N vector were a gift from Rachel Klevit (University of 
Washington). USP15 and USP11 cDNA were a gift from Hidde Ploegh (Whitehead Institute 
for Biomedical Research). USP12 and UAF1 plasmids were a gift from Martin Cohn (Univer-
sity of Oxford). For recombinant protein expression in insect cells USP15, USP16, USP48 and 
BAP1 were cloned into pFastBacNKI-his-3C-LIC, USP1, USP3 and USP12 were cloned into the 
pFastBacHTb vector. UAF1 was cloned into pFastBac1. USP7 was cloned into pGEX6p-1 vector 
and expressed in E.coli. USP11 was cloned into pET-NKI His-3C-LIC54 vectors and expressed 
in E.coli. For experiments in cells, human USP48 isoform 2 was cloned into pcDNA5/FRT/TO 
with addition of an N-terminal FLAG tag. Point mutations to generate siResistance and cata-
lytic dead (C98S) versions were made by site-directed mutagenesis and all constructs were 
confirmed by sequencing (Source Biosciences). All primers used for mutagenesis are given 
in Supplemental Table 2. HA-H2A and HA-H2A-Ub (H2A-K13,15,118,119,125,127,129R-Ub-
Kless) were described previously2. YFP-Rad52 was a kind gift from Claudia Lukas (University 
of Copenhagen, Denmark). 
Protein expression and purification
hUBA1 and ubiquitin hUBA1 and ubiquitin were purified from E. coli as described before53
UBCH5C(UBE2D3) Protein was expressed in E. coli. Cells were grown at 37 oC until an OD 
of 0.8 and then induced with 200 μM IPTG. Temperature was set to 18 oC and protein was 
expressed overnight. Cells were harvested in lysis buffer (50 mM TRIS pH7.5, 150 mM NaCl, 
1 mM TCEP, 2mM Imidazole) with “Complete EDTA-free protease inhibitor” and lysed by 
sonication. Lysate was cleared by spinning down at 21000 x g and loaded on TALON beads 
(Clontech Laboratories, Inc). Beads were washed with 20 CV of lysis buffer + 6 mM Imidazole 
and eluted in lysis buffer + 300 mM Imidazole. His-tag was cleaved over night at 4 oC with 
3C protease, dialyzing against gel filtration buffer (25 mM HEPES pH 8, 150 mM NaCl, 5 mM 
DTT). Protease and uncleaved protein were removed using TALON beads and sample was 
purified by size exclusion chromatography on a Superdex 75 16/60 column (GE). 
RNF168 RING domain (residues 1-113) Protein was expressed in E. coli Cells were grown at 
37 ºC until an OD of 0.6 and the induced with 200 uM IPTG. Temperature was set to 18 oC 
and protein was expressed overnight. Cells were harvested in lysis buffer (50 mM TRIS pH 8, 
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500 mM NaCl, 1 μM ZnCl
2
,1 mM TCEP, 2 mM Imidazol) with “Complete EDTA-free protease 
inhibitor” and lysed by sonication. Lysate was cleared by spinning down at 21000 x g and 
loaded on TALON beads (Clontech Laboratories, Inc). Beads were washed with 20 CV of lysis 
buffer + 10 mM Imidazol and eluted in lysis buffer + 300 mM Imidazol. His-Sumo tag was 
cleaved overnight with SENP protease at 4 oC dialyzing against dialysis buffer (50 mM TRIS 
pH 8, 250 mM NaCl, 1 μM ZnCl
2
,1 mM TCEP). Protease, uncleaved sample and His-Sumo 
were removed with TALON beads. Sample was diluted to a salt concentration of 50 mM 
NaCl and loaded onto a Heparin column (GE). Sample was eluted with a salt gradient ranging 
from 50 mM to 1000 mM NaCl in 12 CV. Fractions containing RNF168 were combined and 
further purified by size exclusion chromatography using a Superdex 75 16/60 column (GE 
healthcare) in 50 mM TRIS pH 8, 150 mM NaCl, 1 μM ZnCl
2 
and 1 mM TCEP.
RING1b/BMI1 RING domain Purification of RING1b/BMI1 RING domain constructs has been 
described before53
BRCA1/BARD1 RING domain BRCA1 (1-303) and BARD1 (1-306) were co-expressed in E.coli. 
Cells were grown in LB at 37 oC until OD of 0.6 was reached and then induced with 100 μM 
IPTG. Protein was expressed for 4 hours at 37 oC. Cells were harvested in lysis buffer (25 mM 
HEPES pH 7.5, 150 mM NaCl, 1mM TCEP, 5 mM Imidazole) and lysed by sonication. Lysate 
was cleared by spinning at 21000 x g and supernatant was loaded onto chelating sepharose 
beads (GE healthcare) charged with Ni2+ in gravity flow columns. Beads were washed with 20 
CV lysis buffer +30 mM Imidazole. Protein was eluted in lysis buffer +300 mM Imidazole. Salt 
concentration was diluted to 50 mM NaCl and sample was loaded on a Resource S cation 
exchange column (GE healthcare). Protein was eluted with a salt gradient (50 - 1000 mM 
NaCl, 25 mM HEPES pH7.5, 1mM TCEP) and fractions containing BRCA1/BARD1 were poo-
led. Pooled fractions were further purified by size exclusion chromatography on a Superdex 
75 column (GE healthcare). 
USP1, USP12 and UAF1 Proteins were expressed and purified as described in55
USP3 Same as USP48 but with 500 mM NaCl and 1 uM ZnCl
2
 in the lysis buffer and TEV pro-
tease was used to cleave the tag
USP7 Protein was expressed in BL21(DE2)Rosetta2 cells. Cells were grown at 37 oC in TB until 
an OD of 1.8-2.0 and induced with 100 uM IPTG. Temperature was set to 18 ºC and protein 
was expressed overnight. Cells were lysed using Emulsiflex in lysis buffer (50 mM HEPES pH 
7.5, 250 mM NaCl, 1 mM EDTA, 1mM DTT) + 0.1 mM PMSF and 1mg DNAse1. Lysate was 
cleared by centrifugation at 20k x g and supernatant was loaded on Glutathione Sepharose 
4B beads (GE healthcare) in gravity flow column. Beads were washed in lysis buffer and 
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eluted in lysis buffer + 15 mM reduced glutathione. GST-tag was cleaved overnight with 
3C protease dialyzing against 10 mM HEPES pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT. 
Sample was purified using a ResourceQ anion exchange column (GE healthcare) using a salt 
gradient (50 to 500 mM NaCl, 10 mM HEPES pH 7.5, 1 mM DTT). USP7 containing fractions 
were pooled and further purified by size exclusion chromatography on a Superdex 200 col-
umn (GE healthcare). 
USP11 Protein was expressed in E.coli and purified as described before in56
USP15, USP16 and USP48 Proteins were expressed in Sf9 insect cells for 48 – 72 hours. Cells 
were lysed by sonication in 25 mM HEPES pH7.5, 300 mM NaCl, 2 mM DTT and 5 mM Imi-
dazole supplemented with Pierce EDTA-free protease inhibitor (Thermo Fischer). Lysate was 
cleared by centrifugation at 21000 x g at 4 oC and the supernatant was loaded on chelating 
sepharose beads (GE) charged with Ni2+. Beads were washed with 20 column volume of lysis 
buffer +30 mM Imidazole and then eluted in lysis buffer +300 mM Imidazole. The His-tag 
was cleared using His-tagged 3C protease over night at 4 oC while dialyzing against 25 mM 
HEPES 7.5, 150 mM NaCl, 1 mM DTT. The sample was then run over chelating sepharose 
beads charged with Ni2+ to remove protease and uncleaved sample and subsequently puri-
fied by size exclusion chromatography using a Superdex S200 16/60 column (GE) in 25 mM 
HEPES 7.5, 150 mM NaCl, 1 mM DTT.
BAP1/ASXL1 (1-390) Protein was expressed and purified as described in57
Nucleosome reconstitution. Histones and 146bp DNA with Widom601 strong positioning 
sequence were purified, octamers folded and nucleosomes reconstituted by salt dialysis as 
described previously58,59
Cell lines. Flp-InTM Doxycyclin inducible Hela parent cell lines were grown in DMEM (Sig-
ma), 10 % Tetracycline-Free Foetal Calf serum (Clontech) supplemented with 1 % penicillin/
streptomycin. All other cell lines were grown in DMEM supplemented with 10% foetal calf 
serum (Sigma) and 1 % penicillin/streptomycin. Mycoplasma testing was by Hoechst DNA 
staining. Stable doxycycline inducible cell lines were made by co-transfection of pcDNA5/
FRT/TO-FlagUSP48-siResistant-WT or -C98S constructs with pOG44 recombinase into HeLa 
FlpIn cells. Clones were selected in hygromycin (400 μg/ml) and expanded. Flag-USP48 ex-
pression following 48-72 hour induction with doxycycline (1 μg/ml) was confirmed by wes-
tern blot. 
Transfections. siRNA transfections were performed using Dharmafect1 (Dharmacon) and 
DNA plasmids using FuGENE 6 (3 µl:1 µg FuGENE:DNA) (Promega) following the manufac-
turer’s protocols. Cells were grown for 48 hours post-transfection before treatment and 
73
3
USP48 is a H2ABRCA1ub-specific DUB
harvesting. All siRNA sequences are given in Supplemental Table 3.
Western Blots. A full list of antibodies used for western blots can be found in Supplemental 
Table 4. 
Kinetics on minimal substrate Ubiquitin-Rhodamine. Ubiquitin linked to a cleavable small 
peptide labeled with Rhodamine (UbRHO, UbiQ) was used as a substrate. Reaction was fol-
lowed through increase of fluorescence intensity at 590 nm due to liberation of free fluo-
rescent Rhodamine from the quenched substrate upon cleavage by a DUB. The assays were 
done in 384-well plates (Corning, flat bottom, low flange) in a Pherastar plate reader (BMG 
labtech) at 30 oC using an assay buffer of 25 mM HEPES pH 7.5, 150 mM NaCl, 5 mM DTT and 
0.05 % TWEEN-20. For full Michaelis-Menten analysis substrate was titrated starting from 
30 μM in eight two-fold dilutions while enzyme concentration was kept constant. Enzyme 
concentrations are indicated in Figure S1. Cleavage was started by addition of the respective 
DUB. The initial velocity of the reaction was calculated from the slope of the linear phase 
of the curve and was plotted against the substrate concentration and fitted to the Michae-
lis-Menten equation using the program GraphPad Prism. 
For single point assays (Figure 1D) 2 μM of substrate and different concentrations of enzyme 
were used. Assays were done at 30 oC. The different enzyme concentrations are indicated 
in the figure. 
Fluorescent labeling of ubiquitin. Ubiquitin with a cysteine residue introduced at the N-ter-
minus right after the methionine at position 1 was labeled using maleimide-linked TAMRA 
dye. 250 μM ubiquitin was labeled with 1500 μM TAMRA (5)-Maleimide (Setareh) at 4 oC 
overnight. Excess dye was removed by size exclusion chromatography using a Superdex 75 
16/60 column (GE) in 50 mM TRIS pH7.5, 150 mM NaCl and 1 mM DTT. 
Ubiquitination assay. Nucleosomes were ubiquitinated using 0.5 μM hUBA1, 1 μM UbcH5C 
(UBE2D3), 1 μM E3 RING domain (RNF168, RING1B/BMI1 or BRCA1/BARD1) 5 μM NCP, 20 
μM ubiquitin or TAMRAUb and 3 mM ATP in 25 mM HEPES pH7.5, 150 mM NaCl, 3 mM MgCl
2 
and 1 mM DTT for 60 minutes at 30 oC. Substrates for figure 1C were ubiquitinated for 40 
minutes, all the others for 60 minutes (as stated). Ubiquitinated NCPs were then gel filtered 
on a Superose 6 Increase column using the Akta micro purifier system (GE) in 25mM HEPES 
pH 7.5, 150 mM NaCl, 1 mM DTT.
Double ubiquitination at polycomb and BRCA1 site. NCPs containing the H2A K118R were 
used to assure only K119 is ubiquitinated by RING1B/BMI1. Mutant NCP were ubiquitinated 
with RING1B/BMI1RING and gel filtered on the Superose 6 increase using the Akta micro pu-
rifier system (GE healthcare). Purified NCP ubiquitinated at K119 were then ubiquitinated 
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a second time using BRCA1/BARD1RING and TAMRAUb, generating NCP ubiquitinated on K119 
with unlabeled ubiquitin and on the BRCA1 site with TAMRAUb. 
Fluorescence polarization assay to measure DUB activity and normalization to minimal 
substrate. FP assays were done in 384-well plates (Corning, flat bottom, low flange) in a 
Pherastar plate reader (BMG labtech) at 30 oC using an assay buffer of 25 mM HEPES pH 7.5, 
150 mM NaCl, 5 mM DTT and 0.05 % TWEEN-20 (Sigma). NCPs ubiquitinated with TAMRAUb 
on either of the three sites were used at 2 μM label concentration. 500 nM of the respective 
DUB was added to start the assay and reaction progression was followed by measuring FP 
signal at Excitation: 540 nm, Emission 590/590 nm. A reaction without DUB was run in pa-
rallel to subtract baseline drift from the experimental data. An exponential function  , where 
FP0 – FP is the signal of ubiquitinated substrate and FPmin – FP the signal of free 
TAMRAUb, was 
fitted to determine k
obs(NCP) 
as a measure of the enzymes processivity. To normalize the data 
to the intrinsic DUB activity on minimal substrate cleavage of 2 uM UbRho was measured un-
der the same conditions. The curve was fitted to obtain k
obs(Rho)
. k
obs(NCP)
 was then normalized 
to k
obs(Rho)
 using the equation , where [ERho] is the concentration of the DUB in the reaction 
with minimal substrate and [ENCP] is the concentration of the DUB in the reaction with NCP.
Biotinylation, USP48 inactivation and SPR measurements. Measurements were done on a 
Biacore T200 (GE). NCPs of different ubiquitination status at a concentration of 2 μM were 
biotinylated over night at 4 oC using EZ-link Sulfo-NHS-LC-Biotin (Thermo Fischer) with a 2:1 
excess of NCP over biotin. Biotinylation was stopped by adding 1 mM TRIS pH7.5. USP48 at 
30 μM was inactivated by incubating with 25 mM Iodoacetamide for 20 minutes at room 
temperature. Excess Iodoacetamide was removed using Zeba Spin Desalting Columns (Ther-
mo Fischer) according to manufacturer’s protocol. The buffer used for SPR experiments was 
25 mM HEPES pH 7.5, 150 mM NaCl, 0.05% TWEEN-20, 1 mg/ml BSA, 1mg/ml Dextran. 
Biotinylated NCPs were immobilized on a (Series S SA chip, GE) to roughly 100 RU and inac-
tivated USP48 was flown over at varying concentrations with two-fold dilutions starting at 
2.56 μM. A reference flow cell without immobilized NCP was included to subtract unspecific 
binding. Data was processed using GraphPad Prism 7.0. 
USP48 cleavage reactions. All cleavage reactions were done in reaction buffer 25 mM HEPES 
pH7.5, 150 mM NaCl, 5 mM DTT. NCPs ubiquitinated on either one of the H2A ubiquitination 
sites with TAMRAUb were used and reaction was started by addition of USP48. Concentrations 
are indicated in the figures. Samples were taken at the indicated time points and reaction 
was stopped by addition of SDS-loading dye. Samples were separated on a NuPage 4-12 
% Bis-TRIS SDS gel in MES buffer (Thermo Fischer) and the fluorescence signal was read 
out on a Typhoon FLA-9500 gel scanner (GE healthcare). Quantification of individual bands 
was achieved by measuring the fluorescence intensity and relating it to the total intensity 
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of each lane at a known concentration of dye used in the respective assay. This way each 
band represents a fraction of the concentration of dye used in the experiment. To convert 
to molar concentration of ubiquitinated histones the dye concentration was divided by the 
number of labeled ubiquitins present on the respective histone species (H2Aub3, H2Aub2, 
H2Aub1). 
USP48 kinetic modeling. USP48 cleavage reactions as described before were done at va-
rying substrate and enzyme concentration to allow subsequent kinetic modeling. Different 
conditions are indicated in figure S3 and S4. Concentrations of the different reaction species 
were quantified and quantified data were used to globally fit the three different catalytic 
rates defined in figure 2E, k
cat(ub3)
, k
cat(ub2)
 and k
cat(ub1)
. Binding constants were fixed to k
on 
= 20 
μM-1s-1, an order of magnitude we routinely observe in SPR experiments, and k
off
 = 10 s-1 to 
reflect a Kd of 500 nM as approximated by SPR. Fitting was done using the software KinTek 
Explorer Version 6.1.170209. 
DNA repair reporter assays. U20S-DR3-GFP (gene conversion), U20S-SA-GFP (Single-strand 
annealing) and U20S-EJ5-GFP (Non-homologous end-joining) were a generous gift from 
Jeremy Stark (City of Hope, Duarte USA). U20S reporter cell lines were simultaneously 
co-transfected with siRNA using Dharmafect1 (Dharmacon) and DNA (RFP, or Flag-USP48 
and I-Sce1 endonuclease expression constructs) using FuGene6 (Promega) respectively. Af-
ter 16 hours the media was replaced and cells were grown for a further 48 hours before 
fixation in 2% PFA. RFP and GFP double positive cells were scored by FACS analysis using a 
CyAn flow cytometer and a minimum of 10000 cells counted. Data was analyzed using Sum-
mit 4.3 software. Each individual experiment contained 3 technical repeats and normalized 
to siRNA controls or to WT-complemented cells. Graphs shown are combined data from a 
minimum of 3 independent experiments and error bars show standard error. 
Colony Assays. Cells were plated at 2 x 105 cells/ml in a 24 well plate and treated as re-
quired. Cells were then trypsinized and plated at limiting dilution to form colonies and 
grown on for 10-14 days. Colonies were stained using 0.5% crystal violet (BDH Chemicals) in 
50% methanol and counted. Each individual experiment contained 3 technical repeats and 
is normalized to untreated controls. Graphs shown are combined data from a minimum of 3 
independent experiments and error bars show standard error.
Laser Microirradiation. Laser-microirradiation experiments were performed on BrdU-pre-
sensitized cells (10 μM BrdU, 24h) as described 60 using a Zeiss PALM MicroBeam equipped 
with a 355 nm UV-A pulsed-laser and the 40x objective with laser output at 40%, assisted by 
the PALMRobo-Software supplied by the manufacturer.
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Measurement of resection tracks (BrdU). 24 hours before fixation cells were incubated with 
10 µM BrdU and then 10 µM Olaparib for the last 16 hrs of treatment. Cells were trypsinized 
and resuspended in ice cold PBS to a concentration of 10 x 105 cells/ml. In order to lyse the 
cells, 2 µl of sample was placed on a slide and mixed with 7 µl of spreading buffer (200 mM 
Tris pH 7.4, 50 mM EDTA, 0.5% SDS) and incubated for 2 mins. Slides were then placed at a 
shallow angle to cause the droplet to gradually run down the slide, ensuring constant move-
ment of the droplet. Slides were fixed in 3:1 Methanol: Acetic Acid for 10 mins and then sto-
red at 4°C. Slides were washed in PBS and Blocking solution (2 g BSA, 200 µl Tween-20, 200 
ml PBS) and then incubated with mouse anti BrdU primary antibody. Slides were washed 
in PBS before being incubated with AlexaFluor donkey anti mouse 488. Images were taken 
on the Leica DM6000B microscope and analysis performed using ImageJ software. Lengths 
were calculated using a scale bar to convert pixels to µm and this ratio, of 3.493 pixels per 
µm, was used to measure BrdU track lengths. >100 fibres per treatment were measured and 
plotted on a Whisker plot using Graphpad.
Immunofluorescence. HeLa FlpIn, HeLa-Flag-USP48 or HeLa-Flag-USP48-C98S cells were 
seeded onto coverslips and transfected with siRNA, expression constructs and/ or induced 
with doxcycline as described. Cells were labelled with 10 µM EdU 10 minutes prior to irra-
diation using a Gamma-cell 1000 Elite irradiator (caesium-137 source). At 2 hours post-irra-
diation cells were washed briefly in CSK buffer (100 mM sodium chloride, 300 mM sucrose, 
3 magnesium chloride, 10 mM PIPES pH 6.8) before fixation with 4 % Paraformaldehyde for 
10 mins. For IF staining cells were permeabilized with 0.2% TritonX100 in PBS for 10 mins 
before blocking in 10 % FBS in PBS. EdU was visualised by Click-iT® chemistry according to 
the manufacturer’s protocols (Life Technologies) with Alexa-647-azide. Cells were incubated 
with primary antibody for 1 hr, washed three times in PBS and incubated with secondary 
AlexaFluor antibodies for 1 hr. The DNA was stained using Hoechst at 1:20,000. 
Microscopy. For 53BP1/BRCA1 foci analysis: Images of immunofluorescent staining were 
captured on the Zeiss 510 Meta confocal microscope, using three lasers to give excitation at 
647, 555 and 488 nM wavelengths. Images at each wavelength were collected sequentially 
at a resolution of approximately 1024 x 1024 pixels, using the Plan-Apochromat 100x/1.4 
Oil objective. All other immunofluorescent staining was imaged using the Leica DM6000B 
microscope using a HBO lamp with 100W mercury short arc UV bulb light source and four 
filter cubes, A4, L5, N3 and Y5 to produce excitations at wavelengths 360 488, 555 and 647 
nm respectively. Images were captured at each wavelength sequentially using the Plan Apo-
chromat HCX 100x/1.4 Oil objective at a resolution of 1392x1040 pixels. 
Statistics. BrdU resection tracks which were analysed by one-sided Mann-Whitney test with 
centre values given as median. All other statistical analysis was by two-sided Students T-test 
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throughout. *<p0.05, **p<0.01, ***P<0.005. All centre values are given as the mean and all 
error bars are standard error about the mean (S.E.M). For kinetic modelling, data was fitted 
globally to the defined model by numerical integration and best-fit parameters were deter-
mined by finding minimum Chi2 values using KinTek Explorer. Quality of the fit was evaluated 
by calculating the FitSpace shown in Figure 2 E.
Acknowledgements
Grant funding for this project was as follows. NWO-CW TOP 714.012.001, ERC 249997, Gra-
vity CGC.nl, CRUK: C8820/A19062 (RMD). JRM is HEFCE funded. We thank J. Stark (City of 
Hope) for U20S-DR3, U20A-SA and U20S-EJ5 cells and I-SCE1 plasmid and Claudia Lukas 
(University of Copenhagen) for YFP-RAD52. We thank the TechHub Facility at the University 
of Birmingham for Microscope and FACS support. 
Author Contributions
MU devised the screen and kinetic analysis and performed all in vitro assays, HHKW re-
constituted NCPs, AF supervised kinetic analysis, RMD performed cell and biochemical 
experiments, designed experiments and interpreted data. TKS initiated the project and su-
pervised MU, JRM contributed to data interpretation, directed the project and supervised 
RMD. MU, RMD, TKS and JRM contributed to writing the paper.
References
1. Chapman, J. R., Taylor, M. R. G. & Boulton, S. J. Playing the End Game: DNA Dou-
ble-Strand Break Repair Pathway Choice. Molecular Cell 47, 497–510 (2012).
2. Densham, R. M. et al. Human BRCA1-BARD1 ubiquitin ligase activity counteracts 
chromatin barriers to DNA resection. Nat. Struct. Mol. Biol. 23, 647–55 (2016).
3. Zimmermann, M. & De Lange, T. 53BP1: Pro choice in DNA repair. Trends in Cell Biol-
ogy 24, 108–117 (2014).
4. Ceccaldi, R., Rondinelli, B. & D’Andrea, A. D. Repair Pathway Choices and Conse-
quences at the Double-Strand Break. Trends in Cell Biology 26, 52–64 (2016).
5. Bhargava, R., Onyango, D. O. & Stark, J. M. Regulation of Single-Strand Annealing 
and its Role in Genome Maintenance. Trends in Genetics 32, 566–575 (2016).
78
3
Chapter 3
6. Bhattacharjee, S. et al. Choices have consequences: the nexus between DNA repair 
pathways and genomic instability in cancer. Clin. Transl. Med. 5, 45 (2016).
7. Ivanov, E. L., Sugawara, N., Fishman-Lobell, J. & Haber, J. E. Genetic requirements for 
the single-strand annealing pathway of double-strand break repair in Saccharomy-
ces cerevisiae. Genetics 142, 693–704 (1996).
8. Panier, S. & Boulton, S. J. Double-strand break repair: 53BP1 comes into focus. Nat. 
Rev. Mol. Cell Biol. 15, 7–18 (2014).
9. Jiang, Q. & Greenberg, R. A. Deciphering the BRCA1 tumor suppressor network. 
Journal of Biological Chemistry 290, 17724–17732 (2015).
10. Escribano-Díaz, C. et al. A Cell Cycle-Dependent Regulatory Circuit Composed of 
53BP1-RIF1 and BRCA1-CtIP Controls DNA Repair Pathway Choice. Mol. Cell 49, 
872–883 (2013).
11. Wu, L. et al. Identification of a RING protein that can interact in vivo with the BRCA1 
gene product. Nat. Genet. 14, 430–40 (1996).
12. Hashizume, R. et al. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inac-
tivated by a breast cancer-derived mutation. J. Biol. Chem. 276, 14537–40 (2001).
13. Reid, L. J. et al. E3 ligase activity of BRCA1 is not essential for mammalian cell viabil-
ity or homology-directed repair of double-strand DNA breaks. Proc. Natl. Acad. Sci. 
U. S. A. 105, 20876–20881 (2008).
14. Shakya, R. et al. BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Bind-
ing, But Not Its E3 Ligase Activity. Science (80-. ). 334, 525–528 (2011).
15. Drost, R. et al. BRCA1185delAG tumors may acquire therapy resistance through ex-
pression of RING-less BRCA1. J. Clin. Invest. 126, 2903–2918 (2016).
16. Drost, R. et al. BRCA1 RING function is essential for tumor suppression but dispens-
able for therapy resistance. Cancer Cell 20, 797–809 (2011).
17. Li, M. et al. 53 BP 1 ablation rescues genomic instability in mice expressing ‘ RING-
less ’ BRCA 1. EMBO Rep. 17, 1–10 (2016).
18. Bouwman, P. et al. 53BP1 loss rescues BRCA1 deficiency and is associated with tri-
ple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol. 17, 688–695 
(2010).
79
3
USP48 is a H2ABRCA1ub-specific DUB
19. Cao, L. et al. A Selective Requirement for 53BP1 in the Biological Response to Ge-
nomic Instability Induced by Brca1 Deficiency. Molecular Cell 35, 534–541 (2009).
20. Kalb, R., Mallery, D. L., Larkin, C., Huang, J. T. J. & Hiom, K. BRCA1 is a histone-H2A-spe-
cific ubiquitin ligase. Cell Rep. 8, 999–1005 (2014).
21. Mattiroli, F. et al. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage 
signaling. Cell 150, 1182–1195 (2012).
22. Wang, H. et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 
431, 873–8 (2004).
23. Xie, A. et al. Control of sister chromatid recombination by histone H2AX. Mol. Cell 
16, 1017–1025 (2004).
24. Muñoz, M. C. et al. Ring finger nuclear factor RNF168 is important for defects in 
homologous recombination caused by loss of the breast cancer susceptibility factor 
BRCA1. J. Biol. Chem. 287, 40618–40628 (2012).
25. Zhou, Y., Caron, P., Legube, G. & Paull, T. T. Quantitation of DNA double-strand break 
resection intermediates in human cells. Nucleic Acids Res. 42, e19 (2014).
26. Ochs, F. et al. 53BP1 fosters fidelity of homology-directed DNA repair. Nat. Struct. 
Mol. Biol. 23, 714–21 (2016).
27. Joo, H.-Y. et al. Regulation of cell cycle progression and gene expression by H2A deu-
biquitination. Nature 449, 1068–1072 (2007).
28. Lancini, C. et al. Tight regulation of ubiquitin-mediated DNA damage response by 
USP3 preserves the functional integrity of hematopoietic stem cells. J. Exp. Med. 
211, 1759–77 (2014).
29. Nicassio, F. et al. Human USP3 Is a Chromatin Modifier Required for S Phase Progres-
sion and Genome Stability. Curr. Biol. 17, 1972–1977 (2007).
30. Scheuermann, J. C. et al. Histone H2A deubiquitinase activity of the Polycomb re-
pressive complex PR-DUB. Nature 465, 243–7 (2010).
31. Sharma, N. et al. USP3 counteracts RNF168 via deubiquitinating H2A and γh2AX at 
lysine 13 and 15. Cell Cycle 13, 106–114 (2014).
32. Kalb, R. et al. Histone H2A monoubiquitination promotes histone H3 methylation in 
80
3
Chapter 3
Polycomb repression. Nat. Struct. Mol. Biol. 21, 569–71 (2014).
33. Nishi, R. et al. Systematic characterization of deubiquitylating enzymes for roles in 
maintaining genome integrity. Nat. Cell Biol. 16, 1016–26, 1–8 (2014).
34. Johnson, K. A., Simpson, Z. B. & Blom, T. FitSpace Explorer: An algorithm to evaluate 
multidimensional parameter space in fitting kinetic data. Anal. Biochem. 387, 30–41 
(2009).
35. Johnson, K. A., Simpson, Z. B. & Blom, T. Global Kinetic Explorer: A new comput-
er program for dynamic simulation and fitting of kinetic data. Anal. Biochem. 387, 
20–29 (2009).
36. Zhu, Q. et al. BRCA1 tumour suppression occurs via heterochromatin-mediated si-
lencing. Nature 477, 179–184 (2011).
37. Shibata, A. et al. Role of ATM and the Damage Response Mediator Proteins 53BP1 
and MDC1 in the Maintenance of G2/M Checkpoint Arrest. Mol. Cell. Biol. 30, 3371–
3383 (2010).
38. Stark, J. M., Pierce, A. J., Oh, J., Pastink, A. & Jasin, M. Genetic steps of mammali-
an homologous repair with distinct mutagenic consequences. Mol. Cell. Biol. 24, 
9305–16 (2004).
39. Adachi, N., So, S. & Koyama, H. Loss of nonhomologous end joining confers campto-
thecin resistance in DT40 cells: Implications for the repair of topoisomerase I-medi-
ated DNA damage. J. Biol. Chem. 279, 37343–37348 (2004).
40. Symington, L. S. Role of RAD52 epistasis group genes in homologous recombination 
and double-strand break repair. Microbiol. Mol. Biol. Rev. 66, 630–70, table of con-
tents (2002).
41. Rothenberg, E., Grimme, J. M., Spies, M. & Ha, T. Human Rad52-mediated homology 
search and annealing occurs by continuous interactions between overlapping nucle-
oprotein complexes. Proc. Natl. Acad. Sci. U. S. A. 105, 20274–9 (2008).
42. Mortensen, U. H., Lisby, M. & Rothstein, R. Rad52. Current Biology 19, R676–R677 
(2009).
43. Sahtoe, D. D. & Sixma, T. K. Layers of DUB regulation. Trends in Biochemical Sciences 
40, 456–467 (2015).
81
3
USP48 is a H2ABRCA1ub-specific DUB
44. Wang, Z. et al. USP51 deubiquitylates H2AK13, 15ub and regulates DNA damage 
response. Genes Dev. 30, 946–959 (2016).
45. Lee, B.-H. et al. USP14 deubiquitinates proteasome-bound substrates that are ubiq-
uitinated at multiple sites. Nature 532, 398–401 (2016).
46. Awad, S., Ryan, D., Prochasson, P., Owen-Hughes, T. & Hassan, A. H. The Snf2 homo-
log Fun30 acts as a homodimeric ATP-dependent chromatin-remodeling enzyme. J. 
Biol. Chem. 285, 9477–9484 (2010).
47. Stewart, M. D., Duncan, E. D., Coronado, E., Brzovic, P. S. & Klevit, R. E. Tuning BRCA1 
and BARD1 activity to investigate RING ubiquitin ligase mechanisms. Protein Sci. 26, 
475–483 (2016).
48. Shanbhag, N. M., Rafalska-Metcalf, I. U., Balane-Bolivar, C., Janicki, S. M. & Green-
berg, R. A. ATM-Dependent chromatin changes silence transcription in cis to dna 
double-strand breaks. Cell 141, 970–981 (2010).
49. Kakarougkas, A. et al. Requirement for PBAF in Transcriptional Repression and Re-
pair at DNA Breaks in Actively Transcribed Regions of Chromatin. Mol. Cell 55, 723–
732 (2014).
50. Ui, A., Nagaura, Y. & Yasui, A. Transcriptional elongation factor ENL phosphorylated 
by ATM recruits polycomb and switches off transcription for DSB repair. Mol. Cell 58, 
468–482 (2015).
51. Treuner, K., Helton, R. & Barlow, C. Loss of Rad52 partially rescues tumorigenesis 
and T-cell maturation in Atm-deficient mice. Oncogene 23, 4655–4661 (2004).
52. Delahaye-Sourdeix, M. et al. The 12p13.33/RAD52 Locus and genetic susceptibili-
ty to squamous cell cancers of upper aerodigestive tract. PLoS One 10, e0117639 
(2015).
53. Buchwald, G. et al. Structure and E3-ligase activity of the Ring-Ring complex of poly-
comb proteins Bmi1 and Ring1b. EMBO J. 25, 2465–74 (2006).
54. Luna-Vargas, M. P. A. et al. Enabling high-throughput ligation-independent cloning 
and protein expression for the family of ubiquitin specific proteases. J. Struct. Biol. 
175, 113–119 (2011).
55. Dharadhar, S., Clerici, M., van Dijk, W. J., Fish, A. & Sixma, T. K. A conserved two-step 
82
3
Chapter 3
binding for the UAF1 regulator to the USP12 deubiquitinating enzyme. Journal of 
Structural Biology 196, 437–447 (2016).
56. Clerici, M., Luna-Vargas, M. P. A., Faesen, A. C. & Sixma, T. K. The DUSP-Ubl domain 
of USP4 enhances its catalytic efficiency by promoting ubiquitin exchange. Nat. 
Commun. 5, 5399 (2014).
57. Sahtoe, D. D., van Dijk, W. J., Ekkebus, R., Ovaa, H. & Sixma, T. K. BAP1/ASXL1 recruit-
ment and activation for H2A deubiquitination. Nat. Commun. 7, 10292 (2016).
58. Luger, K., Rechsteiner, T. J. & Richmond, T. J. in Chromatin Protocols 119, 1–16 (Hu-
mana Press, 1999).
59. Lowary, P. . & Widom, J. New DNA sequence rules for high affinity binding to histone 
octamer and sequence-directed nucleosome positioning. J. Mol. Biol. 276, 19–42 
(1998).
60. Lukas, C., Falck, J., Bartkova, J., Bartek, J. & Lukas, J. Distinct spatiotemporal dynam-
ics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5, 
255–260 (2003). 
83
3
USP48 is a H2ABRCA1ub-specific DUB
Supplemental Material
Supplemental Figure 1
a Michaelis-Menten kinetics of the purified DUBs on minimal substrate UbRho. Different enzyme concentrations 
were used for different DUBs as indicated in the figure. The speed of the linear phase of the reaction is plotted at 
different substrate concentrations. The data were fit to the Michaelis-Menten equation using the program Graph-
Pad Prism. See also supplemental Table 1. Replicates of two experiments ± SEM
b Purified DUBs used on in this study. * Indicates bands corresponding to the respective DUB
c DUBs tested show no exclusive site specificity but rather preferential cleavage of H2A168ub, H2APRC1ub and H2A-
BRCA1ub in NCPs. Site specific reaction speed quantified for all DUBs tested. k
obs
 values were obtained by fitting an 
exponential function to the traces in D). Replicates of two experiments ± SEM. 
d Raw data of the FP assay to identify site specific DUBs. 2 μM of H2A168ub, H2APRC1ub or H2ABRCA1ub were cleaved 
by 500 nM of the indicated DUB. Different amplitudes are because the distance from the center of mass to the 
ubiquitination sites is different for differently modified NCP. Replicates of two experiments ± SEM
e Activity of the DUBs included in this study on minimal substrate. Cleavage of 2 μM minimal substrate UbRho 
using the same conditions as in the FP screen on nucleosomal substrates. Concentrations of the respective DUB 
used are indicated. 
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Supplemental Figure 2
a Time course of cleavage of 2 μM H2A168ub , H2APRC1ub and H2ABRCA1ub in NCPs by USP48 (50 nM) on SDS-gel quan-
tified using TAMRAUb. Fluorescent gel scans and quantification of the individual reaction species are shown. Repli-
cates of two experiments ± SEM
b Cleavage of all the di-Ubiquitin linkages by USP48 (100 nM). USP16 (500 nM) serves as an unspecific positive 
control.
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Supplemental Figure 3
a Gel based cleavage assay of H2ABRCA1ub kinetic analysis in Figure 2. TAMRAUb was used as readout and concentrati-
on of USP48 and H2ABRCA1ub were varied across the range indicated. Fluorescence readout of the gels and quantifi-
cations are shown including the fit obtained from fitting with KinTek explorer. 
b USP48 binding to NCPs of different ubiquitination status. Raw traces from the SPR experiments fitted in Figure 
2d.
c USP48iso1 cleavage of 2 μM H2ABRCA1ub in the absence and presence of 25 μM ubiquitin.  
d Ubiquitin does not activate USP48. Cleavage of 2 μM UbRho by 50 nM USP48 in the presence of indicated ubiqui-
tin concentrations.
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Supplemental Figure 4.
a Western blot for USP48 expression levels with two independent siRNA sequences. 
b Quantification of RAD51 foci in S-phase HeLa cells depleted for USP48 and fixed at 2 hours post 5 Gy IR. Graph 
shows mean RAD51 foci/cell, n >30 cells, errors = S.E.M. *** p<0.005 Student’s T-test.
c Quantification of RAD51 foci in S-phase HeLa cells depleted for USP48 and BRCA1 and fixed at 2 hours post 5 Gy 
IR. Graph shows mean RAD51 foci/cell, n=60 cells, errors = S.E.M. *** p<0.005 Student’s T-test.
d Quantification of RAD51 foci in S-phase HeLa cells depleted for USP48 and 53BP1 and fixed at 2 hours post 5 
Gy IR. Graph shows mean RAD51 foci/cell, n=115 cells, errors = S.E.M *** p<0.005, ns=non-significant, Student’s 
T-test.
e Quantification of RAD51 foci in S-phase HeLa cells depleted for USP48 and SMARCAD1 and fixed at 2 hours post 
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5 Gy IR. Graph shows mean RAD51 foci/cell, n=145 cells, errors = S.E.M *** p<0.005 Student’s T-test.
f Measures of non-homologous end-joining (NHEJ) are slightly decreased on USP48 depletion. Integrated NHEJ 
assay of cells treated with control (NTC) and USP48 siRNA. GFP-positive cells were normalised to the transfection 
efficiency (RFP) and %-repair is given compared to NTC. Graph shows mean of 5-independent experiments, error 
bars are S.E.M.
g Colony survival of HeLa cells depleted for USP48, BARD1 or treated with control siRNA and treated with ionising 
irradiation (IR). After treatment cells were plated at limiting dilutions and grown for 10-14 days to form colonies. 
Graph shows mean % survival normalised to untreated controls, n=4, error bars are S.E.M.
h Colony survival of HeLa cells depleted for USP48, CtIP and both USP48 and CtIP. Cells were treated with 1 Gy IR 
before plating out at limiting dilutions and grown for 10-14 days to form colonies. Graph shows mean % survival 
normalised to untreated controls, n=3, error bars are S.E.M. * p<0.05 Student’s T-test.
i Western blot of siRNA treated lysates probed for USP48 and CtIP.
Supplemental table 1
Best fit values for Michaelis-Menten kinetics from Figure S1A.
Supplemental table 1 
  Kcat (s-1) Km (uM) Kcat/Km (s-1 uM-1) 
USP1/UAF1 1.18 ± 
0.06 
0.34 ± 
0.06 
3.450 
USP3 0.00360 ± 
0.00006 
6.29 ± 
0.21 
0.0006 
USP7 0.51 ± 
0.04 
17.50 ± 
2.52 
0.029 
USP11 0.020 ± 
0.001 
0.31 ± 
0.03 
0.076 
USP12/UAF1 0.064 ± 
0.002 
4.31 ± 
0.45 
0.079 
USP15 0.23 ± 
0.02 
1.61 ± 
0.21 
0.143 
USP16 0.26 ± 
0.006 
8.20 ± 
0.49 
0.032 
USP48 0.02 ± 
0.0007 
5.14 ± 
0.53 
0.004 
BAP1/ASXL1 1.78 ± 
0.031 
3.57 ± 
0.19 
0.499 
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ABSTRACT
During DNA damage response, the RING E3 ligase RNF168 ubiquitinates nucleosomal H2A 
at K13-15. Here we show that the ubiquitination reaction is regulated by its substrate. We 
define a region on the RING domain important for target recognition and identify the H2A/
H2B dimer as the minimal substrate to confer lysine specificity to the RNF168 reaction. 
Importantly, we find an active role for the substrate in the reaction. H2A/H2B dimers and 
nucleosomes enhance the E3-mediated discharge of ubiquitin from the E2 and redirect the 
reaction towards the relevant target, in a process that depends on an intact acidic patch. 
This active contribution of a region distal from the target lysine provides regulation of the 
specific K13-15 ubiquitination reaction during the complex signaling process at DNA damage 
sites.
INTRODUCTION 
Ubiquitin conjugation is a regulatory post-translational modification employed by the cell 
in a variety of processes1. A three step cascade of E1, E2 and E3 enzymes is required for the 
reaction and the molecular mechanism of the ubiquitination process varies with the target 
and the enzymes involved.
Target specificity in the ubiquitination reaction is regulated in most cases by the E3 ligases2 
that can mono-, multi- or poly-ubiquitinate their substrates. The vast majority of these 
proteins function through a structurally conserved RING domain that is able to allosterically 
activate the E2~ubiquitin complex to release the ubiquitin moiety directly onto the lysine 
residue of the selected substrate3. 
In some cases, the modification site on the substrate is relatively undefined (for example, 
on p53, p27 and DDB2)4-6. In other cases, E3 ligase reactions are highly specific for a single 
residue (for example, PCNA, IκB, H2B and H2A)7-16. The difference in the stringency of 
the site-specificity of the E3 reactions highlights the diversity of signals generating from 
ubiquitination events. Some ubiquitin signals do not require a specific attachment site on the 
substrate, as they signal primarily through the ubiquitin moieties (for example, K48 chains 
for proteasomal degradation). However, in those cases where ubiquitination stimulates a 
specific molecular signal, the choice of target lysine must be restricted, resulting in a highly 
selective E3 reaction. Examples include the site-specific mono-ubiquitination of PCNA, H2B 
and H2A, which are recognized by specific interacting proteins, thus providing a selective 
signaling response17-21. 
How RING E3 ligases determine target selection is highly variable. In some classes of RING 
E3s components outside the RING domain are responsible for target selection. For instance, 
91
The acidic patch activates RNF168 driven H2A ubiquitination
4
in the family of Cullin-RING Ligases (CRLs) substrate recognition involves a separate molecule 
besides the subunit carrying the RING domain22. Similarly, for some RING E3s not belonging 
to the CRL family (for example, CHIP and c-Cbl)23,24, domains outside the RING motif are 
required for target recognition. 
In other cases, the isolated RING domains appear to be sufficient for lysine specificity13,14,25. 
In these instances, a selective RING/E2~Ub-substrate interaction must occur to orient the 
ubiquitination machinery to the correct lysine. However, the RING is situated at least 20-30 
Å away from the active site cysteine on the E2 enzyme where the C-terminal end of ubiquitin 
forms a thioester bond, ready to be attacked by the amino group of the target lysine. This 
implies that a region of the substrate, relatively far from the target lysine, may be involved 
in the ubiquitination reaction. 
The molecular mechanism of activation of the E2~Ub complex by the RING domain of E3s 
has recently been clarified by several studies26-28. These show how the RING domain and 
the ubiquitin-charged E2 form a trimeric complex that positions ubiquitin in a conformation 
proficient for efficient release onto the substrate lysine. In this orientation, the donor 
ubiquitin makes contact with the E2 via the I44 hydrophobic patch and a salt bridge via its 
R42, but also engages interactions with the E3 via residues of the I36 hydrophobic patch26-30. 
Stabilization of this state is a largely conserved mechanism among different RING-mediated 
reactions and mutation of these residues on ubiquitin affects E2 discharge and target 
modification. However, in this rather detailed mechanistic description of the ubiquitination 
reaction by RING domains, the role of the target molecule has thus far been poorly defined. 
Molecular insights on the potential catalytic roles of targets so far have been restricted to 
ubiquitin itself as a substrate during the formation of specific chain types by E2 conjugating 
enzymes29,30.
Here, we investigate the relative contributions of E3 and substrate during histone H2A 
ubiquitination by RNF168. H2A is one of the histone proteins composing the nucleosome 
core. H2A is abundantly modified on its C-terminal tail at K119 by the RING E3 ligases present 
in the Polycomb repressive complex 1 (PRC1), where RING1B/BMI1 is the most studied E3 
dimer12,13,31,32. Recently, the E3 ligase RNF168 has been described to target the N-terminal 
residues K13-15 during DNA double-strand break signaling14,15. 
RNF168 is a monomeric E3 ligase that is recruited to sites of DNA damage by interaction 
of its conserved ubiquitin interaction motives with ubiquitin chains33-37. Its recruitment 
depends on the signaling of a large number of other proteins that are localized at damage 
sites with faster kinetics35-37. Once RNF168 is localized at these sites, its ability to target K13-
15 on H2A is required for a functional response cascade14,20. This ubiquitination reaction is 
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highly selective for K13-15 in cells and interestingly the RING domain of the E3 is sufficient 
to confer target specificity in vitro with the E2 UbcH5c14,20. This provides a useful system 
for mechanistic studies of the molecular determinants on the E3 and the substrate that 
regulate this specificity. 
In this study we identify the region on the RING domain of RNF168 that interacts with its 
targets, namely the nucleosomes and H2A/H2B dimers. We find that these susbtrates activate 
the RNF168-dependent reaction and this effect is dependent on a conserved acidic patch 
present on the H2A/H2B surface. These findings indicate that RNF168-dependent K13-15 
modification is regulated by a region located distally to the target lysines. In addition, they 
highlight the importance of accessibility to the acidic patch by the ubiquitination machinery 
during DNA damage signaling.    
RESULTS 
RNF168 can site-specifically modify H2A/H2B dimers 
We previously showed that the E3 ligase RNF168 is specific for K13 and K15 on H2A in 
oligonucleosomes in vivo and in vitro14. Here, by using recombinant nucleosome core 
particles (NCPs) carrying lysine mutations on H2A we find that, although eventually other 
lysines are also modified, the RING domain of RNF168 is sufficient to favour modification 
of the K13-15 lysines in vitro (Supplementary Fig 1a). As we use a RNF168 construct (R; 
residues 1-189), carrying not only the RING domain but also the MIU1 and UMI motives33-37 
we wondered if specificity for the K13-15 site is affected upon deletion of these ubiquitin-
binding regions (Supplementary Fig. 1b). With a minimal RING domain construct (residues 
1-113) we observe a decrease in activity towards H2A in NCPs but the specificity for K13-15 
is retained (Supplementary Fig. 1c), confirming that the short RING domain provides the 
observed lysine specificity20.
Next, we investigated the minimal substrate requirements for RNF168 activity. As previously 
shown14, RNF168 can target the isolated histone H2A in vitro in an aspecific manner, as the 
K13-15R mutant is modified at similarly low levels as WT H2A (Fig. 1a). This is not surprising 
as the histone in isolation is mostly unfolded.
In contrast, when a reconstituted dimer of H2A and H2B is provided as substrate, the RING 
domain of RNF168 can modify the WT protein efficiently, but not the K13-15R variant, 
indicating that the reaction becomes specific for these lysines on H2A (Fig. 1b). These findings 
indicate that the isolated H2A/H2B dimer is sufficient to provide H2A lysine specificity for 
the RNF168 RING domain reaction. 
When we compare the activity of RNF168 towards H2A, the H2A/H2B dimer and NCPs, we 
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observe that rates of modification for dimer and NCP are very similar and much higher 
than on H2A alone (Fig. 1c), showing that the histone dimer contains the minimal molecular 
features that define the relevant substrate for RNF168 activity. 
RNF168 RING uses a charged region for nucleosome recognition
To understand how the RNF168 RING domain recognizes its substrate, we first set out to 
identify the region on the RING domain involved in nucleosome interactions. We have 
previously shown that a charged residue located adjacent to the second Zn ion in the 
RNF168 RING domain (R57, Fig. 2a) is important for nucleosomal H2A ubiquitination but 
not for targeting the isolated histone or making ubiquitin chains14. 
First, we observed that the R57D RING domain mutant has lost activity towards H2A in the 
H2A/H2B dimer (Fig. 2b), indicating that the function of this residue is retained when only 
H2A and H2B are present. Additionally, we tested an RNF168 R57A mutant RING domain. 
Figure 1 The H2A/H2B dimer is specifically modified at K13-15 by the RNF168 RING domain
a) RNF168 targets H2A in isolation in an inefficient manner and its activity is not specific for K13-15. RING1B/BMI1 
are inactive towards the histone protein alone. Ubiquitination assay performed in presence of H2A WT or K13-
15R in isolation. b) RNF168 targets H2A specifically on K13-15 within the H2A/H2B dimer. Ubiquitination assays 
performed in presence of WT or K13-15R H2A in H2A/H2B dimer. Single time point assay, where RING1B/BMI1 
were used as negative control. Time course assay (10-30-60-90 minutes) in presence of WT or K13-15R dimers 
(assays performed at 200 mM NaCl). c) RNF168 has comparable activity for H2A in dimers and in nucleosomes, 
while isolated H2A is targeted with low efficiency. Time course assay (10-30-60-90 minutes) to compare activity of
RNF168 RING domain towards H2A alone, H2A/H2B dimers and NCPs. 
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This protein also inhibits the E3 ligase function towards the histone dimer (Fig. 2c), excluding 
the possibility that the observed effect is caused by electrostatic repulsion of the aspartate 
mutant.
To further explore this region on the RING domain we analyzed the importance of a helix 
adjacent to this site in RNF168, rich in positively charged residues. We replaced this helix 
(residue 58-72, Fig. 2a) with a shorter loop that is present on RNF8, an E3 ligase that is inactive 
towards nucleosomal H2A14 (residues 444-449, Fig. 2a). The constructs include either the 
helix alone (8loopR) or the helix and the R57D mutation (8loopD). Neither of these mutants 
is affected in its ability to promote ubiquitin chain formation (Fig. 2d). Nevertheless, both of 
these have lost the ability to modify H2A within the H2A/H2B dimer (Fig. 2b). Overall, these 
results show that both R57 and the adjacent helical region on the RING domain of RNF168 
are required for H2A modification. 
To test whether this region is involved in direct interaction with the substrate, we analyzed 
binding of the RNF168 RING domain to recombinant NCPs using native gel-shift assays and 
to H2A/H2B dimers using fluorescence polarization (FP) experiments. The RING domain of 
RNF168 binds to H2A/H2B dimers with an apparent dissociation constant (Kd) of ~1 µM (Fig. 
2e) and it can shift NCPs on a native gel (Fig. 2f). In contrast, the R57D mutant shows impaired 
binding to both substrates (Fig. 2e,f), indicating a role for this site in direct interaction with 
the H2A/H2B dimer and the NCPs.
In the RING domain of RING1B (Fig. 2a), the structurally analogous region to this C-terminal 
helix is involved in DNA binding and thereby in target recognition25, therefore we tested the 
DNA binding capacity of the RING domain of RNF168. In a buffer containing 50 mM NaCl, 
RING1B/BMI1 binds a double-strand 15mer DNA (Kd = 1-1.5 µM, Fig. 2g)25. In contrast, even 
at this low salt concentration, RNF168 shows very weak interaction with DNA (>10 µM, Fig. 
2g). At higher salt concentrations no binding is observed. This indicates that RNF168 doesn’t 
recognize NCPs through DNA interactions, in line with the observation that the H2A/H2B 
dimer is sufficient to provide an efficient substrate. 
Overall, these data show that RNF168 RING domain binds the H2A/H2B dimer and the 
nucleosomes. The charged region at the C-terminal end of the RING domain of RNF168 
is involved in this binding and thereby in substrate selection. Mutations in this positively 
charged region impair the RNF168-mediated H2A modification by disrupting the binding to 
its substrate, the NCPs. Notably, the intrinsic free ubiquitin chain forming activity of RNF168 
is not affected in these mutants (Fig. 2d).
H2A modification requires an intact nucleosomal acidic patch
We next investigated how the H2A/H2B dimer confers selectivity to the RNF168-driven 
reaction. The H2A/H2B dimer is known to form an acidic patch on the surface of the 
nucleosome core, by clustering several glutamate residues from H2A and H2B (Fig. 3a). This 
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Figure 2 
RNF168 RING domain interacts with the target through a charged region 
a) Position of the targeting region on the RNF168 RING domain: 8loopD: replacement of residues 57-72 on RNF168 
(PDB-code:3L1154, in magenta) with residues 443-449 of RNF8 (PDB-code: 4AYC14, in orange). 8loopR: replacement 
of residues 58-72 on RNF168 with residues 444-449 of RNF8: R57 is present in this RING domain mutant. The 
residues in RNF8 used in the 8loopD mutant are highlighted in olivegreen (D443 in sticks). Position of the targeting 
region relative to E2 binding (Model based on the RNF4/UbcH5a~Ub structure PDB-code: 4AP427) b) H2A/H2B 
dimer targeting by RNF168 requires both the helix (58-72) and R57. Anti-H2A blots of time course experiment 
(30-60-90 minutes) performed in presence of H2A/H2B WT dimer (5 µM) and different mutants of RNF168 RING 
domain (1 µM). Anti-ubiquitin blot of these samples are shown in panel d. c) Mutation of R57 to A or D inhibits 
the activity of the RING domain towards H2A/H2B dimers. Time course single turnover assay (1,2,4,8,16 minutes), 
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acidic patch is employed by a variety of proteins, including the H4 tail, for binding to the 
nucleosomes in different processes38. To investigate a potential role for this patch in the 
RNF168 reaction, we assembled H2A/H2B dimers with mutant histones (E61,64,91A on H2A 
and/or E102,110A on H2B). These mutations do not affect the formation of the H2A/H2B 
dimers (Supplementary Fig. 2a), but they prevent RNF168-dependent H2A ubiquitination 
(Fig. 3b). Similar results were obtained when we reconstituted NCPs with all five glutamates 
mutated (NCP EA) indicating that the integrity of this patch is required for productive 
ubiquitination by RNF168 (Fig. 3c). 
To confirm these findings, we performed ubiquitination assays using wild-type NCPs in 
presence of a peptide known to bind on the acidic patch (LANA)39. In these experiments, 
increasing amounts of LANA peptide were found to inhibit the ubiquitination of nucleosomal 
H2A. Using a mutant variant of this peptide (LRS), unable to bind the nucleosome39, did 
not affect the reaction (Fig. 3d). This supports the hypothesis that the acidic patch on the 
nucleosome is required for activity of the RNF168/UbcH5c ubiquitination machinery.
The acidic patch is not involved in binding by RNF168/UbcH5c
To analyze the importance of the acidic patch for recruitment of the E3, we compared 
binding of the RNF168 RING domain to wild-type or EA mutant NCPs and H2A/H2B dimers. 
Surprisingly, the presence or absence of the acidic patch does not affect the binding of 
RNF168 RING domain to these substrates (Fig. 4a-b). Moreover, binding of the RNF168 RING 
domain on wild-type NCPs cannot be competed out by the LANA peptide (Fig. 4c) although 
this does inhibit ubiquitination activity (Fig. 3d).
These observations indicate that, in contrast to the RNF168 R57 site, the acidic patch on the 
target is not involved in the direct interaction with the E3 ligase. Since simple recruitment of 
the E3 ligase to the substrate does not explain the importance of the acidic patch for RNF168 
activity, a different step in the ubiquitination reaction must be affected. We wondered 
whether the acidic patch would affect the formation of the NCP-E3-E2~Ub complex. 
We used a mutant UbcH5c where the active site cysteine is mutated to lysine (C85K) to 
form a stable isopeptide linkage with the C-terminal tail of ubiquitin27, preventing the 
release of the ubiquitin in presence of the E3 and the substrate. With this stable E2~Ub 
complex we could assess how the RING/E2~Ub complex binds to NCPs in gel-shift assays. 
coomassie staining of SDS-PAGE gel. Appearance of ubiquitinated H2A is visible only in presence of WT RNF168. 
Experimental conditions as in Fig. 5b-c (100 nM E3). E2~Ub discharge occurs only in presence of a targetable 
substrate. d) Mutation of the helix (58-72) and R57 do not inhibit ubiquitin chain formation by RNF168 RING 
domain. Anti-ubiquitin blot of the samples shown in panel b. e) RNF168 RING domain interacts with H2A/H2B 
dimers via the R57 site. Fluorescence Polarization (FP) assay using Cy5H2A/H2B dimers (10 nM) and increasing 
amounts of RNF168 RING domain WT or R57D mutant. BSA is shown as a control to assess the effect of protein 
crowding in the reactions. Mean and SEM are shown, calculated on at least two independent experiments. f) 
RNF168 RING domain interacts with NCPs via the R57 site. Gel shift assay performed in presence of WT NCPs 
(100 nM) and increasing concentrations of RNF168 RING domain WT or R57D (0.77-1.55-3.1-6,2-12,5-25-50 µM). 
g) RNF168 RING domain binds DNA with very low affinity at 50 mM NaCl, compared to the RING domains of 
RING1B/BMI1 (RB R). DNA binding measured by FP assay of TAMRA-labeled 15mer DNA. Mean and SEM are shown, 
calculated on two replicates.
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In these assays the E2~Ub complex alone does not bind to NCPs (Fig. 4d, lane 8 and 4e, 
lanes 1-6) but it causes an additional shift of the E3-NCP complex when E2~Ub is present at 
high concentrations (>25 µM) (Fig. 4d). This shows that a trimeric complex can assemble on 
NCPs containing E3/E2~Ub, although the E2~Ub component does not significantly alter the 
affinity of the RING for NCPs. 
Interestingly the trimeric complex is observed for both WT and EA NCPs with the charged E2 
complex (Fig. 4e). This implies that its assembly takes place independently of the integrity of 
the acidic patch. We conclude that binding of the ubiquitination machinery to the substrate 
does not rely on the nucleosomal acidic patch.
The acidic patch is critical for H2A ubiquitination by RNF168
Since the importance of the acidic patch for activity (Fig. 3) is not explained by a role in 
binding (Fig. 4), we postulated that these negative charges on the nucleosome core may 
Figure 3
Targeting H2A requires an intact and accessible acidic patch  a) Position of the acidic patch within the nucleosome. 
NCP structure (1KX555) where H2B is shown in orange, H2A in yellow-orange, H3 in light-pink and H4 in violet. 
K118-119 on H2A are highlighted in blue, K13-15 are in green and the glutamate residues of the acidic patch are 
shown in red. Distance between K13-15 and the acidic patch are indicated on the left. Electrostatic potential (red 
is negative, blue is positive) of the histone core in the NCP highlights the acidic patch on the surface of the H2A/
H2B dimer. b) Mutations in the acidic patch on H2A or H2B impair H2A ubiquitination in H2A/H2B dimers. Time 
course experiment (30-60-90 minutes) following activity of RNF168 RING domain towards H2A in the different 
H2A/H2B mutant dimers. c) Acidic patch mutations prevent ubiquitination of NCPs. Time course experiment (30-
60-90 minutes) to investigate the activity of RNF168 RING domains towards H2A in nucleosome WT or EA (H2A 
E61,64,91A and H2B E102,110A). d) Binding of a LANA peptide, but not a mutant LRS variant, to the nucleosome 
competes with RNF168-dependent ubiquitination of NCPs. Ubiquitination assay with 3-10-30-100 µM peptide. 
Note that E91 on H2A is part of the epitope recognized by the anti-H2A antibodies, therefore there is reduced 
signal on western blots when the E91A mutation is introduced.
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have a role in the actual catalysis by the RNF168 RING domain and the E2 UbcH5c.
To address this point we performed single turnover assays following the rate of ubiquitin 
discharge from UbcH5c in presence of RNF168 and of the different substrates. 
In these reactions, when the E3 concentration is low (100 nM), RNF168 is hardly capable 
to activate ubiquitin discharge (Fig. 5a, lanes 4-5-6), compared to conditions where we 
use 1 µM E3 concentrations (Fig. 5a, lanes 10-11-12). Nevertheless, when substrate (NCPs) 
was added to the reactions, we observed a drastic activation of the discharge rate even 
Figure 4 
The nucleosome interacts with the E2~Ub/E3 complex independently of the acidic patch
a) Mutation of the acidic patch on H2A/H2B dimers does not affect RNF168 RING domain binding. Fluorescence 
Polarization (FP) assay using Cy5-labelled H2A/H2B dimers (10 nM) and increasing amounts of RNF168 RING 
domain WT. Mean and SEM are shown, calculated on at least two independent experiments. b) The RNF168 RING 
domain binds equally well to NCPs with (WT) and without acidic patch (EA). Gel-shift assay with NCPs WT and 
EA (100 nM) and RNF168 RING domain (1.55-3.1-6.2-12,5-25-50 µM). c) Binding to NCPs does not rely on the 
accessibility of the acidic patch. Gel-shift assay where NCPs WT (100 nM) are assessed for binding by RNF168 RING 
domain (25 µM) with increasing concentration of LANA peptide WT (12-25-50-100 µM). d) The E2~Ub thioester 
shifts the E3-NCP complex at high concentrations. Gel-shift assay where WT NCPs (100 nM) are assessed for binding 
by RNF168 RING domain (3.1-6.2-12.5-25-50-100 µM, lanes 2-7) and/or UbcH5c~Ub (3.1-6.2-12.5-25-50-100 µM, 
lanes 9-14). In lanes 9-14 the E3 concentration was kept constant to 100 µM. e) Both WT and EA NCPs can form a 
E2~Ub/E3/target complex. Gel-shift assay where NCPs WT (100µM, lane 1-14) and EA (100 nM, lane 15-28)) are 
assessed for binding by UbcH5c~Ub (3.1-6.2-12.5-25-50-100 µM, lanes 2-7/15-21) or for binding of RNF168 RING 
domain (3.1-6.2-12.5-25-50-100 µM, lane 8-13/22-27) in the presence of 100 µM UbcH5c-Ub.
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at these low RNF168 concentrations (Fig. 5a, lanes 1-2-3). This effect was only observed 
in presence of RNF168 (Fig. 5a, lanes 13-14-15), confirming that the NCPs alone do not 
promote discharge of the E2~Ub complex.
As quantified in Fig. 5b-c, the activating contribution of the substrate to the RNF168 reaction 
was observed both for NCPs and H2A/H2B dimers (Fig. 5b-c, solid black lines). Moreover, in 
these experiments we also noticed that the substrate seems to redirect the ubiquitination 
from chain formation to target protein modification. While the sole addition of the RNF168 
RING domain increases the amount of ubiquitin conjugates in the reaction as expected 
Figure 5
The active role of the substrate in the reaction depends on the acidic patch. 
a) The substrate activates the discharge of ubiquitin from the E2 by RNF168 RING domain. Single turnover 
experiment performed at different E3 concentration shows that in presence of NCPs, there is activation of the 
enzymatic activity of RNF168 RING domain. The NCPs alone, in absence of RNF168, (lanes 13-15) are unable to 
stimulate E2 discharge. b-c) NCPs (b) and H2A/H2B dimers (c) further stimulate E2 discharge by RNF168. In the 
absence of the charges on the acidic patch the substrate-dependent activation is not taking place. Quantification 
of time course single turnover assays (1,2,4,8,16 minutes), where peak height of the E2~Ub band was used from 
Coomassie stained SDS-PAGE gels. Example gels are shown, the gels were run for longer time to increase the 
separation between the E2~Ub and the H2Aub bands. The samples at time 0 were used for the normalization. At 
least two independent experiments per time point and condition where used for quantification. Mean and SEM 
are shown. 100 nM E3 was used in these reactions. d) Ubiquitin residues required for E3 allosteric activation are 
important in the reaction towards the substrate. Single turnover assays in presence and absence of NCPs performed 
with 20 µM E2~Ub and 1 µM E3 and 5 µM substrate, time course 1,5-3-4-6-8 minutes. The R42E ubiquitin mutant 
samples were run using oligonucleosomes and not recombinant NCPs.
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(Fig. 5a, lanes 4-5-6-10-11-12 and Supplementary Fig 3a-b, lane 7 to 11), the concomitant 
addition of the substrate NCP or H2A/H2B dimer strongly reduces the formation of high 
molecular weight ubiquitin species in favor of H2A modification (Fig. 5a, lanes 1-2-3-7-8-9 
and Supplementary Fig 3a, lanes 12 to 16 and 3b, lanes 13 to 17). This suggests that the 
substrate is actively involved in catalysis by directing the E2/E3 activity towards the target 
lysine on H2A.
Interestingly, when we used NCPs or H2A/H2B dimers with mutation of the acidic patch (EA), 
the activation of the E2~Ub discharge due to the presence of the substrate was lost (Fig. 5b-
c, solid gray lines) and the high molecular weight ubiquitin chains were formed in similar 
amounts compared to the reactions where the substrate is not present (Supplementary Fig. 
3a, lanes 17-21 and 3b, lanes 18-22). These findings show that the acidic patch residues are 
critical for catalysis by RNF168/UbcH5c, without being involved in the interaction between 
the ubiquitination machinery and the target (Fig. 4). 
In previous studies of the RING E3 mechanism it became clear that an important step in 
the reaction can be the positioning of ubiquitin for catalysis26-30. A possible function of the 
substrate in these reactions may cause a different catalytic mechanism by forcing a different 
orientation of ubiquitin in respect to the E3/E2 machinery to enhance the ubiquitin transfer. 
We investigated if mutation of key residues critical in RING-dependent stabilization of an 
E2~ubiquitin complex26-28 could affect the RNF168 reactions in presence or absence of 
the target. In these assays the I44, L8, R42 and K33 sites are required for both substrate-
independent and -dependent reactions (Fig. 5d), indicating that RNF168-dependent 
catalysis is likely to utilize a similar mechanism as previously described26-28 both in presence 
and in absence of the substrate. This suggests that the acidic patch effect during the RNF168 
reaction is not due to a repositioning of the ubiquitin moiety in the ubiquitination complex. 
Moreover, since mutation of the residues forming the acidic patch on either H2A or H2B 
individually has comparable effects (Fig. 3a), it seems likely that the role of the acidic patch 
is not mediated by a single glutamate residue involved in catalysis, but rather that the 
nucleosomal negative surface at this region influences the reaction by RNF168/UbcH5c, 
either by orienting the machinery or by long-range effects on the catalysis (Fig. 6a). 
DISCUSSION
The mechanism of RING-dependent ubiquitination reactions is complex and does not involve 
enzymes with conventional catalytic properties. Recent studies have highlighted how RING 
domains allosterically activate the release of ubiquitin from the E226-28, but relatively little is 
known about the influence of the substrate on the reaction. 
H2A ubiquitination is particularly interesting because the RING domains of the respective 
E3 ligases can provide lysine specificity to the in vitro reactions with the same E2 enzyme, 
UbcH5c. Therefore the RING domains of PRC1 and RNF168 must contain the molecular 
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requirements to orient themselves, providing a minimal system for studying substrate 
recognition and its role in the catalytic process. 
This study focuses on the recently described K13-15 ubiquitination of H2A by RNF168, which 
has roles in the DNA damage signaling. We showed that the isolated H2A/H2B dimer is the 
minimal relevant substrate required for an efficient and specific reaction. Then we identified 
a region on the RING domain of the E3 involved in substrate binding. Next, we found that 
the substrate is able to accelerate the reaction catalysed by RNF168/UbcH5c, redirecting 
ubiquitination activity towards the physiologically relevant lysines on H2A. These effects are 
highly dependent on an intact acidic patch on the H2A/H2B dimer within the nucleosome. 
The actual mechanism used by these substrates to regulate  catalysis and the selectivity for 
specific lysines require further analysis. Particularly the target lysines (K13-15) are likely to 
play a role in this mechanism, but we have not succeeded in uncoupling the contribution 
of these residues, because the lysine mutants are still modified in these in vitro reactions. 
Nevertheless, our results are important for understanding the mechanistic aspects of the 
RNF168 reaction as well as its functional requirements in the biological context of DNA 
damage signaling. The acidic patch is located far from the target lysine, providing the first 
distal substrate region with a direct role in ubiquitination catalysis beyond mere binding. 
This proposes a novel role for substrates in ubiquitination reactions that may well be more 
general, although it is unlikely that all ubiquitination targets will contribute to ubiquitination 
reactions in this manner. When the target is non-specific and it is not important which lysine 
is modified, as proposed for example for Cullin-mediated reactions40, such an involvement 
is less likely. For cases where the lysine location is a critical signal, however, the catalytic 
involvement of the substrate can provide an important step in optimizing selectivity and 
efficiency of the ubiquitination reaction, with unique aspects. Such a complex mechanism 
ensures that modification takes place only when sufficient E3/E2~Ub is available that 
contacts the substrate in a specific configuration, where two conditions are met: the lysine 
Figure 6
The nucleosomal acidic patch is critical for RNF168 reaction 
a) The ubiquitination of K13-15 on H2A in nucleosomes requires a positive patch on RNF168 for recruitment of the 
E3 ligase to the H2A/H2B dimer and the nucleosome. The negatively charged acidic patch formed by H2A and H2B 
activates and redirects the reaction from chain formation to selective H2A modification.
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is available in proximity to the E2-ubiquitin thioester and the machinery can cross-talk to a 
distal region involved in the activation. Active involvement of the substrate may explain the 
low affinity interactions that are observed between RING E3s and their substrates, since it 
adds a regulatory step additional to proper target recognition. 
Our data shows that RNF168 requires accessibility to the acidic patch on nucleosomes to 
target H2A. A large number of proteins are known to bind to this site, and RNF168 will 
have to compete with those to exert its function at DNA double-strand breaks sites. 
RNF168 is recruited to damaged chromatin by binding to ubiquitin chains, controlling 
the local concentration. The low affinity we measure for the E3 to the substrate ensures 
a dependence on the recruitment step and prevents premature action of RNF168. Here 
we propose that RNF168 reaction can only progress after adequate preparation of the 
chromatin fibers around the site of damage, where the acidic patch will be exposed. Many 
proteins are known to act upstream of RNF168, including E3 ligases such as RNF8 and HERC2 
and other enzymes, for example, ATM and chromatin remodelers35-37,41-46. Some of these are 
required to recruit RNF168, but it is plausible that others are necessary to create the proper 
chromatin conformation around the damage that allow access to the acidic patch and hence 
promote ubiquitination of H2A. In addition, our study highlights that different histone H2A 
variants with alterations to the acidic patch residues may be treated differently by RNF168, 
for example, H2A.Bbd and H2A.Z47,48. 
Overall, our findings contribute to the understanding of the molecular requirements 
necessary for proper RNF168 activity on nucleosomal H2A and to the clarification of the 
necessary steps required for DNA damage signaling in response to DNA double-strand 
breaks. 
 METHODS
Protein Expression and Purification
E1 was purified using His-tag affinity purification, PorosQ and gel-filtration columns49. 
UbcH5c was purified by GST-tag affinity purification and gel filtration after tag cleavage; 
untagged ubiquitin was purified by perchloric acid precipitation, Sepharose SP and Superdex 
75 columns13,14. RNF168 (1-189) and RING1B/BMI1 RING domains were purified using a His-
SUMO tag and a GST- and His-tags respectively, after cleavage of the tag, the proteins were 
run on a Superdex 75 column13,14. Oligonucleosomes were purified from HEK-293T cells13,14. 
Histone proteins were purified in denaturing conditions50. All point mutants, the RING loop 
substitutions and the acidic patch mutants were generated using the quickchange site 
directed mutagenesis kit (Stratagene). RNF168 (1-113) was cloned into a pGEX6p vector and 
it was expressed in E.coli with an overnight induction with 0.2 mM IPTG at 16ºC. After lysis in 
buffer containing 30 mM Hepes 8.0, 500 mM NaCl, 10% glycerol, 1 µM ZnCl
2
, 1 mM TCEP, the 
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protein was purified using GSH beads (GE healthcare) and eluted with 50 mM glutathione. 
The tag was cleaved by GST-3c overnight in dialysis with lysis buffer. After removal of the 
protease, the uncleaved protein and the GST with GSH beads, the protein was loaded into a 
Superdex 75 column (GE healthcare) in 30 mM Hepes 8.0, 250 mM NaCl, 1 µM ZnCl
2
, 1 mM 
TCEP. The fractions containing the protein were concentrated and stored at -80ºC. SDS-PAGE 
of the final sample is shown in Supplementary Fig. 1b. Histone dimers were prepared by 
mixing H2A and H2B proteins in denaturing buffer. After refolding in dialysis tubes against 20 
mM HEPES pH 7.5, 2M NaCl and 0.5 mM EDTA and 0.5 mM TCEP at 4ºC overnight, the dimer 
was purified by gel-filtration on a S200 column (GE Healthcare) in 20 mM HEPES pH 7.5, 2 M 
NaCl and 0.5 mM EDTA and 0.5 mM TCEP, then concentrated and stored at -80ºC. To minimize 
the NaCl contribution in the assays containing dimers, gel filtration in presence of buffer 
containing 500 mM NaCl was performed. The elution profile of the dimers in this condition 
remained unaltered. Assays shown in Fig. 5 and 3 were performed with dimers stored at 500 
mM NaCl. Nucleosome core particles were prepared using a KCl gradient (2-0.15M)51,52. DNA 
used for the reconstitution was the 167 bp Widom 601 sequence53. The final purification 
step was a DEAE ion exchange column instead of preparative gel electrophoresis. After the 
linear salt gradient, NCPs were stored at 4ºC in 20 mM HEPES pH 7.5, 200 mM KCl, 0.5 mM 
EDTA and 0.5 mM TCEP, for longer storage at -80ºC a final concentration of 20% glycerol was 
added to the samples. Mutant proteins were treated and prepared as wild-type. 
In vitro ubiquitination assays
All in vitro ubiquitination assays (except those involving discharge assays in Fig. 2c, 5 and 
Supplementary Fig. 3r ) were done as follows: E1 (0.2 µM) was mixed with UbcH5c (0.5 
µM), E3 ligase (0.5-1 µM), ubiquitin (3-5 μM), ATP (3mM) and 1 μM of histone H2A, H2A/
H2B dimer or NCPs. The reactions were incubated at 32 oC for 90 minutes (unless otherwise 
stated) in buffer 50 mM Tris/HCl pH 7.5, 100 mM NaCl, 10 mM MgCl
2
, 1 µM ZnCl
2
, 1 mM TCEP. 
Final salt concentration in the assays was normally around 150 mM, unless otherwise stated. 
Western blot analysis was performed using anti-H2A (Millipore 07-146, 1:1000 dilution) or 
anti-ubiquitin (Santa Cruz P4D1, 1:1000 dilution) antibodies, followed by secondary HRP-
conjugated anti-rabbit or anti-mouse antibodies respectively (BioRad, 1:10000 dilution).
E2 discharge assays
For the single turnover assays, the E2 was pre-charged with ubiquitin. Concentrations are 
given for Fig. 5 and 2c, in brackets for Fig. 5 and Supplementary Fig. 3. To load the E2, E1 at 
0.5 µM was mixed with 100 µM (70 µM) UbcH5c in presence of 100 µM (70µM) ubiquitin 
Mg2+ and 3 mM ATP in buffer 50 mM Tris/HCl pH 7.5, 100 mM NaCl, 10 mM MgCl
2
. The 
sample was incubated 30-60 minutes at room temperature. Reaction was stopped with 
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50 mM EDTA final concentration and incubation on ice for 2 minutes. This mixture was 
then used for the discharge reactions, a final concentration of 15 µM (20 µM) E2~Ub was 
incubated at 32°C with 100 nM (1 µM) of RNF168 RING domain alone or in presence of 10 
µM (5 µM) NCPs or 20 µM (5 µM) dimers. Samples were stopped at given times and were 
analyzed by Coomassie staining on SDS-PAGE in non-reducing conditions and subsequently 
western blot analysis was carried out using anti-H2A (Millipore,07-146) or anti-Ub (Santa 
Cruz, P4D1) antibodies. Samples were run on either 12% or 4-12% NuPAGE gels in MOPS 
buffer (Life Technologies). Images were taken using ChemiDoc XRS system (BioRad) and 
ImageLab program. Quantifications were done using the peak height value of the E2~Ub 
band on Coomassie gels in ImageLab and GraphPad was used to prepare graphs.
Fluorescence Polarization (FP) assay
DNA binding reactions were carried out with 5 nM TAMRA-labeled DNA (TAACCCTAACCCCTA), 
25 mM HEPES pH 7.4, 50 mM NaCl, 0.5% (w/v) BSA, 0.5% (v/v) Triton X-100. The RING 
domain protein solutions with the highest concentration were prepared in this buffer and 
subsequent dilutions were achieved by serial 1:1 dilutions in two repeats. The reaction was 
incubated for 15 min at room temperature before the measurements. 
For H2A/H2B dimer affinity studies an H2A mutant, carrying an additional cysteine at the 
N-terminus was engineered using PCR site directed mutagenesis. The cysteine was labeled 
with a Cy-5 maleimide dye (GE Healthcare) using a 1:5 excess of dye over protein. The 
labeling reaction was carried out for 8 hours at room temperature and stopped with 10 mM 
DTT. This mutant was used to prepare Cy-5H2A/H2B dimers, following the same protocol used 
to prepare wild-type dimers. 
To assess binding of RNF168 to Cy-5H2A/H2B dimer 10 nM of labeled dimer was titrated with 
increasing concentrations of RNF168 RING domain in a buffer containing 50 mM Tris pH 7.5, 
100 mM NaCl, 10 mM MgCl
2
 1 mM TCPE and 0.05% TWEEN20. The reaction was incubated 
for 5 minutes at room temperature prior to the measurement. 
Fluorescence polarization was measured in 384-low volume plates (Corning) using a 
PHERAstar plate reader (BMG Labtech) with a FP filter module, with excitation filter 540 nm 
and emission filter 590 nm for TAMRADNA and Ex 590 nm, Em 675 nm for Cy-5H2A/H2B. The 
data was analyzed with GraphPad and fitted to a one site binding model (Y=Bmax*X/(Kd + 
X)+offset).
UbcH5c C85K loading
The C85K mutation was inserted in pGEX6p, UbcH5c; the protein was expressed in E.coli 
with an overnight induction at 16ºC with 0.2 mM IPTG. After lysis in buffer containing 50 
mM Hepes pH 8 , 150 mM NaCl, 0.5 mM TCEP the protein was purified using GSH beads (GE 
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healthcare) and eluted with 50 mM glutathione. The tag was cleaved by GST-3c overnight 
in dialysis with lysis buffer. After removal of the protease, the uncleaved protein and the 
GST with GSH beads, the protein was loaded into a S75 column in 20 mM Hepes 8.0, 150 
mM NaCl, 1 mM TCEP. The fractions containing the protein were concentrated and stored 
at -80ºC. The mutant E2 was loaded  in a reaction containing 200 µM UbcH5c C85K, 200 
µM ubiquitin, 1 µM Uba1 and 50 mM Tris pH 9.5, 150 mM NaCl, 0.8 mM TCEP, 3 mM ATP, 
5 mM MgCl
2
27. The reaction was incubated at 35ºC for ~20 hours. The E2~Ub complex was 
purified on a S75 gel-filtration column and the fractions containing only the loaded E2 were 
concentrated and used for the gel-shift analysis shown in Fig. 4d-e.
Gel Shift experiments
Gel shift assays were performed using native gelelectrophoresis on 4-12% Pre-Cast Tris-
Glycine gels (Life Technologies), pre-run for at least 1 hour at 125V in Novex Tris-Glycine 
buffer. 100 nM NCPs were incubated with increasing amounts of E3 and/or E2~Ub in Shift 
Buffer (50mM Tris pH 7.5, 150 mM NaCl, 2mM arginine, 0,01% CHAPS, 0,01% Nonidet P-40). 
5x Loading buffer containing 40% Sucrose and 0.25% Bromophenol Blue was added to the 
sample and 5 µl of the samples were loaded and the gel was run for 90 minutes at 125 V. 
Gels were stained with GelRed and visualized using the ChemiDoc XRS and ImageLab.
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Supplemental Material
Supplementary Figure S1
RNF168 RING domain is sufficient for specific K13-15 modification
a) The RNF168 RING domain modifies preferentially K13-15 in H2A in NCPs whereas the PRC1 complex RING1B/
BMI1 prefers K118-119. Time course (15-30-60 minutes) assay using wild-type (WT), K13-15R or K118-119R H2A 
assembled NCPs. b) Schematic representation of the RNF168 domains and constructs used. Full-length protein 
architecture is shown in light gray. The construct used throughout the paper is labeled as R and spans residues 
1-189. The shorter RING domain spans residues 1-113, only used in Supplementary Fig. 1c as control. SDS-PAGE gel 
showing the samples of the RNF168 constructs used in this manuscript. c) RNF168 (1-113) retains K13-15 specificity 
on NCPs, although it is less active than RNF168 (1-189). Time course assay (10-30-90 minutes) in presence of WT 
and K13-15R NCPs. 
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Supplementary Figure S2
The acidic patch mutations do not affect H2A/H2B dimer formation.
a) Gel-filtration profiles of the different H2A/H2B dimer mutants (in 2M NaCl containing buffer) illustrate that dimer 
formation is not affected by mutagenesis. The horizontal black line highlights the fractions that were taken and 
concentrated for the assays. 
Supplementary Figure S3
The acidic patch activates E2 discharge and is critical for K13-15 modification.
a-b) EA mutant NCPs (a) and dimers (b) do not redirect ubiquitin chain formation to the target lysines on H2A. Time 
course (1.5,3,4,6,8 minutes) experiment performed with 0.5 µM E3. Coomassie stained SDS PAGE (12% NuPage gel, 
run in MOPS buffer), anti-H2A and anti-Ubiquitin (4-12% NuPage gel, run in MES buffer). Note that E91 on H2A is 
part of the epitope recognized by the anti-H2A antibodies, therefore there is reduced signal on western blots for 
this mutant, higher exposure of the anti-H2A blots are shown in panel a. 
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Abstract
The importance of lysine-specificity of RING E3 ligases is exemplified in the DNA damage 
response where three different ligases, RNF168, RING1B in a PRC1 complex and BRCA1/
BARD1, modify three distinct groups of lysines on H2A. The ubiquitination status eventually 
influences repair pathway choice and guides faithful repair. The molecular details of how 
specificity is achieved are not well understood, furthermore there is no generalized model 
put forward to explain RING E3 ligase specificity. Missing structural information on RING 
E3-target complexes, due to the often transient nature of these complexes, is one major 
limitation in understanding the basis for lysine specificity. Here we present three strategies 
to stabilize the RNF168-E2-Nucleosome complex for structural analysis. The strategies are 
generalizable and can potentially be applied to many other RING E3-E2-target complexes.
Introduction
To maintain genomic integrity DNA lesions need to be faithfully repaired1. The cell’s repair 
processes are in part guided by reversible histone modifications2. Specific ubiquitination of 
histone H2A is one such histone modification that plays an important role in the DNA dama-
ge response3. Lysine-specific monoubiquitination of target proteins is generally believed to 
be a crucial signaling entity in the ubiquitin system4. One family of E3 ligases that facilitate 
the transfer of ubiquitin to a target lysine are RING E3 ligases. These enzymes exert their 
function by promoting a conformation of the ubiquitin-charged E2 that is prone to aminoly-
sis5–8 while at the same time orienting the E2-active site towards the target lysine9. 
Three different RING E3 ligases have been shown to modify three different groups of lysines 
on H2A, RNF168, RING1B (RNF2) in a PRC1 complex and BRCA1/BARD110–12. Each of these 
ligases shows exclusive in vitro specificity for their cognate site on H2A, K13/15 for RNF168 
(H2A168), K118/119 for PRC1 (H2APRC1) and K125/127/129 for BRCA1/BARD1 (H2ABRCA1). Ubi-
quitination on any of these sites has distinct biological outcomes.   
H2APRC1 ubiquitination has a well-known role in transcriptional regulation12,13. There is ac-
cumulating evidence that this function extends to the DNA damage response, where tran-
scriptional silencing around a break site might be necessary for faithful repair14,15. Ubiqui-
tination on H2ABRCA1 is thought to increase the extent of DNA end resection by recruiting 
SMARCAD1 for 53BP1 repositioning16. This long-range DNA end resection primes the cell for 
repair through one of the homologous recombination pathways. Ubiquitination on H2A168 
on the other hand limits end resection by recruiting 53BP1 (TP53BP1),  which establishes 
an early resection block that will result in repair through non-homologous end joining17,18. 
Though ubiquitination of the individual sites can be linked to certain biological responses, 
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ultimately the integration over the ubiquitination status over all three ubiquitination sites is 
likely a guiding factor in the DNA damage response3 
The distinct contributions of the three different ubiquitination sites to the biological out-
comes highlight the importance of lysine specificity of the three E3 ligases involved and thus 
the importance of understanding the molecular details that determine specificity. A crystal 
structure of a RING1B/BMI1-E2 fusion protein in complex with a nucleosome core particle 
(NCP) explains how specificity for H2APRC1 is achieved19  but fails to explain why RNF168 
and BRCA1/BARD1 modify a different group of lysines. Previous studies showed that the 
nucleosomal acidic patch is crucial for efficient ubiquitination of H2A by RNF16820,21 but the 
exact molecular details remain unsolved. We aim to close this knowledge gap by providing 
structural information for a RNF168-E2-NCP complex. 
The RNF168-E2-NCP complex is a transient, low affinity complex, which makes it difficult 
to analyze with current methods in structural biology. In fact, this is true for many different 
E3-target complexes. Sample heterogeneity of low affinity complexes poses a problem for 
both cryo EM and protein crystallography, thus stabilizing a transient protein-protein com-
plex is crucial for successful structure resolution. Established ways of stabilizing transient 
protein complexes, which have long been used in different disciplines of structural biology, 
are chemical crosslinking and the genetic fusion of different complex members. Chemical 
crosslinking has been used in cryo-EM to address sample heterogeneity22, in mass spec-
troscopy to probe conformational flexibility and protein-protein interaction sites23,24 and in 
crystallography to trap transient complexes25,26. 
Crosslinking and fusion strategies have been employed successfully to stabilize multi-pro-
tein complexes in the ubiquitin/ubiquitin-like system for structural analysis. Cysteine-cys-
teine crosslinking was used to crystallize PCNA in complex with a SUMO-loaded E2 and the 
E3 ligase Siz127. The E2 was charged by introducing a lysine close to the active site to which 
SUMO was readily conjugated by Siz1, leaving the active site cysteine unoccupied. The tar-
get lysine on PCNA was mutated to a cysteine, making it possible to crosslink the active site 
cysteine to the target ubiquitination site using ethanedithiol (EDT). In another study the 
structure of an E1-E2 complex was solved by activating the E2 active site cysteine for disul-
fide formation using 2,2-dipyridyldisulfide and then mixing with E1. The resulting disulfide 
linkage between the two active sites helped to stabilize the complex28. 
Here we outline strategies to stabilize the RNF168-E2-NCP complex to make structural stu-
dies more feasible. We expand on and combine several different published strategies for 
complex stabilization and crosslinking techniques that involve E2-E3 fusion constructs29, cy-
steine-cysteine crosslinking27,30 and E3-ubiquitin fusion proteins19. We believe the overall 
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approach can easily be generalized and could serve as a blueprint for structural studies on 
transient E3-target complexes in the ubiquitin field. 
Results  
To obtain structural information that could inform on the unique specificity of RNF168 we 
set out to crystallize RNF168 in complex with its cognate E2, UBCH5C (UBE2D3), and a re-
combinant nucleosome core particle (NCP). We decided to use UBCH5C charged with ubi-
quitin to get a more complete picture of the complex in its pre-conjugation state. To stably 
charge UBCH5C with ubiquitin we used a published strategy5 involving an E2 mutant where 
the active site cysteine is mutated to a lysine (UBCH5CC85K). That allows stable conjugation 
of ubiquitin to the E2 active site at high pH (Fig.1A). Following this approach we were able 
to charge UBCH5CC85K efficiently with ubiquitin and separate it from uncharged UBCH5C and 
free ubiquitin (Fig.1B). RNF168 (residues 1-113) and reconstituted recombinant nucleosome 
core particles (NCPs) were produced according to established protocols20,31, which yielded 
sufficient quantities and purity to start crystallographic trials. Trials were set up in molar 
ratios of 2:2:1 (RNF168:UBCH5C:NCP) and standard commercial screens were used.
It soon became apparent that the transient nature of the interactions prevented us from 
obtaining stable complexes suitable for crystallography. Diffracting crystals could be obtain-
ed but only for single components (E2, NCP), never for the whole complex. Therefore we 
sought to develop strategies to stabilize the complex. Analogous to a study on RING1B/
BMI119, we designed an E3-E2 fusion, i.e. RNF168-UBCH5C fusion protein to increase af-
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finity for the nucleosome. We defined the boundaries of the construct by superimposing 
a structure of the RNF168 RING domain (PDB:4GB0) on the RING1B RING domain in the 
RING1B-UBCH5C fusion construct used for crystallizing the RING1B/BMI1-UBCH5C_NCP 
complex (PDB: 4R8P)(Fig.2A). We decided to use RNF168 residues 1-94 fused to full length 
UBCH5C via a short linker with the amino acid sequence SGSGS to allow for a certain degree 
of flexibility. The RNF168-UBCH5C fusion protein (RNF168fusion) expressed well in E.coli and 
was readily purified (Fig.2B) to allow biochemical characterization. We tested the activity 
of the construct in H2A ubiquitination assays and found that it ubiquitinates H2A more ef-
ficiently than RNF1681-113 (Fig.2C). Comparison of the affinities of the fusion construct vs. 
RNF1681-113 towards the NCP by native gel-shift assays shows that RNF168fusion binds with an 
estimated tenfold higher affinity (Fig.2D). Activity and binding assays taken together suggest 
that the RNF168-E2 fusion improves complex stability. We proceeded with crystallization tri-
als which did not yield diffracting crystals. We speculate that the RNF168fusion-NCP complex 
is still of a too transient nature and we searched for ways to further stabilize the complex. 
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We turned to crosslinking strategies to literally trap the 168-E2 fusion construct on the nu-
cleosome. Crosslinking of cysteine residues with dichloroacetone (DCA)  has been used to 
produce non-hydrolysable ubiquitin-histone mimics30. We adapted this strategy to produce 
non-hydrolysable RNF168fusion-NCP crosslinks (Fig.3A). To this end we mutated one of the 
RNF168 target lysines (K13) to a cysteine and reconstituted NCPs containing this mutant 
H2A (NCPK13C). The rationale being that the active site cysteine (C85) of the E2 in the E2-E3-
target complex will be positioned in close proximity to the lysine targeted for ubiquitination 
(K13 or K15). By mutating K13 to cysteine we would then be able to crosslink the E2 active 
site to C13 on H2A using DCA (Fig.3A). 
We analyzed crosslinking time courses using different concentrations of DCA (Fig.3B) to find 
optimal crosslinking conditions. RNF168fusion can indeed be crosslinked to H2A in nucleo-
somes as evident by the shifting of the RNF168fusion band towards a higher molecular weight, 
corresponding to the addition of one H2A molecule, and the disappearance of the band cor-
responding to H2A (Fig.3B). We aimed for conditions where most of the H2A is crosslinked 
but no unspecific byproducts are formed. The most promising conditions in this regard were 
10 minutes of crosslinking with 50 μM DCA. We scaled up the reaction under these conditi-
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ons and were successful in purifying the crosslinked complex from free RNF168fusion (Fig.3C). 
Nucleosomes crosslinked to RNF168fusion however could not be separated from unmodified 
nucleosomes due to the relative small difference in size. We used the purified material for 
crystallization trials but no diffracting crystals could be obtained so far.    
Parallel to the crosslinking approach we followed another strategy to stabilize the 168-E2-
NCP complex. A recent study showed that ubiquitin can be fused to E3 ligases29 while re-
taining the enzymes functionality. This fusion protein can then be conjugated, or conjugate 
itself, to target protein lysines and helped to identify cellular targets of E3 ligases29. We 
extended this approach by including UBCH5C, creating a RNF168-UBCH5C-Ubiquitin fusion 
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protein (RNF168fusion2). The rationale behind this approach is that RNF168fusion2  will follow 
the regular ubiquitination cascade (E1 activation, E2-ub thioester formation, E3 activated 
discharge to target lysine) and as such conjugate itself to H2A K15 via the free C-terminus of 
the ubiquitin within the fusion construct (Fig.4A). RNF168fusion2 expressed well and was rea-
dily purified to a degree of purity suitable for crystallographic studies (Fig.4B). We tested the 
activity of the construct in H2A ubiquitination assays and found that RNF168fusion2 is indeed 
conjugated to H2A, as evident by a shift of the band corresponding to RNF168fusion2 towards 
a higher molecular weight (Fig4C). Importantly, activity is only observed in the presence of 
E1, showing that RNF168fusion2 follows the canonical ubiquitination cascade. At longer time 
points a considerable amount of unspecific, higher molecular weight bands forms. These 
might correspond to H2A modified at several individual lysines or/and RNF168fusion2 chains 
formed by conjugation of one RNF168fusion2 to one of the available lysines on another fusion 
protein. Analysis on native gel (Fig.4D) shows that NCPs are still intact after conjugation of 
RNF168fusion2. Five minutes into the reaction most NCPs are modified with one or two mo-
lecules of RNF168fusion2. At longer time points NCPs with more than two fusion proteins are 
also observed. 
One nucleosome is expected to be modified by two RNF168fusion2 as each nucleosome is 
composed of  two of each of the four histones and it’s structure resembles a symmetrical 
disc with two nearly identical faces. To reduce sample heterogeneity to a minimum, conditi-
ons where all of the NCPs are modified with two 168-E2-Ub molecules (i.e. one RNF168fusion2 
on each face of the NCP) would be most desirable for crystallographic studies. A five minute 
conjugation reaction seems to give the least heterogeneity under the conditions tested. 
Still, even under these conditions roughly one third of the NCP are unmodified, one third are 
modified with one 168-E2-Ub and another third carries two 168-E2-Ub. This sample hetero-
geneity will likely complicate the growth of diffraction grade crystals. Nonetheless we scaled 
up the reaction and were able to purify NCPs with 168-E2-Ub conjugated via size exclusion 
chromatography. Crystallographic trials are ongoing.
Discussion
Transient, low affinity, multi-protein complexes are  notoriously difficult to analyze using 
current methods in structural biology and structural information for many is missing. RING 
E3 ligase-target complexes are often of a transient nature, yet structural information of the-
se is crucial to establish a clear picture of the molecular mechanisms of regulation of ubiqui-
tin-driven signaling networks. Given the importance of the ubiquitin system for many cel-
lular processes and its significance in disease and treatment32 there is a need to study basic 
mechanisms of the enzymes involved. That establishes a necessity for tools to stabilize these 
complexes and make them accessible for structural analysis. Here we have described vari-
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ous strategies to stabilize transient E3 ligase-target complexes for structural analysis using 
the RNF168-UBCH5C-NCP complex as example. We believe the approaches presented are 
easily transferable to other RING E3 ligase-target complexes where ubiquitination is specific 
for a certain lysine. Furthermore, stabilization of these complexes and reduction of sample 
heterogeneity in the way presented is not only crucial for crystallography but also helpful 
for cryo-EM.   
Lysine specific RING E3 ligase stabilize the ubiquitin-charged E2 in a conformation prone for 
catalysis and at the same time orient the E2 active site towards the target lysine4–9 . As such, 
the catalytic cysteine of the E2 should always be oriented towards the target lysine in the 
E3-E2-target complex. It follows that the presented combination of E3-E2 fusion protein and 
cysteine-cysteine crosslinking should, in theory, work for any E3-E2-target complex, given 
the target lysine is mutated to a cysteine. In practice, such an approach will be limited by the 
ability to produce soluble fusion proteins that retain lysine specificity and by the extent of 
cross reactivity of these fusion proteins with other cysteine residues on the target protein. 
Similarly, the approach using a E3-E2-ub fusion protein should, in theory, work for any spe-
cific E3-E2-target pair if functional and lysine specific fusion protein can be produced. Here 
additional limitations are the ability of the fusion protein to participate in the canonical 
ubiquitination cascade and the propensity to form ubiquitin chains (i.e. chains of the fusion 
protein). Strong autoubiquitination activity of the E3 ligases studied is also a likely limitation.
Sample homogeneity is an important parameter for success in both, cryo-EM and crystal-
lographic studies. For both approaches mentioned above the optimization of the reaction 
conditions to achieve crosslinking or conjugation of one fusion protein per target and the 
subsequent purification of the trapped E3-E2-target complex from the individual compo-
nents will likely play an important role in successfully solving these structures.
To draw useful conclusions from the crosslinked structure and extrapolate to interpret the 
underlying biology of the native protein complexes it is crucial that the geometry of the 
native complexes is accurately reflected in the crosslinked situation. Previous studies have 
pointed out that the choice of the right crosslinker is important to maintain the native ge-
ometry of a E3-E2-target complex27. For the PCNA/SUMO/SIZ1/UBC9 complex the authors 
first used BMOE as a crosslinker to stabilize the complex but later switched to using EDT 
instead, as it more accurately reflects the length of the actual tetrahedral intermediate of 
the ubiquitination reaction. Here we use DCA which will lead to a crosslinked structure that 
is one atom longer than the natural tetrahedral intermediate. Compared to EDT, DCA pro-
vides the benefit of creating an irreversible crosslink. EDT crosslinks can be reduced and 
thus reversed. Nonetheless, the one atom in length difference might make  a difference in 
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complex geometry and using EDT instead of DCA should be explored further.      
If successful, the combination of both approaches presented here can have a powerful im-
pact as they can be used to solve structures of different states of the ubiquitination reaction. 
The crosslinked complex likely resembles most closely the conformation of the E3-E2-target 
complex when the target lysine would attack the charged E2-ub thioester bond, just befo-
re conjugation. The E3-E2-ub fusion construct conjugated to the target lysine would likely 
resemble the conformation just after catalysis, which would in fact be the enzyme-product 
complex. Comparison of these two states will provide valuable information on subtle diffe-
rences in the architecture of the enzyme-substrate and the enzyme-product complex. For 
enzyme-target complexes of pharmacological interest these subtle differences can be of po-
tential use in the design of compounds to modulate either one of these two different states. 
Material and Methods
Protein production
RNF1681-113 was cloned in pGEX6p vector and purified as described before20. 
hUBA1, ubiquitin and UBCH5C (wildtype and mutant) were purified as described before33.
RNF168fusion and RNF168fusion2 were cloned into the petNKI-his3c-LIC-amp vector34. BL21 cells 
were transfected and grown in LB medium until a OD of ~0.8 was reached. Protein expres-
sion was then induced with 200 μM IPTG and the protein was expressed overnight at 18 °C. 
The cells were harvested and lysed by sonication in 50 mM TRIS pH 7.5, 500 mM  NaCl, 1 
mM TCEP, 1 μM ZnCl
2
. The lysate was cleared by spinning at 21000 x g and the supernatant 
was loaded on to chelating sepharose charged with Ni2+. The beads were washed with lysis 
buffer + 20 mM Imidazol and protein was eluted with lysis buffer + 350 mM Imidazol. The 
His-tag was cleaved overnight using His-tagged 3C protease while dialyzing against 50 mM 
TRIS pH 7.5, 250 mM NaCl, 1 mM TCEP, 1 μM ZnCl
2.
. After cleavage of the tag, the sample 
was run over Ni2+- charged chelating sepharose to remove the protease and uncleaved pro-
tein, concentrated and gel-filtered using a Superdex S75 16/60 column in 50 mM TRIS 7.5, 
150 mM NaCl, 1 mM DTT, 1 μM ZnCl
2
.
Histone proteins were purified as described previously31 and nucleosomes were reconsti-
tuted by salt dialysis31. Briefly, refolded histone octamers containing the desired mutant (or 
wildtype) H2A at a concentration of 7 uM were combined with equimolar concentration 
of 147 bp DNA containing the ‘Widom 601’ sequence35 at 2 M NaCl. The sample was then 
dialyzed against 400 ml of a buffer containing 50 mM TRIS pH 7.5, 2 M KCl, 1 mM EDTA and 
5 mM 2-mercaptoethanol for at least 3 hours. Then the salt concentration was gradually 
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decreased from 2 M KCl to 250 mm KCl over the course of 48 hours. The sample was then 
dialyzed for at least 4 hours against 50 mM TRIS pH 7.5, 150 mM KCl and 1 mM DTT, concen-
trated and stored at 4 °C.      
Charging of UBCH5CC85K
Charging of the UBCH5CC85K mutant with ubiquitin was done as described previously5. 200 
μM of UBCH5CC85K were incubated with 1 μM hUBA1, 200 μM ubiquitin and 3 mM ATP in 
30 mM TRIS pH9.5, 150 mM NaCl, 0.8 mM TCEP and 5 mM MgCl
2
 for 20 hours at 35 °C. The 
charged E2 was purified using a Superdex S75 column in 50 mM TRIS pH 7.5, 150 mM NaCl, 
0.5 mM TCEP.  
Crosslinking of RNF168fusion to NCPs
One day before the actual crosslinking experiment NCPK13C at 20 μM were reduced using 1 
mM DTT and then dialyzed over night against at least two changes of 1 l of 50 mM TRIS pH 
7.5, 150 mM NaCl  to remove the DTT.
For small scale test reactions 10 uM reduced NCPK13C were incubated with 20 uM RNF168fusion 
for twenty minutes. Then 10, 25 or 50 uM of Dichloroacetone (DCA) dissolved in Dimethy-
lformamide (DMF) were added and the reaction was stopped after 1, 5, and 10 minutes by 
adding 5 mM DTT. Samples were analyzed by SDS-Page.
For large scale reactions 10 uM reduced NCPK13C were incubated with 20 uM RNF168fusion for 
20 minutes and then crosslinked by adding 50 uM of DCA. The crosslink reaction was stop-
ped after 10 minutes by adding 5 mM DTT. The crosslinked sample was then purified by size 
exclusion chromatography on a Superdex S200 column (GE healthcare) in 50 mM TRIS pH 
7.5, 150 mM NaCl and 1 mM DTT . 
NCP ubiquitination with RNF168fusion2
10 μM recombinant NCPs were mixed with 20 μM RNF168fusion2 and 1 μM hUBA1. The reac-
tion was started by adding 3 mM ATP and stopped after 2, 5, 15 and 30 minutes for small 
scale test reactions and after 5 minutes for large scale preparations by adding 25 mM EDTA. 
NCPs ubiquitinated with RNF168fusion2 were purified by size-exclusion chromatography using 
a Superdex S200  column in 50 mM TRIS pH 7.5, 150 mM NaCl, 1 mM TCEP.      
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Ubiquitination is a posttranslational modification that regulates a vast array of cellular sig-
naling pathways. Ubiquitin is attached to specific lysine residues on target proteins following 
an enzymatic cascade including E1, E2 and E3 enzymes. Substrates can get monoubiquiti-
nated or modified with ubiquitin chains of different linkage types by conjugating one ubi-
quitin to one of the available lysine residues on another. Depending on which residues are 
modified with which type of modification the signaling outcome can be very different. K48 
chains, for example, lead to proteasomal degradation1. In the event of a DNA double strand 
break different monoubiquitination events and the formation of K63-linked chains are ne-
cessary to initiate and sustain the DNA damage response2,3. 
Tight regulation of the ubiquitin system is crucial to prevent short-circuiting the cell. The right 
lysines need to be ubiquitinated at the right time to assure that proteins are only degraded 
when needed and signaling cascades are only initiated and propagated when appropriate. 
Selective modification of lysines is not only achieved by the intrinsic substrate preferences 
of the enzymes involved but also by the balance that is struck between ubiquitination and 
deubiquitination. The main players responsible for specificity of the system are E3 ligases 
and deubiquitinating enzymes (DUBs). The E3 ligases facilitate lysine selection for the ubi-
quitin conjugation reaction, the DUBs assure selective deubiquitination. Furthermore there 
is competition for access to substrates with other interacting proteins and cross-regulation 
through PTMs other than ubiquitination. Intrinsic substrate specificity, relative protein le-
vels and cross-talk with other PTMs thus guide the lysine specific ubiquitination response. 
The focus of this thesis is on ubiquitination of histone H2A (H2A) and its role in regulating 
the DNA damage response. Three ubiquitination sites have been identified on H2A, lysines 
13/15 (K15), lysines 118/119 (K119) and lysines 125/127/129 (K127) 4–6. We address how 
the enzymes involved in ubiquitinating and deubiquitinating these sites achieve specificity 
and how this affects the double strand break response. 
Specificity of E3 ligases
In chapter 4 we studied the specific ubiquitination of K15 on H2A by the RING E3 ligase 
RNF168. We were able to show that the target, the nucleosome, plays a crucial role in this 
reaction7. An intact acidic patch on the nucleosome surface is necessary for efficient ubi-
quitination of K15. Charge-neutralizing mutations of five acidic residues on the nucleosome 
surface abolish K15 ubiquitination but, curiously, these mutations do not interfere with bin-
ding of RNF168 to the nucleosome. This suggests a more direct involvement of the substrate 
in the reaction. It seems the nucleosomal acidic patch participates in a form of substrate-as-
sisted catalysis by promoting the discharge of ubiquitin from the charged E2 to the target 
lysine. How is this substrate assisted catalysis achieved? An intact acidic patch might be 
necessary to facilitate proper orientation of the E3-E2 complex towards the target lysine to 
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enable the nucleophilic attack on the thioester bond in the E2 active site after initial recog-
nition of the nucleosome.  
Another explanation for the disconnect between RNF168’s recruitment and activity is a di-
rect involvement of residues of the acidic patch in catalysis. In the most generic mechanism 
of substrate-assisted catalysis one residue on the target acts as active site residue in the 
enzyme 8. The acidic patch on the nucleosome could potentially activate the target lysine, 
a task usually fulfilled by aspartic acid 117 (D117) of the E29. The distance from the acidic 
patch to the target lysine however makes this an unlikely scenario unless a major confor-
mational change were to occur that brings the lysine closer to the acidic patch. There is 
also no obvious reason why D117 should be impaired in its function in the UBCH5C-RNF168 
complex as E3-E2 interaction sites are conserved among RING E3s10. 
It seems more likely that the substrate organizes the correct positioning of the E2-E3-com-
plex. A similar behavior has been observed for the APC/C complex, where the degron motif 
on the substrate enhances the catalytic rate of ubiquitination by facilitating a productive 
orientation of the enzyme11. Although in this case the degron motif also enhances affinities. 
Substrate-assisted catalysis has been reported for various different enzyme-substrate com-
plexes. It plays a role in the peptide bond formation catalyzed by the ribosome12,13, in GT-
Pases8,14, mono-ADP-ribosylation15 and restriction endonucleases8, among others. It might 
represent an evolutionary artifact of early catalytic mechanisms that have been replaced, 
for most reactions, by the evolution of highly specialized enzyme active sites12. Others sug-
gest it as a mechanism for promiscuous enzymes to achieve a certain degree of substrate 
specificity16. This could be an attractive model for the ubiquitin system where E3 ligases are 
presented with the task of choosing the right residue to modify among the vast amount 
of potentially available lysines. A ’licensing’ residue on the correct substrate could act as a 
safety check, preventing ubiquitination of unlicensed sites. This licensing residue could have 
an active role in catalysis (e.g. acting as a general base) or a more indirect function such as 
inducing conformational changes in the E3-substrate complex to allow conjugation. 
USP48 counteracts BRCA1 signaling and is regulated by an auxiliary ubiquitin
In chapter 3 we test a subset of DUBs for specificity towards the three different ubiquiti-
nation sites on H2A. Most of the DUBs tested show little substrate preference, but USP48 
turned out to be specific for the BRCA1 site. In vitro BRCA1 ubiquitinates three adjacent 
lysines (K125,127 and 129) on the nucleosome core particle (NCP). Kinetic modelling using 
the software KinTek explorer17,18 allowed us to dissect USP48’s activity towards NCPs with 
one, two or three independent lysines modified. 
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USP48 shows a clear preference for NCPs that are modified on more than one lysine, the 
activity towards monoubiquitinated NCPs is very low. The affinities of USP48 towards NCPs 
of different ubiquitination status are basically the same. This suggests a regulatory mecha-
nism where an additional ubiquitin close to the target site is needed to activate USP48. We 
termed this an ‘auxiliary ubiquitin’ as it aids catalysis but does not get cleaved itself. It is not 
clear yet how USP48 activation is achieved. Repositioning of USP48 by the auxiliary ubiquitin 
towards the target ubiquitination site is one possible mechanism that might enhance cata-
lytic rates. Another possibility is the release of autoinhibition, as has been shown for OTU-
LIN, a DUB cleaving linear ubiquitin chains. In order to release autoinhibition the proximal 
ubiquitin of OTULIN’s substrate needs to make specific contacts with the enzyme20. A similar 
relief of autoinhibition would be possible for USP48. Analogous to RNF168 activation by the 
acidic patch, activation of USP48 by the auxiliary ubiquitin is not achieved due to a change 
in affinities, indicating that a direct role of the substrate in ubiquitination reactions might 
be a more general feature in the ubiquitin system. The substrate could function by inducing 
catalytically competent conformations of the enzymes involved or could have a direct role 
in catalysis.   
Another question that remains is where on H2A the auxiliary ubiquitin needs to be placed in 
order to activate. It could be on one specific, or any, of the three lysines of the BRCA1 site. 
Future research needs to establish if one of these lysines is designated for the auxiliary ubi-
quitin and another one acts as the signaling entity or if it is a random process where either 
one of two ubiquitinated lysines can activate cleavage of the other. 
The identification of the auxiliary ubiquitin adds to the growing repertoire of regulatory 
mechanisms to modulate DUB activity21. USPs in particular seem to be in need of regulation 
as most are rather promiscuous with respect to their substrate choice. The work presented 
in chapter 3 shows that most of the USPs tested can cleave all three ubiquitination sites on 
H2A. When presented with di-ubiquitins of different linkage types as a substrate USPs are 
also not very selective22. It should be stressed though, that unspecific cleavage of di-ubi-
quitins does not necessarily mean that there is no specificity towards longer chains. The 
topology of longer chains cannot be accurately recapitulated by only two ubiquitins. Con-
sequently, di-ubiquitins are missing features that may be crucial for specific recognition by 
DUBs. Studies on linkage preference of DUBs towards longer chains are needed to address 
this point. For USP48 it remains to be shown if the activation by an auxiliary ubiquitin is 
a substrate specific mechanism that only applies to the BRCA1 site on H2A, or a broader 
regulatory mechanism that allows USP48 to cleave different substrates with multi-monou-
biquitinated lysines. A similar mechanism has been observed for USP14, which cleaves su-
pernumerary chains (chains on at least two lysines on one substrate) of proteasome bound 
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substrates23, and it will be interesting to work out similarities and differences in activity 
regulation between these enzymes.  
Regulation of the DNA damage response by site specific H2A ubiquitination
Chapter 2 discusses how ubiquitination of different sites on the nucleosome guides the dou-
ble strand break response. Very generally, ubiquitination of H2A by RNF168 on lysine 15 
promotes repair through NHEJ, ubiquitination by BRCA1/BARD1 triggers HR-repair and PRC1 
ubiquitination of lysine 119 leads to transcriptional silencing. USP48’s involvement in this 
regulation illustrates nicely how site specificity of a deubiquitinating enzyme directly trans-
lates to a unique biological outcome. USP48 cleaves one of the three distinct ubiquitination 
sites on H2A, the BRCA1 site. By doing so it regulates the extent of DNA end resection, the 
first step in HR repair24. Loss of USP48 causes opposite phenotypes compared to loss of 
BRCA1 function, indicating that both enzymes work in the same pathway but in opposite 
directions. The function of BRCA1 is to promote DNA end-resection25 while USP48 seems 
to limit it.
But how does site specific ubiquitination and deubiquitination of the nucleosome transla-
te into regulation of DNA end-resection? One important mechanism is the recruitment of 
downstream effectors. K15 ubiquitination on H2A serves as a binding platform for 53BP1, 
a protein that acts as a DNA-end resection block, which promotes repair through NHEJ26,27. 
H2A ubiquitination by BRCA1 on the other hand recruits the chromatin remodeler SMAR-
CAD125, which leads to displacement of 53BP1 away from the break site. 53BP1 displace-
ment allows long range resection, which promotes repair by HR. If SMARCAD1 is a direct 
interactor of ubiquitinated nucleosomes or if SMARCAD1 recruitment is dependent on ad-
ditional mediators is not known. 
In the model we propose in chapter 3, USP48 and BRCA1 are competing with each other 
to regulate HR by defining the length of resected DNA around a break site. The length of 
DNA-end resection is set by the extent of H2A ubiquitination on the BRCA1 site, which is de-
fined by the relative activities of the specific E3 and DUB. Whenever possible, the preferred 
way of DNA double strand break repair is through gene conversion, the error-free and least 
mutagenic repair pathway28. For gene conversion to take place, DNA-end resection needs 
to be fine-tuned to a defined length. Resection should be long enough to allow homology 
search, but should not exceed a certain length to avoid mutagenic single strand annealing28. 
BRCA1 and USP48 likely play an important role in this fine tuning mechanism. This means 
the activity of both enzymes needs to be restricted to a defined area around the break site. 
Close to the break BRCA1 needs to be active to facilitate 53BP1 displacement and drive 
end-resection. USP48 needs to counteract BRCA1-induced H2A ubiquitination and establish 
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the resection block at a distance from the break far enough to allow gene conversion, but 
short enough to prevent single strand annealing. To achieve this, the activity of BRCA1 and 
USP48 must be tightly regulated, possibly on different levels. Selective recruitment to areas 
at a defined distance to the break, activity modulation by interacting proteins, and relative 
protein levels are likely candidate mechanisms for this regulation.
Our discovery of an auxiliary ubiquitin necessary for full USP48 activity opens up an inte-
resting possibility for an alternative regulatory mechanism. It is tempting to speculate that 
this auxiliary ubiquitination might be placed on the polycomb site, on K119 of H2A. H2A 
ubiquitinated by PRC1 would then act as an on-switch to activate USP48 for cleavage of 
the BRCA1 ubiquitination site. It would be an elegant mechanism, where crosstalk between 
two different ubiquitination sites regulates the damage response, albeit conclusive experi-
mental evidence for this mechanism is still missing. This crosstalk would also suggest that 
DNA-repair through HR pathways is shut down in polycomb-silenced areas of the genome. 
It is possible that in these areas the maintenance of the silenced state has top priority and 
overwrites the need for error-free DNA repair. BRCA1-induced ubiquitination and chromatin 
remodeling during HR repair might disrupt the silenced state of chromatin and as such may 
need to be disabled by K119 ubiquitination in polycomb-silenced regions. 
Targeting the ubiquitin system
The lysine specificity of the ubiquitin system makes it an interesting drug target for precision 
medicine. At the same time it is hard to exploit this specificity for therapeutic purposes, 
as many signaling cascades are guided by RING E3 ligases, enzymes lacking an active site. 
Targeting E1 or E2 enzymes through their active sites has had some success29 but E1s and 
E2s contribute to modification of a wide range of unrelated substrates which can give rise to 
unwanted side effects. To enable precision targeting of the ubiquitin system the lysine-spe-
cificity of the E3 ligases needs to be leveraged, a particular challenge if the enzyme to be 
targeted lacks an active site. Unique enzyme-substrate interaction sites or mechanisms of 
allosteric regulation could be exploited to interfere with RING E3 ligase activity. This has 
been a successful strategy to target the p53 pathway, where the small molecule nutlin-3a 
disrupts the interaction of p53 and MDM230. Outside the ubiquitin field the remarkable suc-
cess of BET-inhibitors shows not only the potential of targeting protein-protein interactions 
but also the importance of epigenetic modification as potential drug targets31–34. BET inhi-
bitors prevent bromodomains from binding chromatin by mimicking the shape of acetylated 
lysines on histone tails, the natural binding partner of bromodomains33. To identify leverage 
points of this kind in the ubiquitin system, high resolution structures of E3-substrate and 
E3-interactor complexes are crucial. The trapping strategies that are presented in chapter 5 
will help to solve structures of otherwise transient E3-substrate complexes and will help to 
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identify unique interaction sites.
As a whole, this thesis aims to help discern the rules governing site specific ubiquitination 
of H2A. We have provided tools that will help to solve structures of E3-substrate complexes 
and uncovered an active role of the substrate in the E3-ligase reaction. Our analysis of DUB 
specificity has shown an intriguing mechanism of USP48 activity regulation by ubiquitin it-
self. Building and expanding on these early results it may at some point be possible to iden-
tify the ‘Achilles heel’ of different H2A ubiquitination and deubiquitination reactions and 
exploit those weaknesses for therapeutic intervention.  
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Summary
Ubiquitination describes the conjugation of the small protein ubiquitin to a target protein 
lysine residue, following an enzymatic cascade involving three different groups of enzymes, 
ubiquitin activating enzymes (E1), ubiquitin conjugating enzymes (E2) and ubiquitin liga-
ses (E3). Ubiquitination can be lysine specific and specificity is conferred by the E3 ligases. 
Ubiquitination of histone H2A is one of the many different posttranslational modifications 
guiding the DNA damage response. H2A can get ubiquitinated at three distinct groups of 
lysines by three different E3 ligases. RNF168 ubiquitinates lysine 15, RING1B/BMI1 in a PRC1 
complex ubiquitinates lysine 119 and BRCA1/BARD1 ubiquitinates lysines 125/127 and 129. 
Which particular site is modified in a given situation will determine downstream signaling. 
The work presented in this thesis provides conceptual and mechanistic insights into the 
biology of lysine specific H2A ubiquitination and deubiquitination.
Chapter 2 reviews the current understanding of the biology of H2A ubiquitination. We de-
scribe how site specificity is achieved on a molecular level and how ubiquitination on the 
three different sites will trigger different signaling pathways. We describe readers, writers 
and erasers of H2A ubiquitination and put forward a concept of signal integration, where 
the final biological outcome is determined through integration over the three ubiquitination 
sites and in crosstalk with other posttranslational modifications.
Since the E3 ligases acting on H2A show such a remarkable site specificity we decided to 
study lysine selective deubiquitination of DUBs acting on H2A. In chapter 3 we tested a sub-
set of DUBs and find USP48 to be specific for the BRCA1 site on H2A. We show that USP48 
knockdown results in increased DNA end resection and increased 53BP1 foci formation, 
opposite phenotypes compared to the loss of BRCA1. USP48 knockdown only has an effect 
if BRCA1 is active, indicating that both work in the same pathway. Our accumulating evi-
dence suggests a model where BRCA1 drives DNA end-resection by ubiquitinating H2A and 
USP48 counteracts this activity. On a mechanistic level we describe a novel way of regulating 
USP48’s activity through an ‘auxiliary ubiquitin’. This auxiliary ubiquitin needs to be placed 
adjacent to USP48’s target ubiquitination site in order for the enzyme to be fully active. The 
auxiliary ubiquitin does not get cleaved itself.
In chapter 4 we study ubiquitination of H2A on lysine 15 by RNF168 and describe an active 
role of the substrate in the ubiquitination reaction. An intact acidic patch on the nucleo-
some surface is necessary for efficient ubiquitination of lysine 15. Disruption of the acidic 
patch results in loss of RNF168 activity but does not abolish binding. This suggests a form of 
substrate assisted catalysis where the acidic patch on the nucleosome functions either by 
repositioning the enzyme after initial binding or by actively participating in catalysis.
High resolution structures of E3-substrate complexes are important to understand the mo-
lecular mechanisms that determine lysine specificity. These complexes, however, are mostly 
transient in nature, which makes them hard to analyze with current methods of structural 
biology where sample heterogeneity is a disadvantage. In chapter 5 we describe methods to 
stabilize E3-substrate complexes using crosslinking strategies and fusion proteins.     
Chapter 6 discusses the results presented in  this thesis, puts them in a broader perspective 
and points out future directions. In summary, this thesis contributes mechanistic insight into 
site specific ubiquitination of H2A and illustrates how modification of selective lysines can 
translate into regulation of the DNA damage response.
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Samenvatting
Ubiquitination is het koppelen van het kleine eiwit ubiquitine aan een lysine van een ander 
eiwit, het zogenoemde target eiwit. Deze ubiquitinatie wordt uitgevoerd door een enzyma-
tisch stappensysteem met drie verschillende groepen eiwitten: ubiquitine activerende en-
zymen (E1), ubiquitine conjugerende enzymen (E2) en ubiquitine ligases (E3). Het koppelen 
of conjugeren van ubiquitine aan een bepaalde lysine kan heel precies gebeuren en deze 
specificiteit wordt gereguleerd door de E3 ligases. 
Ubiquitinatie van het histoneiwit H2A is een van de vele verschillende, posttranslationele 
modificaties die de signalering bij DNA schade dirigeren. H2A kan worden ubiquitineerd op 
drie verschillende groepen lysines door drie verschillende E3 ligases. RNF168 ubiquitineert 
lysine 15 (K15), RING1B/BMI1 uit het PRC1 complex ubiquitineren lysine 119 (K119) en het 
complex met BRCA1 en BARD1 kunnen lysines 125, 127 en 129 van een ubiquitinemodifi-
catie voorzien. Welke lysine er precies wordt ubiquitineerd hangt af van de situatie en is van 
belang voor de daaropvolgende signalering. Het werk in deze thesis geeft zowel conceptuele 
als mechanistische inzichten in de biologie van de lysine-specificiteit van H2A-ubiquitinatie 
en –deubiquitinatie.
Hoofdstuk 2 geeft een overzicht van de huidige staat van het onderzoek naar de biologie 
achter H2A ubiquitinatie. We beschrijven op moleculair niveau hoe de specificiteit voor een 
bepaalde lysine wordt bereikt en wat de gevolgen zijn van deze ubiquitinatie voor de daa-
ropvolgende signaleringscascades van elk van de drie mogelijke ubiquitinatieplekken. We 
beschrijven eiwitten die de ubiquitinatie kunnen uitlezen, aanbrengen of juist verwijderen 
en postuleren een model hoe deze signalen in het grote geheel passen. Dit model beschrijft 
hoe de biologische uitkomst wordt bepaald door samenspel van de drie ubiquitinatieplek-
ken naast andere posttranslationele modificaties.
Aangezien de E3 ligases een opmerkelijke specificiteit hebben voor een bepaalde ubiquiti-
natieplek wilden we onderzoeken of het verwijderen van de ubiquitine van H2A door deu-
biquitinerende enzymen (DUBs) ook zo specifiek is. In hoofdstuk 3 hebben we hiervoor een 
subset van verschillende DUBs getest en vonden we dat USP48 specifiek is voor de plek 
die door BRCA1 wordt geubiquitineerd. We laten zien dat het uitschakelen (knockdown) 
van USP48 in de cel zorgt voor langere resectie van het DNA einde en een verhoging in de 
formatie van 53BP1 foci: beide observaties zijn tegengesteld aan het fenotype dat wordt 
geobserveerd als BRCA1 is verwijderd uit de cel. Het uitschakelen van USP48 in de cel heeft 
alleen effect als BRCA1 actief is, iets wat aangeeft dat beide in dezelfde signaleringscascade 
werken. Deze observaties tezamen leiden tot een model waarin BRCA1 de resectie van DNA-
eindes aanjaagt en waarin USP48 deze activiteit tegengaat.  Verder hebben we ontdekt hoe 
de activiteit van USP48  op een mechanistisch niveau wordt gereguleerd door een extra 
ubiquitine als hulpmiddel. Deze ‘hulpubiquitine’ moet dichtbij de locatie van het doelwit 
van USP48, de BRCA1 ubiquitinatieplek, zitten om ervoor te zorgen dat USP48 volledig actief 
is en wordt hierbij niet zelf verwijderd van zijn lysine.
In hoofdstuk 4 bestuderen we hoe RNF168 lysine 15 van histon H2A ubiquitineert en bes-
chrijven we de belangrijke rol van het substraat in de ubiquitinatiereactie. Een regio op het 
nucleosoom met vele negatief geladen aminozuren (acidic patch) blijkt essentieel om de 
ubiquitinatie op lysine 15 efficiënt te laten verlopen. Als deze regio wordt ontwricht verni-
etigt dat de ubiquitinatie-activiteit van RNF168 alhoewel RNF168 nog wel kan binden. Dit 
suggereert een type katalyse waarbij het substraat  meehelpt an de reactie. De acidic patch 
op het nucleosoom kan hierbij helpen door het enzym goed te positioneren na de initiële 
binding of door actief mee te helpen aan de katalyse.
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Om de moleculaire mechanismen achter de lysinespecificiteit te begrijpen zijn structuren, 
het liefst hoge resolutie, van complexen van E3s met substraat van groot belang. Deze com-
plexen bestaan vaak echter maar kortstondig; dit maakt het bestuderen ervan erg lastig. Bij 
de huidige methoden in de structuurbiologie is heterogeniteit een groot nadeel. In hoofd-
stuk 5 beschrijven we manieren om de E3-substraat complexen te stabiliseren door de ei-
witten chemisch aan elkaar te conjugeren of door het creëren van fusie-eiwitten.
In hoofdstuk 6 worden tenslotte de resultaten uit dit proefschrift bediscussieerd en bekeken 
in een bredere context. Dit resulteert ook in mogelijke (onderzoeks)richtingen voor de toe-
komst. Samenvattend: deze thesis draagt bij aan het begrip en inzicht in de mechanismen 
achter de specifieke ubiquitinatie van H2A en illustreert hoe deze specifieke modificatie zich 
vertaalt naar de regulatie van de cellulaire respons op DNA schade.
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